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ABSTRACT 
Introduction:  Developing countries are experiencing a double burden of malnutrition, with 
persistently high levels of stunting and micronutrient deficiencies combined with an increasing 
prevalence of childhood overweight and obesity. South Africa is no exception with both 
stunting and overweight prevalence above 20% in children under five years of age. The Global 
Targets on Nutrition call for a 40% reduction in stunting and no increase in childhood 
overweight by 2025. In order to develop effective interventions to achieve these targets, an 
understanding of the determinants of childhood stunting and overweight is required. 
Longitudinal birth cohort studies have provided evidence that a variety of maternal and infant 
factors are implicated in the development of childhood overweight and obesity. These studies 
have been conducted predominantly in developed countries with very little evidence coming 
from a developing country setting where overweight and stunting coexist, sometimes in the 
same child. 
The ongoing MACE longitudinal birth cohort study, conducted in the city of Durban, was 
designed to determine the effect of pollution exposure on childhood respiratory development.  
Longitudinal anthropometric and dietary intake data of infants as well as maternal and 
household information has been collected. This data, collected between 2013 and 2017, were 
used in the current MSc Dietetics study to investigate factors associated with overweight and 
stunting at 12 months of age in participating infants.  
Objectives:  
1. To describe the prevalence of stunting and overweight at 12 months of age in infants enrolled   
in the MACE study.  
2. To describe the maternal and household characteristics of the study infants and to determine 
their association with the growth outcomes of stunting and overweight at 12 months. 
3. To describe birth anthropometrics, and patterns of growth from 0-6, and 6-12 months, and 
to determine their associations with growth outcomes at 12 months. 
4. To describe infant feeding practices at 6 and 12 months and to determine their association 
with growth outcomes at 12 months. 
Methods: Secondary analysis was performed using anthropometric, infant feeding, and 
maternal and household information collected by MACE study staff from 290 infants at 12 
months of age. An additional infant feeding questionnaire, adapted from the World Health 
Organization (WHO) Infant and Young Child Feeding (IYCF) Indicators was administered to 
a subset of 94 mothers attending the 12 month follow up visit. Anthropometric data were 
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entered into the WHO Anthro programme and used to determine prevalence of stunting and 
overweight in the study infants at 12 months and to describe growth patterns in the first year 
of life. Anthropometric information of 144 study infants who had reached the age of 24 months 
by the end of the data collection process was also included. Statistical techniques were used to 
determine the association of maternal and household factors, infant growth patterns, and 
feeding practices, with the outcome variables of stunting and overweight at 12 months of age.  
Results:  Prevalence of stunting at 12 months was 5.9% while there was a combined 
overweight and obesity prevalence of 21.7%. By 24 months both stunting and overweight had 
increased to 10.4% and 26.6% respectively. The households were predominantly low income 
with half reporting an annual income of R2000 or less but virtually all had access to tap water 
and electricity. Maternal HIV prevalence was 35%. Only type of housing was associated with 
growth outcomes; infants living in informal housing were significantly more likely to be 
severely stunted or overweight than those living in formal, detached houses (p=0.048). By 6 
months of age over half of the infants were receiving infant formula, with HIV positive mothers 
significantly more likely to formula feed than HIV negative mothers (p<0.0005). 
Complementary feeding was started before 6 months by 50% of mothers. Assessment of 
complementary feeding practices at 12 months using the IYCF Indicators showed a lack of 
dietary diversity and only 30% of infants achieved the Minimum Adequate Diet (MAD) 
Indicator. Regular intake of inappropriate foods was common. There was however no 
association of feeding practices with growth outcomes. There was a significant association of 
growth patterns with growth outcomes at both 12 and 24 months. Infants who were stunted at 
12 and 24 months had lower birth weights and lengths and slower linear growth between 6 and 
12 months. Infants with higher birthweight and greater weight gains, especially in the 6-12 
month period, were more likely to be overweight at both 12 and 24 months. BMI at 12 months 
was strongly predictive of BMI at 24 months. 
Conclusion:  In this urban longitudinal birth cohort, stunting prevalence was fairly low while 
overweight prevalence was high. Low socioeconomic status (SES) was associated with both 
severe stunting and overweight. The link between birth weight and length and stunting and 
birth weight and overweight emphasises the need for optimal nutrition and care during 
pregnancy to prevent both outcomes. Poor infant feeding practices were common, but 
unexpectedly there was no association with growth outcomes. However, the fact that growth 
during the 6-12 month period is most strongly associated with later growth outcomes indicates 
that further investigation of complementary feeding practices, collecting more detailed 
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information from a larger sample, is warranted. Follow up of the study infants at 4-5 years to 
determine if early growth patterns remain significant in later childhood is recommended. 
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 INTRODUCTION TO THE PROBLEM AND ITS SETTING 
  Importance of the study                                                                                                                 
Low and middle-income countries (LMICs) are increasingly facing a double burden of 
malnutrition (Black et al., 2013).  In 2014 the number of stunted children globally was 159 
million while 41 million children under five were overweight or obese (UNICEF et al., 2015). 
While stunting rates are decreasing, childhood obesity is increasing, with the prevalence in 
Africa doubling in the last 20 years (WHO, 2013). In recognition of this problem the World 
Health Organisation (WHO), in its 2025 Global Targets for  maternal, infant and young child 
nutrition, called for a 40% reduction in the number of children under 5 who are stunted and no 
increase in the proportion of children who are overweight (WHO, 2012).  
 
South African children have high levels of stunting and overweight/obesity while  
micronutrient deficiencies, particularly Vitamin A deficiency, remain a problem (Shisana et 
al., 2013).  The South African National Health and Nutrition Examination Survey 
(SANHANES) from 2012 revealed a national prevalence of both stunting and overweight at 
above 20% in children under five years of age (Shisana et al., 2013), with stunting rates 
showing little or no signs of improvement from earlier surveys (Said-Mohamed et al., 2015). 
Overweight prevalence appears to be increasing (Kruger et al., 2012; Labadarios et al., 2005) 
although determining trends in both stunting and overweight is made difficult because different 
growth standards and age ranges were used across the surveys (Said-Mohamed et al., 2015; 
Bosman et al., 2011). 
 
Both stunting and overweight have short and long term consequences for the individual. 
Further, at a national level they have an impact on the economy through decreased productivity 
and increased health care costs (Black et al., 2013). The short term consequences of stunting 
include increased morbidity and mortality, with a severely stunted child having four times the 
risk of death compared to a non-stunted child (Black et al., 2008). For those children that 
survive, the consequences can be far reaching and can leave them trapped in a cycle of poverty 
and malnutrition, that is often transferred into the next generation  (Dewey & Begum, 2011).   
 
Childhood overweight can delay motor development in infancy which can lead to reduced 
physical activity thereby creating a vicious cycle (Slining et al., 2010).  In later childhood 
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overweight can lead to lack of confidence and poor self-esteem which can persist into 
adulthood (Rossouw et al., 2012)  The main concern however, is its association with adult 
obesity and NCD risk which is especially a concern in LMICs with limited health care budgets 
(WHO, 2016a; Black et al., 2013).  Childhood stunting and overweight are linked and they can 
coexist in the same community, household and even in the same child. Poor growth in the first 
few years of life may also lead to a short but overweight adolescent at risk of chronic diseases 
in adulthood (Black et al., 2013; WHO, 2013).  
 
Identifying the determinants of stunting and overweight is vital for the development of effective 
prevention strategies. The importance of maternal nutrition and nutrition in the first two years 
of life, the period known as the first 1000 days, for the prevention of stunting, and other forms 
of undernutrition, was highlighted in the Lancet Special Series on Maternal and Child 
Undernutrition in 2008 (Black et al., 2008). Five years later, the 2013 Lancet Series on 
Maternal and Child Nutrition reemphasised the importance of the first 1000 days, extending it 
into the female adolescent period. Furthermore, the 2013 Series acknowledged the growing 
problem of overweight in LMICs and the importance of good nutrition during this crucial time 
for preventing both stunting and overweight  (Black et al., 2013). The 2013 Series also 
emphasised the need to include nutrition sensitive- as well as nutrition specific interventions1 
in order to address the underlying social determinants of malnutrition (Black et al., 2013). 
 
Complex social determinants are a feature of both forms of malnutrition. Poor socioeconomic 
conditions, low levels of maternal education and repeated infections, particularly diarrhoea, are 
closely linked to stunting and explain why nutrition specific interventions alone have had 
disappointing results (de Onis et al., 2013). Childhood overweight, while associated with low 
socioeconomic status (SES) in high income countries (HICs) (Olds et al., 2011), was 
                                                 
1 ”Nutrition specific interventions- address the immediate determinants of fetal and child nutrition and 
development- adequate food and nutrient intake, feeding, caregiving and parenting practises, and low burden of 
infectious diseases eg micronutrient supplementation, breastfeeding promotion. 
Nutrition sensitive interventions-address the underlying determinants of fetal and child nutrition and 
development—food security; adequate caregiving resources at the maternal, household and community levels; 
and access to health services and a safe and hygienic environment—and incorporate specific nutrition goals and 
actions” (Ruel&Alderman, 2013) 
 
3 
 
 
previously linked to higher SES in LMICs (Black et al., 2013) but this appears to be changing. 
The most recent South African DHS of 2016 illustrates this with the highest prevalence of both 
stunting and overweight in the lowest quintile of SES (DoH et al., 2017).  
 
Birthweight and rate of growth in infancy and early childhood have also been implicated in 
poor growth outcomes. Low maternal BMI and short stature are associated with restricted 
foetal growth and low birthweight  (LBW) in their offspring which, together with poor growth 
in the first 2 years of life, are major determinants of stunting (Black et al., 2013).  On the other 
hand, maternal pre-pregnancy BMI >30kg/m2  is associated with increased risk of obesity in 
the child (Black et al., 2013). The Avon Longitudinal Birth study, conducted in the United 
Kingdom, linked childhood obesity to eight factors including parental obesity, high birthweight 
and rapid weight gain in the first year of life (Reilly et al., 2005). The importance of rapid 
weight gain in the infancy period as a predictor of later obesity was confirmed in a number of 
subsequent studies (Druet et al., 2011; Taveras et al., 2009; Ong & Loos, 2006), including a 
2015 South African study that linked it to a lack of breastfeeding (Ramokolo et al., 2015).  
 
Poor infant and young child feeding practices, which include lack of exclusive breastfeeding 
and poor complementary diets, together with a food system that fails to deliver sufficient 
amounts of nutritious foods, can lead to both stunting and overweight (WHO, 2013). Many 
LMICs have experienced a rapid nutrition transition; from a traditional diet based on unrefined 
grains and legumes to one that is comprised largely of cheap, highly processed, energy dense 
but nutrient poor foods. Healthier, nutrient dense foods such as vegetables, fruit, lean meats 
and fish are expensive and often not available in rural areas (Igumbor et al., 2012; Popkin et 
al., 2011). This contributes to poor complementary diets characterised by low dietary diversity 
and high intakes of inappropriate snack foods such as “crisps” or fizzy drinks (Faber et al., 
2016). Although a number of studies have investigated the association of breastfeeding with 
stunting and overweight, the role of poor complementary feeding practices has been less well 
explored. 
 
Longitudinal birth cohort studies are important tools to investigate early life risk factors for 
later disease, including later childhood stunting and overweight (Lawlor et al., 2009). The high 
cost of conducting these studies, together with logistical issues, means that there have been 
very few LMIC birth cohort studies conducted (Batty et al., 2007). There is therefore a dearth 
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of information on the determinants of stunting and overweight in countries where both forms 
of malnutrition are present. Ongoing at the time of this MSc study, the Mother and Child in the 
Environment (MACE) longitudinal birth cohort study, conducted in Durban, KwaZulu-Natal 
province, provided a valuable opportunity to explore the association of a range of potential risk 
factors with stunting and overweight. Although the MACE study was designed to determine 
the effect of ambient and environmental pollution exposure on childhood respiratory 
development, anthropometric data at a number of time points, together with information on 
sociodemographic factors and infant feeding practices was collected. This data, with additional 
complementary feeding information collected by the researcher, were used to investigate early 
life determinants of overweight and stunting in the study infants.  
 
The longitudinal data provided by a birth cohort study allows for the investigation of a number 
of research questions: 
 What is the prevalence of stunting and overweight in this cohort of urban children at 12 
months of age? 
 Do childhood stunting and overweight share common sociodemographic risk factors?  
 Given the high prevalence of antenatal HIV infection in KZN, is there an association 
between HIV exposure and growth outcomes at 12 months? 
 Are there specific times in early infancy when linear growth faltering or rapid weight gain 
are particularly significant for later stunting and overweight? 
 Are poor infant feeding practices such as lack of breastfeeding, early introduction of solid 
foods, lack of dietary diversity and consumption of inappropriate snack foods associated 
with both stunting and overweight? 
 
It was anticipated that this study would provide important information regarding the 
anthropometric status of infants living in an urban/peri urban community. Furthermore, the 
study would provide information on patterns of growth in the first year allowing for the 
identification of critical time periods most predictive of later stunting or overweight. This 
information can inform growth monitoring practices in the wider community. The results of 
this study will help to describe infant feeding practices in this population and identify those 
practices associated with poor growth outcomes. It is anticipated that the findings of this study 
may assist in the development of effective strategies to address the double burden of 
malnutrition.  
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 Statement of the problem 
The purpose of this study was to determine the prevalence of stunting and overweight in the 
MACE study infants at 12 months of age. Furthermore, it aimed to make use of the longitudinal 
data provided by a birth cohort study to explore associations between early life factors and the 
growth outcomes at 12 months. Although not in the original objectives, due to the longitudinal 
nature of the study, 24 month data became available for 144 infants and was included in the 
study. 
   Research objectives 
This study set out to achieve the following objectives using infants enrolled in the MACE 
study: 
1.3.1 To describe the prevalence of stunting and overweight at 12 months of age in infants 
enrolled in the MACE study.  
 To describe the prevalence of stunting and overweight at 24 months of age in those 
infants enrolled in the MACE study who had 24 month data.  
1.3.2 To describe the maternal and household characteristics of the study infants and to 
determine their association with the growth outcomes of stunting and overweight at 12 months. 
1.3.3 To describe birth anthropometrics, and patterns of growth from 0-6, and 6-12 months, 
and to determine their associations with growth outcomes at 12 months. 
 To determine the association of patterns of growth with growth outcomes at 24 months, 
in those infants with 24 month data. 
1.3.4 To describe infant feeding practices at 6 and 12 months and to determine their association 
with growth outcomes at 12 months. 
 
 Hypotheses 
It was proposed that: 
1)  Poor breastfeeding practices were associated with stunting and overweight. 
2)  Lack of dietary diversity was associated with stunting and overweight. 
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 Inclusion and exclusion criteria 
 MACE study inclusion and exclusion criteria 
The inclusion criteria for the MACE study were as follows: 
 Pregnant women of less than 18 weeks’ gestation. 
 Residents within a 5km radius from the clinic and monitoring station who would remain 
in this area for the full duration of the pregnancy, and for the follow-up period of 5-6 
years. The children, from the pregnancy of interest, would reside in the communities 
for the duration of follow up.  
 Women who tested positive or negative for human immunodeficiency virus (HIV) 
during their routine antenatal testing were included in the study.  
 
The exclusion criteria for the MACE study were as follows: 
 Participating females with any complications during pregnancy including hypertension, 
diabetes, placenta praevia or genital tract infections, or other complications that would 
result in adverse growth effects on the foetus. 
 
 MSc Dietetics study inclusion and exclusion criteria 
For the purpose of this study the inclusion criteria were as follows: 
 Pregnant women and their infants who met the MACE study inclusion criteria. 
 MACE study infants who had attended the 12 month follow up between 2013 and 2017. 
 
For the purpose of this study the exclusion criteria were as follows: 
 Pregnant women excluded from the MACE study 
 Infants born preterm, defined as < 37 weeks gestation. 
 
 Definitions  
 
Complementary feeding:   “the process starting when breast milk alone is no longer 
sufficient to meet the nutritional requirements of infants, and 
therefore other foods and liquids are needed, along with breast 
milk” (PAHO/WHO, 2003).  
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Exclusive breastfeeding:  “the infant receives only breast milk. No other liquids or solids 
are given, not even water, with the exception of oral rehydration 
solution, or drops/syrups of vitamins, minerals or medicines” 
(WHO, 2001).   
HIV exposed infant:  infant born to an HIV positive mother (DoH, 2015a). 
HIV positive infants:  positive DNA-PCR test (DoH, 2015a). 
HIV positive mothers:  positive rapid test (DoH, 2015a). 
Low birthweight infants:     birthweight < 2500g. 
Mixed feeding: “infant receives both breastmilk and any other food or liquid 
including water, non-human milk and formula before 6 months 
of age.”  (WHO, 2001). 
Overweight children:  WHO- BMI for Age > +2 Z-score (WHO, 2006). 
    IOTF-BMI for Age > age specific cut off (Cole, 2000). 
Obese children:   WHO- BMI for Age > +3 Z -score (WHO, 2006). 
                             IOTF- BMI for Age > age specific cut off (Cole, 2000). 
Stunted children:    Length/Height for Age < -2 Z- score (WHO, 2006). 
Severely stunted children:  Length/Height for Age < -3 Z score (WHO, 2006). 
Wasted children:   Weight for length < -2 Z score (WHO, 2006). 
Severely wasted children: Weight for length < -3 Z score (WHO, 2006). 
Z score:   The number of standard deviations a data point is from the mean. 
    (WHO, 2006). 
 
 Abbreviations 
ARV:   Antiretroviral 
ART:    Antiretroviral Therapy 
BAZ:     BMI for age Z score  
BMI:   Body Mass Index 
DEXA:  Dual-energy X-ray absorptiometry 
DHS:   Demographic and Health survey 
HAART:  Highly Active Antiretroviral Therapy 
HAZ:   Height for age Z score 
HIC:    High income country 
HIV:   Human Immunodeficency Virus 
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HFS:   High fat snack 
IRF:   Iron rich food 
IYCF:   Infant and Young Child Feeding 
IOTF:   International Obesity Task Force 
KZN:   KwaZulu-Natal 
LFA:   Length for age 
LAZ:   Length for age Z score 
LBW:   Low birthweight 
LMIC:   Low and middle income country/ies 
MACE:  Mother and Child in the Environment 
MAD:   Minimum adequate diet 
MDD:   Minimum dietary diversity 
MMF:    Minimum meal frequency 
PMTCT:   Prevention of Mother to Child Transmission 
SES:    Socioeconomic status 
SSB:    Sugar sweetened beverage 
TDF:    Tenofovir 
WFA:    Weight for age 
WAZ:    Weight for age Z score 
WFL/H:   Weight for length/height 
WFLZ:   Weight for length Z score 
WHO:    World Health Organization 
UNICEF:   United Nations Children’s Fund 
 
 Assumptions  
The following assumptions were made: 
 All MACE fieldworkers had been trained thoroughly. 
 All anthropometric measurements were accurately taken by the trained fieldworkers. 
 The fieldworkers asked the questions in a standardised manner. 
 The participants were honest with their answers. 
 The birth anthropometric details and HIV status information that were collected from 
clinic records were reliable. 
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 Summary 
South Africa has a double burden of malnutrition with national surveys reporting rates of both 
childhood stunting and overweight above 20%. The consequences of both forms of 
malnutrition can be far reaching and have an impact at an individual and national level. Stunting 
and overweight both have a complex set of determinants. Identifying these determinants is 
important in order to develop effective prevention strategies. Longitudinal birth cohort studies 
are the most powerful research tools to investigate potential determinants but very few have 
been conducted in LMIC settings where there is a high prevalence of both stunting and 
overweight. The MACE birth cohort study provided an opportunity to use longitudinal data to 
investigate the association of a number of potential maternal, sociodemographic and infant 
factors with growth outcomes at 12 months of age. It was envisaged that the findings of this 
research could be used in the development of appropriate intervention strategies within the 
larger population. 
 
 Dissertation overview 
This dissertation consists of six chapters. The first chapter discusses the importance and 
relevance of the study and presents the study objectives. The second chapter reviews the 
literature regarding the global and South African prevalence of childhood stunting and 
overweight and the trends over time. The consequences, determinants and prevention strategies 
are also discussed. The third chapter discusses the methodology used in the study and the 
results of the statistical analyses are presented in the fourth chapter. The fifth chapter discusses 
the results, placing them in the context of the literature presented in chapter two. Chapter six 
concludes the dissertation, discusses the limitations of the study and makes recommendations 
for further research. 
 
 Referencing style 
This dissertation has been written using the Experimental Agriculture referencing style. 
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 LITERATURE REVIEW 
 Introduction 
Low and middle income countries (LMICs) are still faced with problems related to 
undernutrition such as stunting and micronutrient deficiencies (Black et al., 2013). However, 
in recent years there has been a significant increase in childhood overweight. The WHO Global 
Targets on maternal, infant and young child nutrition highlight this double burden of both over- 
and under nutrition in LMICs. Out of six global targets to be achieved by 2025, the first is a 
reduction of stunting in children under five by 40%; while the fourth target calls for no increase 
in childhood overweight (WHO, 2012). These targets have also been incorporated into the 
Sustainable Development Goals (SDGs), set by the United Nations in 2015, which includes, 
among others, a call for an end to malnutrition in all forms by 2030, and the prevention and 
control of non-communicable diseases (WHO, 2015). 
 
Both stunting and overweight have short- and long term consequences with effects persisting 
even into the next generation (Black et al., 2013). They both have foetal and early life 
determinants. Prevention requires a multi-dimensional approach including nutrition 
interventions that target the first 1000 days from conception to two years of age (WHO, 2016a; 
Bhutta et al., 2013) 
 
This review will describe the prevalence and trends of stunting and overweight, both globally 
and in South Africa, as well as their consequences. Their determinants will be explored, 
focusing on the postnatal period of the first 1000 days.  Interventions targeting this stage of life 
will also be discussed. 
  
 Childhood stunting and overweight: global trends and distribution 
While stunting affects approximately four times as many children globally than overweight or 
obesity, the rate is declining, whereas childhood overweight is increasing (UNICEF et al., 
2015).  In 2014 the number of stunted children under five years of age was 159 million, which 
represents an estimated 23.8% prevalence, a decline of 37% since 1990.  In the same time 
period the number of children under five who were overweight or obese increased from 31 
million to 41 million, an increase in prevalence from 4.7% to 6.1%  (UNICEF et al., 2015).  
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In the past, childhood obesity was a problem only associated with high-income countries 
(HICs) but due to the nutrition transition2, it is increasingly becoming a problem in LMICs  
(Black et al., 2013). In many communities in these countries stunting and overweight coexist, 
sometimes even in the same child (Dietz et al., 2015). According to WHO (2013) “Both 
stunting and overweight can be linked to a food system that fails to deliver quality food”, with 
energy dense but nutrient poor foods cheap and widely available (Igumbor et al., 2012). Global 
patterns of stunting and overweight will now be discussed in more detail.  
 
 Stunting 
While both stunting prevalence and the numbers of stunted children are declining, Asia still 
has the highest number of stunted children, due to its large population (de Onis et al., 2013). 
India alone is home to more than one third of the world’s stunted children. Latin America and 
the Caribbean have also seen declines in the number of stunted children but in Africa the 
number of stunted children has actually increased as a result of a very limited drop in the 
prevalence combined with an increase in the number of young children in the region (Black et 
al., 2013; de Onis et al., 2013). This is illustrated in Figure 2-1, which shows regional trends 
in the prevalence of stunting as well as the numbers of stunted children from 1990 projected to 
2025.  
 
 
                                                 
2 Nutrition transition- “ Large shifts have occurred in diet and physical activity patterns particularly in the last 
two decades of the 20th century. Modern societies seem to be converging on a diet high in saturated fats, sugar, 
and refined foods but low in fibre-often termed the “Western diet”- and on lifestyles characterized by lower levels 
of activity” (Popkin&Gordon-Lewis,2004). 
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Figure 2-1: Regional trends in stunting- prevalence and numbers: 1990-2025 (de Onis 
et al., 2013) 
 
Within countries there is great inequality in stunting rates. Global Demographic and Health 
Survey (DHS) data shows that children in the poorest quintile of households have 2.47 times 
the stunting prevalence of children in the richest quintile while prevalence in rural children is 
1.45 times that of  urban children (Black et al., 2013). Within the genders, boys have only a 
slightly higher prevalence of stunting than girls (Black et al., 2013). 
 
 Overweight and obesity 
Globally overweight and obesity in children 2-19 years of age  has increased by 47% from 
1980 to 2013  (Ng et al., 2014) and 41 million children under the age of five years (6.1%) are 
now overweight or obese. This is an increase of 10 million since 1990 (UNICEF et al., 2015). 
The prevalence of childhood overweight in HICs is 11.7% which is approximately double that 
of most LMICs at 6.1%. However, in terms of numbers, many more children in LMICs are 
affected and the rate of increase is of particular concern (WHO, 2016a; de Onis et al., 2010). 
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In the WHO Africa Region, the number of overweight children nearly doubled from 5,4 million 
to 10,3 million between 1990 and 2010 and it is estimated that 75% of overweight children  
now live in Asia and Africa (UNICEF et al., 2015).   
  
By contrast in HICs, although at very high levels, overweight and obesity prevalence in 
children and adolescents appears to be stabilising as shown in Figure 2-2 (Ng et al., 2014). This 
was corroborated by the NCD Risk Factor Collaboration which found a similar trend of recent 
stabilising of obesity prevalence in HICs in children and adolescents aged  5-19 years (Abarca-
Gómez et al., 2017).  Younger children appear to be following the same pattern. With the 
exception of England, a review of data from 18 European Union countries  found no evidence 
of increasing prevalence in infants and pre-school children (Cattaneo et al., 2010). In the United 
States, prevalence of obesity in 2-5 year olds actually decreased from 13.9% to 8.4% between 
the NHANES of 2003-2004 and that of 2011-2012 (Ogden et al., 2014). However, data from 
the most recent NHANES of 2015-2016 showed a sharp increase in prevalence of obesity in 2-
5 year olds from the 2011-2012 and 2013-2014 cycles (Skinner et al., 2018). 
   
 
Figure 2-2: Age standardised prevalence of overweight and obesity, and obesity alone,      
ages 2-19 years, by sex, 1980-2013      (Ng et al., 2014) 
 
In HICs prevalence of childhood overweight is higher in poorer communities with immigrant 
children at increased risk (Olds et al., 2011). Analysis of NHANES data over time shows a 
consistently higher prevalence of obesity in Hispanic and African American children and 
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adolescents (Skinner et al. 2018).  In LMICs there is a slightly higher prevalence in richest 
versus poorest quintiles and urban versus rural populations. Gender differences in prevalence 
rates tend to be small in children under the age of five years  (Black et al., 2013).  
 
Having outlined the global trends and distribution of childhood stunting and overweight, this 
review will now focus on patterns of malnutrition in South Africa.  
 
 Childhood stunting and overweight: South African trends and prevalence 
South Africa’s double burden of malnutrition is well illustrated by the results of the 
SANHANES-1 which reported stunting and overweight prevalence above 20% in children 
under the age of 5 years (Shisana et al., 2013). The anthropometric status of South African 
children has been documented in a number of national and regional surveys over the years. The 
results of national surveys are presented in Table 2-1 and those of regional surveys in Table 2-
2. Percentages that are emboldened in the table represent the prevalence of combined 
overweight and obesity. The tables are followed by a discussion of the trends in stunting and 
overweight prevalence.
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Table 2-1: Trends in childhood stunting and overweight in South Africa: National surveys (1994-2016) 
 
Study details Description of study Sample 
size 
Stunting 
prevalence 
(< -2 HAZ) 
Cut offs 
used 
Overweight and 
obesity prevalence 
Cut offs used 
SAVACG 1994 
(Labadarios and Van 
Middelkoop, 1995) 
National; cross sectional 
6 months -72 months 
 
10871 22.9% NCHS 
1977 
Not reported   
NFCS 1999 
(Labadarios et al., 2005) 
National; cross sectional 
1-9 years 
2613 21.6% 
25.5% (1-3 
years) 
 
NCHS 
1977 
17.1% 
12.1% overweight 
5% obese 
NCHS 1977 
Weight for 
length/height) 
NFCS 1999 
Secondary analysis using WHO 
2006 Growth Standards 
(Bosman et al., 2011) 
National; cross sectional 
12-60 months 
 
1512 17.1% 
 
 
20.1% 
NCHS 
1977 
 
WHO 
2006 
18.9% 
13% overweight 
5.9% obese 
30.1% 
20.6% overweight 
9.5% obese 
NCHS 1977 
(weight for 
length/height) 
WHO 2006 
(weight for 
length/height) 
NFCS 2005 
(Kruger et al., 2012) 
National; cross sectional 
1-9 years 
2157 20.7% WHO 
2006 
14% 
10%  overweight 
4% obese 
WHO 2006 
BMI for Age 
SANHANES-1 2013 
(Shisana et al., 2013) 
National; cross sectional 
0-5 years for stunting; 2-5 
years overweight and 
obesity 
1291 21.5% 
26.5% (0-3 y) 
17% (0-9y) 
WHO 
2006 
22.9% 
18.2% overweight 
4.7% obese 
IOTF 
BMI for Age 
cut-offs 
DHS 2016 
(DoH et al., 2017) 
National; cross sectional 
0-5 years 
1404 27% WHO 
2006 
13% WHO 2006 
(weight for 
length/height) 
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Table 2-2: Trends in childhood stunting and overweight in South Africa: Regional studies (1990-2016) 
Study details Description of 
study 
Sample size Stunting 
prevalence 
Cut offs 
used 
Overweight 
Prevalence 
Cut offs used 
Birth to Twenty 
cohort: 
1991-1992 
(Norris et al., 2009) 
 
Longitudinal 
birth 
cohort 
Johannesburg/ 
(urban) 
 
1221(12 
months) 
 
997 (24 
months) 
 
1162(60month
s) 
6.5%  12 months 
17.3%24 months 
5.6%  60 months 
 
7.8%  12 months 
26.5%24months 
9.1%  60 months 
NCHS  
1977 
 
 
WHO 2006 
7.5%  12 months 
6.1% 24 months 
3.5% 60 months 
 
10% 12 months 
12% 24 months 
1.3% 60 months 
NCHS 1977 
Weight for age 
 
 
WHO 2006 
Weight for age 
 
Central Region Limpopo: 
 2001 
(Mamabolo et al., 2004) 
(Mamabolo et al., 2005) 
Prospective birth 
cohort 
Rural villages in 
Limpopo 
156 (12 
months) 
 
162 (36 
months) 
34.6%12 months 
 
 
48%   36 months 
NCHS 1977 12.3% 12 months 
 
46% 36 months 
22%  ow 
24% obese 
19% ow and 
stunted 
NCHS 1977 
Weight for 
length/height 
 
IOTF 
HST/MRC survey 
2003 
(Lesiapeto et al, 2010) 
 
Cross sectional 
baseline survey 
0-60 months 
children 
OR Tambo and 
Alfred Nzo 
districts,, Eastern 
Cape; 
Umkanyakude 
and Zululand 
districts, KZN 
 
2485 23.5% 
 
 
28.6% 
 
NCHS 1977 
 
 
WHO 2006 
 
9.5% 
 
 
 
13.1% 
 
16.1% 
 
NCHS 1977 
Weight for 
length/height 
 
WHO 2006 
Weight for 
length 
 
BMI  
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Table 2.2 continued. 
Study details Description of study Sample size Stunting 
prevalence 
Cut offs 
used 
Overweight 
prevalence 
Cut offs 
used 
MRC    
(Faber and Benade, 2007) 
Cross sectional survey 
Rural KZN 
6-12 months infants 
505 16%  Epi Info 
 
23% Epi Info 
Weight for 
length 
Agincourt ; 2007 
(Kimani-Murage et al, 2010) 
Cross sectional survey 
Agincourt sub district, 
Mpumalanga Province 
Rural 
Children 1-4 years 
671 18% WHO 
2006 
8% 
7% overweight 
1% obese 
 
IOTF 
BMI for age 
Community Based Nutrition 
Security Project 
University of Stellenbosch 
2011 
(du Plessis et al , 2016) 
Cross sectional survey 
Vulnerable communities, 
Breede Valley sub 
district, Western Cape 
Province 
0-23 months infants 
312 28.8% WHO 
2006 
21.8% WHO 2006 
Weight for 
length 
Drakenstein Child Health Study  
2012-2014 
(Budree et al, 2017a; Budree et 
al 2017b 
Longitudinal birth cohort 
study 
Multi ethnic population, 
low resource district 
surrounding Paarl, 
Western Cape Province 
12 months infants 
342 13% WHO 
2006 
8% 
6% overweight 
2% obese 
WHO 2006 
BMI for age 
18 
 
 
 Stunting 
From the figures presented in Tables 2-1 and 2-2, South Africa can be classified as having a 
stunting prevalence of moderate public health importance (Gorstein et al., 1994). National 
surveys in Table 2.1 consistently show stunting prevalence in the 20-23% range, except for the 
DHS of 2016 which showed a prevalence of 27% in children under five years of age. Regional 
surveys have far greater variation in stunting prevalence ranging from 13% to 48% but mostly 
falling in the 20-30% range. Stunting prevalence shows variation across age groups and, given 
the inequity in South Africa, across location, socioeconomic status and race (Said-Mohamed 
et al., 2015). 
 
2.3.1.1 Variation of prevalence with age 
The variation in prevalence with age can be explained by the fact that human growth occurs in 
in four phases; foetal, infancy, later childhood and puberty so there is some potential for 
compensatory growth after the foetal and infancy phases (Luo & Karlberg, 2000). Prevalence 
of stunting will therefore be higher in infants and younger children who have experienced 
growth failure in the foetal and infancy stage but have not yet reached the later childhood 
growth phase. This rapid drop off in height followed by improvement in older children may be 
due to improved resistance to infections by the time children reach the childhood growth phase 
(Prentice et al., 2013). Repeated infections combined with poor infant and young child feeding 
and caring practices are the proximal causes of stunting (Black et al., 2008). There is also 
potential for catch up growth in adolescence due to reported delayed maturation and extended 
pubertal growth phase in children living in LMICs (Prentice et al., 2013).   
 
The cross sectional studies in Tables 2-1 and 2-2 consistently showed this variation with age. 
There was far higher stunting prevalence in the 0-3 years age group compared to older age 
groups in both the National Food Consumption Survey (NFCS) of 1999 and the SANHANES-
1. Stunting prevalence in SANHANES-1 decreased from 26% in the 0-3 year age group to 
9.4% in the 7-9 year age group. The Agincourt study found the highest prevalence of stunting 
in 1 year old infants (32%), decreasing to 20% in the 2 year olds. The lowest prevalence of 
stunting was 5% in the 5-9 year old children.  
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Longitudinal studies provide the best illustration of stunting variation with age. The trend of 
stunting peaking at age two to three years and then decreasing can be seen in the data from the 
Birth to Twenty longitudinal birth cohort study in Table 2.2. Stunting prevalence increased 
from 1 year (7.8%) to 2 years (26.5%) but decreased again by 5 years down to 9.1% which 
indicates that some catch up growth is possible after two years. The Limpopo birth cohort study 
also showed an increase of stunting prevalence from 34.6% at 1 year to 48% at 3 years. 
International longitudinal studies in LMICs report similar findings. The COHORTS 
(Consortium of Health Oriented Research in Transitioning Societies) collaboration included 
data from longitudinal birth cohorts in five LMICs; Brazil, Guatemala, India, Philippines and 
South Africa. The Birth to 20 cohort was the South African study in COHORTS. Height for 
age Z scores (HAZ) decreased rapidly from birth to 24 months and then improved modestly by 
four to five years of age in all the cohorts except India (Stein et al., 2010). Rural Gambian 
children also had the same pattern, with the lowest HAZ at 24 months before gradually 
increasing (Prentice et al., 2013).  
 
2.3.1.2 Variation of prevalence with gender, location, socioeconomic status (SES) and 
race 
Most of the South African surveys did not find a gender difference in prevalence of stunting. 
Although boys had a higher prevalence of stunting than girls in all age categories in 
SANHANES-1, the differences were not significant, but in the DHS 2016 boys had a 
prevalence of 30% vs 25% in girls. There was also no significant difference in children under 
5 in the Agincourt study while the HST/MRC study in rural KZN and Eastern Cape did find an 
increased risk of stunting in boys. 
 
Rural informal areas had the highest prevalence of stunting, followed by urban informal areas. 
This is illustrated in Table 2-2 by the high stunting prevalence in the rural Limpopo birth cohort 
of 48% by 3 years. The rural KZN and Eastern Cape communities in the HST/MRC study also 
had a high under 5 prevalence of 28.8%. Both areas experienced high levels of poverty and 
lack of infrastructure, with the HST/MRC study reporting that 75% of households did not have 
access to tap water and only 26% of households had electricity. 
 
Provincially stunting prevalence varies considerably between different surveys, making any 
conclusions difficult.  SANHANES-1 reported lower prevalence in Gauteng and KZN and the 
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highest prevalence in Eastern Cape, Free State and Northern Cape. In contrast Gauteng had the 
highest prevalence in the DHS with Northern Cape the lowest.  As stunting is strongly linked 
to poor socio economic status it is no surprise that DHS reported a stunting prevalence of 36% 
in children of the lowest quintile compared to 13% in children of the highest wealth quintile. 
In SANHANES-1, White and Indian groups were excluded due to low numbers while Coloured 
children had the highest prevalence of stunting compared with black African children. 
 
2.3.1.3 Trends in stunting prevalence from 1994 to 2016 
Interpreting trends in stunting over time by comparing results from different studies is 
complicated by: 
a) The use of different growth references. The United States National Centre for Health 
Statistics (NCHS) standards (Hamill et al., 1977) were used prior to the release of the 
WHO Growth References in 2006 (WHO, 2006). Stunting prevalence increases when 
using the WHO References as can be seen from secondary analysis performed on the 
1999 NFCS, Birth to Twenty and HST/MRC studies.  
 
b) A lack of consistency in age groups measured. The SAVACG study included  6 months-
72 months (6 years) infants and children, the NFCS (1999 and 2005) 1-9 year olds, 
SANHANES -1 used 0-14 years and the DHS used 0-5years. Prevalence of stunting 
using the SANHANES-1 0-9 years data gives a stunting prevalence of 17% which is a 
3.7% decrease from the NFCS 2005 of 20.7%. However, using the data from children 
under five years in SANHANES -1, which is in line with global and regional reporting, 
gives a stunting prevalence of 21.5%. As was discussed previously, stunting prevalence 
peaks at around 24 months so studies including children from older age groups, for 
instance 1-9 years, will tend to decrease stunting prevalence when compared with 
studies that only include children up to five years or younger. 
 
Despite these issues regarding comparisons between studies, South African stunting prevalence 
appears to have shown little, if any, improvement over time (Said-Mohamed et al., 2015) and 
remains above 20% for children under five at a national level. 
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 Overweight and obesity 
South Africa is also experiencing high levels of childhood overweight and obesity with the 
recent SANHANES-1 reporting overweight and obesity prevalence of 22.9 % in children aged 
2-5 years (Shisana et al., 2013). When referring to Tables2-1 and 2-2 it is difficult to discern a 
clear pattern in trends of prevalence over time due to the same issues encountered when 
describing stunting trends. These include lack of consistency in the growth references, and age 
categories, used across studies. The impact of these factors will be discussed in more detail in 
this section in order to evaluate the prevalence of overweight and obesity and trends over time 
as presented in tables 2-1 and 2-2.  
 
2.3.2.1 Defining overweight and obesity 
The lack of a standard definition of childhood overweight and obesity is of concern as it makes 
meaningful interpretation of prevalence trends very difficult. The various growth 
references/standards used in the studies in Tables 2.2 and 2.2 are shown in Table 2.3. 
 
Table 2-3: Overweight and Obesity Definitions 
Growth Reference Definition of Overweight Definition of Obesity 
NCHS 1977 (Hamill et al., 
1977) 
Children 2-18 years 
>+2 Z score 
Weight for length/height 
>+3 Z score 
Weight for length/ height 
IOTF (Cole et al., 2000) 
Children 2-18 years 
Age specific BMI cut offs 
Corresponding to BMI 
25kg/m2 at 18 years 
Age specific BMI cut offs 
Corresponding to BMI         
30 kg/m2 at 18 years 
WHO 2006 (WHO, 2006) 
Children 0-5 years 
>+2 Z score  
Weight for length/height or 
BMI for Age 
>+3 Z score 
Weight for length/height or 
BMI for Age 
 
Prior to 2000, surveys used the NCHS 1977 growth reference tables (Hamill et al., 1977).  
These, however, were developed using only American children. Many countries also had their 
own growth references which were used in national overweight prevalence studies, making 
comparisons between studies very difficult.  As childhood overweight is a serious public health 
problem, it is important that trends are monitored, which was difficult with no standard 
definitions and cut offs. In order to provide an internationally comparative standard the 
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International Task Force on Obesity (IOTF) published age and sex specific BMI cut off points 
for overweight and obesity for children from 2-18 years (Cole et al., 2000). These cut offs were 
created to correspond with BMI at 18 years of 25 and 30kg/m2 for overweight and obesity 
respectively. They were developed using data from almost 200 000 individuals aged from birth 
to 25 years in 6 countries; Brazil, Great Britain, Hong Kong, the Netherlands, Singapore and 
the United States (Cole et al., 2000). 
 
In 2006 the WHO released the WHO Child Growth Standards for children 0-59 months (WHO, 
2006). These were also internationally representative comprising data from children in 6 
countries; Brazil, Ghana, India, Norway, Oman and the USA.  They differed from previous 
growth references in that they were prescriptive; children had to be healthy, predominantly 
breastfed for at least 4 months and live in optimal environmental conditions. The standards 
therefore describe how children should grow when there are no constraints to their growth (de 
Onis, 2006).  
 
It must be noted that use of the WHO standard produces very difference prevalence rates of 
overweight and obesity in children under 5 years when compared to those obtained using the 
IOTF reference. This was demonstrated by comparing the prevalence of overweight and 
obesity from a national study in the Czech Republic using both the IOTF and WHO definitions. 
According to WHO charts the prevalence of overweight in girls at 5 years was 3.4% while it 
was 15.3% using IOTF cut offs (Monasta et al., 2011). The WHO justified a more cautious 
approach to defining overweight and obesity in younger children on a number of grounds. 
Firstly, younger children are still growing; secondly, the population used in constructing the 
standard was healthy and unhealthy weights for length/height were excluded; and thirdly, the 
potential risks of young children being placed on restrictive diets (De Onis and Lobstein, 2010). 
A concern with the WHO standard is that no BMI cut-offs that are associated with increased 
risk of overweight and obesity later in life have been identified in young children. This is unlike 
the IOTF cut offs which are based on an association with BMI of 25 and 30kg/m2 at 18 years 
(Monasta et al., 2011). 
 
The European Childhood Obesity Group recommended that, although it is not an ideal 
situation, both references should be used in prevalence studies in the absence of consensus on 
a common definition of obesity. They further recommend that the definitions and terms must 
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be clearly stated so that it is clear if the term overweight includes obesity (Rolland-Cachera, 
2011). As the IOTF reference is from 2-18 years, studies involving children younger than 2 
years must use the WHO standard (Cattaneo et al., 2010). A further consideration is the use of 
weight for length/height or BMI for Age to define overweight and obesity; prevalence is 
slightly higher using BMI. 
 
2.3.2.2 Review of South African studies of childhood overweight and obesity prevalence 
The studies presented in Tables 2-1 and 2-2 will now be discussed, examining the effect of 
different growth standards, age categories and other factors on reported prevalence. 
 
Variation in prevalence according to growth reference used 
An analysis of South African national trends over time as depicted in Table 2-1 shows the 
importance of comparing “apples with apples”. The SANHANES-1, using the IOTF cut-offs, 
found that almost one quarter of 2-5 year olds were overweight or obese (Shisana et al., 2013). 
This appears to be an increase from the 1999 and 2005 NFCS which reported combined 
overweight and obesity prevalence of 17.1% and 14% respectively in 1-9 year olds (Labadarios 
et al., 2005; Kruger et al., 2012). However, a reanalysis of the 1999 NFCS 1-5 year olds data 
using WHO 2006 references (weight for length) found a much higher overweight and obesity 
prevalence of 30.1%. Using the same one to five year old data but with the NCHS 1977 (weight 
for length) standards the prevalence was far lower at 18.9% (Bosman et al., 2011). The DHS 
2016 showed a decrease of over 10% from SANHANES-1 in the prevalence of overweight in 
children under five years (DoH et al., 2017).  This could perhaps be attributed to the use of 
WHO 2006 weight for length/height as opposed to the IOTF BMI cut offs used in 
SANHANES-1. The DHS also had a study population aged 0-5 years as opposed to the 2-5 
years in the SANHANES-1 and included relatively small sample sizes.  As can be seen, the use 
of different standards makes establishing a trend very difficult and it would appear that 
overweight prevalence has more than halved from the 1999 NFCS to the 2016 DHS, which is 
highly unlikely.  
 
Regional studies, as with stunting, have great variation in overweight prevalence from 
approximately 10% to just over 20%, with the Limpopo cohort being an outlier at 46%. The 
HST/MRC study in the Eastern Cape and KZN illustrates the problem of different growth 
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references. Overweight prevalence was 9.5% with NCHS 1977 standards; 13% and 16% with 
WHO 2006 weight for length and BMI for Age respectively.  
Variation in prevalence according to age of study population 
As with stunting, overweight and obesity prevalence also shows a pattern of peaking at around 
2 years of age and decreasing again by 5 years. This is illustrated by the Birth to Twenty 
longitudinal cohort. At the age of 2 years, 12% of children were overweight but this had 
decreased to 1.3% at 5 years. The Agincourt study, although not longitudinal, showed a 
decrease in combined overweight and obesity prevalence from 10% in 2 year olds down to 7% 
in the 5 year old children. Overweight prevalence starts to increase again in girls from about 
the age of 10 years (Kimani-Murage et al., 2010). The SANHANES-1 had the highest 
prevalence of overweight and obesity in the 2-5 years age group, with rates increasing again in 
10-14 year old girls (Shisana et al., 2013). 
 
Variation in prevalence according to gender, location and SES 
There is little difference between overweight prevalence in boys and girls in the under five 
years age group but older girls in both the SANHANES-1 and Agincourt study had more than 
double the prevalence of boys (Shisana et al., 2013; Kimani-Murage et al., 2010). Urban areas, 
both formal and informal, had higher prevalence of overweight and obesity compared to rural 
areas in SANHANES-1 (Shisana et al., 2013). When looking at the impact of SES, the 2016 
DHS had a very interesting finding of highest overweight prevalence in the poorest quintile 
and lowest prevalence in the highest quintile (DoH et al., 2017), a pattern typically seen in 
HICs. This was contrary to the Agincourt study which found a positive relationship between 
overweight and socio-economic status (SES), similar to other LMICs (Kimani-Murage, 2013).  
 
The prevalence of combined stunting and overweight 
The combination of overweight and stunting in the Limpopo longitudinal study is concerning 
as 19% of three year old children were both stunted and overweight (Mamabolo et al., 2005). 
Secondary analysis of the 1999 NFCS showed that stunting was the most significant risk factor 
for a child being overweight with a stunted child being twice as likely to be overweight than a 
non-stunted child (Steyn et al., 2005). A secondary analysis using NFCS 2005 data of children 
from Gauteng and Mpumalanga found a strong correlation between stunting and obesity with 
64.8% of obese children also being stunted. Only 13.6% of children in the normal and 
underweight group were stunted (Symington et al., 2016). Another South African survey of 
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952 rural Kwa-Zulu Natal schoolgirls aged 9-12 years found that 9.2% were stunted while 
8.5% were overweight and 3.8% obese. Of particular interest was the fact  that 22.9% of obese 
learners and 11.1% of overweight learners were stunted (Tathiah et al., 2013). 
 
The association between stunting and overweight was also demonstrated in a study looking at 
data from four countries; Russia, China, Brazil and South Africa (Popkin et al., 1996).  
Children who were stunted were at significantly greater risk of being overweight with adjusted 
risk ratios ranging from 1.7 in Brazil to 7.8 in Russia.  The Birth to 20 study also found 
significantly higher BMIs in stunted versus non stunted infants at two years of age, however 
this was not associated with higher subcutaneous fat scores.  The authors argued that the higher 
BMIs in these children did not reflect overweight or obesity but were as a result of the 
proportionally greater contribution of height to the BMI calculation as height squared is used 
as the denominator (Cameron et al., 2005). This study also showed no link between stunting at 
2 years and overweight at 9 years but this will be discussed further in the next section, 2.4.1.2. 
 
Trends in overweight prevalence 1994-2016 
Taking into account the confounding effects of variations in cut offs used and age of the study 
sample, there does appear to be an increasing trend in overweight and obesity prevalence in 
children under the age of 5 years.  The DHS survey prevalence of 13%, a decrease of 10% from 
the SANHANES-1 study prevalence, should perhaps be viewed as an outlier until confirmed 
by other national surveys.  
 
In summary, stunting and overweight in childhood are both highly prevalent in LMICs, and 
South Africa is no exception. The next section of this review will explore the consequences, 
both short and long term.  
 
 Consequences of childhood stunting and overweight 
Childhood stunting and overweight have short and long term consequences both at an 
individual and community/country level (Black et al.,2013; de Onis et al., 2013).  This section 
will describe the effect of stunting on child mortality and both human capital outcomes and 
adult NCD risk.  The increased risk for development of adult obesity and NCDs as a result of 
childhood overweight will also be discussed. 
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     Stunting 
Stunting has both short and long term consequences. The short term consequences are 
increased morbidity and mortality, with a severely stunted child having 4 times the risk of death 
compared to a non-stunted child (Black et al., 2008). For those children that survive, the 
consequences can be far reaching and can leave them trapped in a cycle of poverty and 
malnutrition (Dewey & Begum, 2011). 
 
2.4.1.1 Human capital outcomes 
In the longer term, stunting in childhood results in impaired cognitive development and reduced 
adult stature which both impact on earning ability and human development, often referred to 
as human capital (Victora et al., 2008).  Analysis of data from the COHORTS collaboration 
linked childhood stunting to poorer educational outcomes (Victora et al., 2008). The impact on 
cognitive development has been shown in South Africa using data from the National Income 
Dynamics Survey (NIDS). Stunted children started school later, completed fewer years of 
schooling and were more likely to have failed some grades (Casale, 2016). The effects on 
cognitive development appear to be irreversible as even those children in the Birth to 20 Cohort 
who were no longer stunted at 5 years, after having been stunted at 2 years of age, performed 
significantly worse on cognitive tests than children who had never been stunted. Their 
performance was very similar to children who had remained stunted (Casale & Desmond, 
2016). This is of particular concern when  considering the very high rates of stunting in 0-3 
year old children (26.5%) in SANHANES-1 (Shisana et al., 2013). Stunting appears to affect 
the brain in a number of ways including causing structural changes and reduced exploratory 
behaviour due to lack of energy as a result of undernutrition (Brown & Pollitt, 1996). 
 
Adult stature is most strongly linked to birth length and conditional length at 12 months 
according to analysis of the COHORTS data (Stein et al., 2010).  While educational 
achievement is generally linked to earnings, a lower adult stature and decreased lean body mass 
in men may also impact on earning potential in areas where physical labour is a major source 
of income (Victora et al., 2008).  
 
The cycle of poverty and malnutrition is perpetuated intergenerationally as women who are 
stunted as children and have short stature in adulthood are themselves more likely to give birth 
to a child with intrauterine growth restriction (IUGR).  Maternal mortality and morbidity are 
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also increased in women of short stature (Victora et al., 2008). These findings of an 
intergenerational effect of stunting were confirmed in the 2013 Lancet Maternal and Child 
Nutrition Series (Black et al., 2013). 
 
The impact of stunting on development of human capital is illustrated very clearly in the 
Guatemala cohort that forms part of the COHORTS collaboration. While the other four cohorts 
were observational, the Guatemala study (The Institute of Nutrition of Central America and 
Panama (INCAP) Oriente Longitudinal Study) was experimental and followed children from 
four villages between 1969-1977. Pregnant and lactating women and children aged 0-7 years 
in two of the villages received Atole, a high protein, high energy supplement, while the children 
from the other two received Fresco, a non-protein low energy supplement. Both supplements 
contained added micronutrients (Martorell et al., 1995). Children who received Atole under the 
age of 3 years were taller than the Fresco group but no difference was seen if supplementation 
occurred between 3 and 7 years. A number of follow up studies were conducted when the 
children were teenagers and adults and the results showed clear advantages for the Atole group 
who were taller, performed better in school and in reading comprehension and intelligence tests 
and earned higher wages than the Fresco group. These benefits were only seen if the children 
had received the supplements before the age of 3 years. An intergenerational effect was also 
seen as the babies born to women who had received Atole as children were taller (especially 
boys) and heavier than offspring of women from the Fresco group (Dewey & Begum, 2011). 
This illustrates the long term negative effects of stunting and how interventions can change a 
vicious cycle to a virtuous cycle. 
 
2.4.1.2 Risk of overweight in childhood and adulthood 
The relationship between stunting and overweight was discussed previously with some studies 
reporting higher prevalence of overweight in stunted versus non stunted children (Popkin et 
al., 1996; Mamabolo et al., 2005; Symington et al., 2016; Steyn et al., 2005). However, data 
from the longitudinal Birth to 20 study showed that although children who were stunted at 2 
years of age had higher BMIs than non-stunted children, skinfold thickness measurements 
showed no differences in their fat distribution or centripetal fat ratio (CFR).  The authors 
suggested the higher BMIs were due to distortions related to the mathematical formula for 
calculating BMI; that is “underheight” as opposed to overweight (Cameron et al., 2005).  The 
issue of  “underheight” was also discussed in a paper in the Lancet Obesity Series and the 
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authors recommended including measures of adiposity rather than just BMI in anthropometric 
surveys conducted in LMICs  (Lobstein et al., 2015). 
 
It is unclear whether early childhood stunting increases the risk for overweight in later years.  
In the Birth to 20 study, being stunted at 2 years of age did not increase risk of overweight or 
adiposity once these children reached 9 years of age although this could still be a possibility in 
adolescence (Cameron et al., 2005). The Agincourt study showed high rates of stunting of 2 
year old children together with high prevalence of overweight and obesity in female 
adolescents in the same rural community but this was a cross sectional study so did not provide 
evidence that the overweight adolescents had been stunted earlier (Kimani-Murage et al., 
2010).  A follow up of boys from the Pelotas birth cohort in Brazil at the age of 18, when they 
had to enlist in the army, found no relationship between stunting at 2 or 4 years and overweight 
at 18 years. In fact undernutrition in early life seemed to have a protective effect against 
overweight later in life (Gigante et al., 2007).  The 2008 Lancet Series, which used data from 
the COHORTS collaboration, including that from the Pelotas cohort, did not find any strong 
association between height for age in early childhood and overweight in adults.  In the 
Guatemalan cohort there was an association between previous stunting and adult central 
adiposity but this was not seen in the Indian cohort (Victora et al., 2008). 
 
2.4.1.3 Risk of NCDs in adulthood 
The evidence linking childhood stunting to increased risk of non-communicable diseases in 
later life is not as strong as that linking it to human capital outcomes. There is evidence however 
that adult short stature is linked to metabolic syndrome and increased risk of Type 2 Diabetes 
(Bosy-Westphal et al., 2009). While cohorts in high income countries have shown associations 
between low birthweight and development of chronic disease, the association is much weaker 
in LMICs, although COHORTS did find an association of low birthweight with high blood 
pressure in later life (Adair et al., 2009).  High glucose concentrations, blood pressure and 
harmful lipid profiles were only associated with childhood undernutrition once adult BMI and 
height were adjusted for in the Lancet 2008 Undernutrition Series analysis. This indicates a 
link with rapid weight gain after infancy (Victora et al., 2008). This observation was confirmed 
by further analysis of COHORTS data confirming that growth, particularly linear growth, in 
infancy up until 2 years has a beneficial effect on human capital outcomes with little or no 
negative effect on chronic disease markers. In contrast, rapid weight gain after 2 years, 
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especially after mid childhood, does not benefit development of human capital but negatively 
affects cardiovascular disease risk in studies from developing countries (Adair et al., 2013).  
 
The 2008 Lancet Maternal and Child Undernutrition Series was focused on the prevalence and 
consequences of undernutrition and interventions to address it (Black et al., 2008).  The 2013 
Maternal and Child Nutrition Series highlighted the emergence of the double burden of 
malnutrition in LMICs.  While stunting in particular remained highly prevalent, many countries 
were seeing an increase in the prevalence of overweight and obesity, particularly in females 
and young children (Black et al., 2013).  
 
 Overweight 
2.4.2.1 Short term consequences 
The short term effects of childhood overweight include delayed motor development in infancy 
which can lead to reduced physical activity thereby creating a vicious cycle (Slining et al., 
2010).  In later childhood, overweight can lead to lack of confidence and poor self-esteem 
which can persist into adulthood (Rossouw et al., 2012). Childhood obesity has also been 
linked to asthma and reduced lung function at the age of 18 (Ziyab et al., 2014).  
 
As a result of increasing overweight and obesity in childhood and adolescence, conditions like 
Type 2 Diabetes, high blood pressure and abnormal lipid profiles are being diagnosed at 
increasingly younger ages (WHO, 2016a). Children in the Agincourt study aged from 7-15 
years already had a high prevalence of pre-hypertension, impaired fasting glucose and 
abnormal lipid levels which were all associated with adiposity (Pedro et al., 2014). A Chilean 
study found biochemical markers of increased CVD risk in obese four year olds (Corvalán et 
al., 2009).  
 
2.4.2.2 Risk of overweight and NCDs in adulthood 
While the short term effects of overweight are of concern, the bigger threat is that overweight 
in childhood is linked to adult obesity, diabetes and other non-communicable diseases (NCDs) 
(WHO, 2016a; Black et al., 2013). The increasing prevalence of childhood overweight and 
obesity in LMICs has the potential to create an enormous NCD burden in years to come. 
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As was discussed previously, in South African surveys, overweight prevalence tends to peak 
at around 2 years before decreasing in mid childhood. Prevalence increases again in female 
adolescents (Kimani-Murage et al., 2010; Shisana et al., 2013). The significance of being 
overweight in the first 2 years of life in predicting risk of being overweight in adolescence and 
adulthood is not entirely clear. Birthweight; size at 20 months and 43 months; and most 
significantly, a rapid weight gain from birth to 20 months and 20 to 43 months were all 
associated with adolescent overweight and obesity in children from the Pelotas cohort. 
However, half of all children who were overweight in early childhood did not become 
overweight adolescents and conversely only 20% of overweight adolescents were overweight 
in childhood. (Monteiro et al., 2003). A study using data from the Isle of Wight birth cohort 
identified four different trajectories of BMI in children from birth to 18 years; normal; early 
transient overweight (overweight at 1 year before decreasing); early persistent obesity (obese 
by 4 years, never decreasing); and delayed onset (at 10 years) overweight  (Ziyab et al., 2014). 
This indicates that a number of children who are overweight at 1 year would no longer be 
overweight in later childhood and also that many overweight older children and adolescents 
were not overweight in early childhood. These findings are similar to those of the Pelotas 
cohort.  
 
Most birth cohort studies have been conducted in developed countries. They generally show a 
relationship between rapid weight gain in early life and later risk of overweight or obesity and 
other risk factors for NCDs.  A systematic review of 21 studies from developed countries 
looked at rate of weight gain and risk of obesity at ages ranging from 5 years to 32 years. The 
review found strong evidence of a statistically significant association between rapid weight 
gain up to 2 years of age and subsequent obesity. Infants and children who had rapid weight 
gain, defined as >+0.67 Z score change in weight for age, were 2-3 times more likely to be 
obese when older (Ong and Loos, 2006). These findings were confirmed by a subsequent 
review of systematic reviews on the topic which found rapid weight gain in infancy was 
consistently associated with increased risk of obesity later in life (Monasta et al., 2010).  In a 
Swedish prospective birth cohort study rapid weight gain in both early infancy (0-6 months) 
and later childhood (3-6 years) was associated with an increased BMI, fat mass and waist 
circumference in young adulthood. Rapid weight gain in the infancy phase, which occurred in 
25% of the cohort, also predicted taller adult height (Ekelund et al., 2006). 
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The timing of weight gain and whether it is accompanied by linear growth appears to be 
important for long term risks in children living in developing countries. Data from COHORTS 
showed that rapid weight gain after 2 years and into mid childhood was associated with adult 
overweight, increased adult fat mass, raised blood pressure and dysglycaemia. In contrast 
weight gain combined with linear growth in the first 2 years was associated with adult fat free 
mass and was not associated with cardio metabolic risk factors (Adair et al., 2013). This is 
significant as in developing countries there is a need to balance obesity prevention in early 
childhood with preventing morbidity and mortality associated with poor growth (Lobstein et 
al., 2015; Adair et al., 2013). The evidence suggests that promoting healthy growth, in 
particular linear growth, in the first 24 months has benefits that outweigh the risks (Adair et 
al., 2013). This is in contrast to the findings from developed countries, probably due to a 
number of factors, including different causes of LBW, less catch up growth in developing 
countries and the fact that many of the countries in COHORTS had not yet experienced the 
nutrition transition (Victora et al., 2008). Rapid weight gain in mid childhood and beyond, 
however, especially if not accompanied by gains in length, increases risk of obesity and NCDs 
(Adair et al., 2013).  
 
Childhood stunting and overweight are both important public health problems in LMICs that 
can have lifelong effects. The determinants of both conditions are complex and, in some cases, 
shared. 
 
 Determinants of childhood stunting and overweight 
Childhood stunting and overweight can largely be prevented, however appropriate 
interventions need to be based on an understanding of the underlying causes, as well as the size 
of their effect in order to prioritise allocation of resources (Danaei et al., 2016). 
 
   Stunting 
Stunting starts in utero as it has been estimated that 20% of childhood stunting has its roots in 
poor foetal growth (Black et al., 2013). A recent global risk factor analysis found that foetal 
growth restriction, that is, born term but small for gestational age (TSGA), was the single 
biggest risk for childhood stunting, accounting for approximately 25% of stunted children 
(Danaei et al., 2016). The intergenerational effects of stunting have already been discussed 
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where women of short stature have been shown to be at increased risk of delivering babies who 
have experienced IUGR. The focus of the remainder of this literature review will be on the 
period from birth to two years of age.   
 
After delivery, a combination of exposure to repeated infections as a result of poor 
socioeconomic conditions, poor feeding practices and lack of care all contribute to the further 
drop off in HAZ that is typically seen by two years in LMICs (Black et al., 2013). According 
to the well known UNICEF conceptual framework on malnutrition, these immediate causes 
have their roots in basic and underlying causes of malnutrition that is, the political economy, 
food and agriculture policies, water and sanitation and education (Onyango, 2013; Black et al., 
2013). The large disparities in stunting prevalence between the highest and lowest quintiles of 
socioeconomic status in almost every LMIC illustrates how important these more distal 
determinants are (Black et al., 2013). As discussed previously, the South African DHS reported 
stunting rates of 36% vs 13% in lowest vs highest SES quintiles (DoH et al., 2017). 
 
The global risk factor analysis mentioned previously found that, after being born TSGA, the 
second biggest risk factor for stunting was unimproved sanitation followed by diarrhoea. The 
analysis grouped 18 known risk factors for stunting into five clusters: maternal nutrition and 
infection; teenage motherhood and short birth intervals; foetal growth restriction and preterm 
birth; child nutrition and infection; and environmental factors. Environmental factors included 
unimproved sanitation, unimproved water source and use of biomass fuels, for example 
paraffin, for cooking and heating. These factors together had the second largest impact on 
stunting globally, with the child nutrition and infection cluster only coming in fourth behind 
maternal nutrition and infection (Danaei et al., 2016). A similar risk factor assessment study in 
India, which accounts for over a third of the worlds stunted children, also found child nutrition 
to be less of a risk factor than maternal and socioeconomic factors. Maternal height, BMI, 
education and household wealth were strongly related to stunting. Dietary diversity was also 
important (Corsi et al., 2016).  
 
These two studies show that stunting is far more than just a nutrition problem and is driven by 
underlying social, political and environmental factors that affect household food security and 
access to safe and hygienic living conditions as well as women’s empowerment and education 
(Black et al., 2013). However this review will now focus on the immediate  causes of stunting 
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which include exposure to infections, poor feeding practices and lack of care (Black et al., 
2013).  
 
2.5.1.1 Exposure to infections 
While infections like malaria, pneumonia and measles can cause acute wasting and, to a lesser 
extent, stunting, diarrhoea has been most strongly linked to stunting  (Black et al., 2013). A 
pooled analysis using data from 5 countries showed that each episode of diarrhoea increased 
the odds of stunting at 24 months and that 25% of stunting was as a result of 5 or more episodes 
of diarrhoea (Checkley et al., 2008).  
 
Environmental enteropathy, also known as tropical sprue, occurs in children living in 
unsanitary conditions and causes damage to the structure and function of the small intestine, 
including villous atrophy and inflammation. While it is often subclinical, it is thought to result 
in increased intestinal permeability and malabsorption of nutrients which can lead to poor 
growth (Black et al., 2013; Stewart et al., 2013). 
 
2.5.1.2 Poor feeding practices 
The South African Infant and Young Child Feeding (IYCF) Policy recommends exclusive 
breastfeeding in the first six months followed by introduction of complementary foods with 
continued breastfeeding up until 2 years and beyond (DoH, 2013b). Exclusive breastfeeding, 
although very important for child survival (Jones et al., 2003) has not been shown to have great  
impact on length in infants (Black et al., 2013). A systematic review and meta-analyses of 35 
studies found no significant effect of breastfeeding promotion interventions on length/height z 
scores (Giugliani et al., 2015).  Complementary feeding practices however, have a greater 
impact on linear growth (Black et al., 2013; Marriott et al., 2012; Jones et al., 2014). This was 
demonstrated by Ruel & Menon (2002) using data from DHS in five Latin American countries. 
Feeding practices were significantly associated with HAZ in all seven datasets. This association 
was particularly strong in children aged 12-36 months and persisted even after controlling for 
potential confounders such as SES and maternal education in four out of the five countries.  
 
Poor complementary feeding practices can be divided into three main aspects according to 
Stewart et al. (2013): namely 1) poor quality food, 2) inadequate practices and 3) unsafe food 
and water. 
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1. Poor quality foods: this includes lack of dietary diversity, lack of intake of animal protein 
foods and intake of foods with anti-nutrient properties for example phytates (Stewart et al., 
2013). In LMICs there is increasing consumption of unhealthy snack foods by infants and 
young children which displaces intake of more nutritious foods. Analysis of DHS data from 
18 Asian and African countries found that 20% of infants aged 6-8 months were already 
consuming sugary snacks in one third of the countries studied. Sugar consumption 
increased with age with up to three quarters of Asian children and nearly a half of African 
children consuming these snacks in the second year of life. All the countries had a stunting 
problem in the under 5 population with prevalence ranging from 19%-58%. It was noted 
that sugary snack consumption was invariably more common than consumption of more 
nutritious foods such as eggs, vitamin A rich fruits or fortified infant cereals and 
recommendations were made to investigate the association of unhealthy snack food 
consumption with both stunting and overweight (Huffman et al., 2014). 
 
Dietary diversity is increasingly used as an indicator of complementary diet quality and 
specifically micronutrient content (Allen, 2012). Secondary analysis of data from the 1999  
South African NFCS found that dietary diversity was strongly related to both micronutrient 
adequacy of the diet and HAZ (Steyn et al., 2006). This link between dietary diversity 
scores and micronutrient density of the diet was confirmed in a Madagascan study (Moursi 
et al., 2008). A more recent South African study also reported increasing nutrient density 
of protein and a number of micronutrients with increasing dietary diversity (Faber et al., 
2016).  The Latin America study described previously used a composite child feeding index 
that incorporated a dietary diversity score with six food groups (Ruel & Menon, 2002).  A 
study using DHS data from 11 countries in Africa, Latin America and South Asia also used 
dietary diversity scores and found an association with HAZ. The dietary diversity score in 
this study was adapted to include seven food groups. The association of dietary diversity 
with increased HAZ remained after controlling for socioeconomic status. This independent 
association is important to determine as dietary diversity is strongly associated with socio 
economic status, which has well established links with child health and nutrition outcomes 
(Arimond and Ruel, 2004). This independent relationship of dietary diversity with HAZ 
was also found in a Zambian study (Mallard et al., 2014).  
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Intake of animal protein foods is considered important as these foods are good sources of 
high quality protein as well as rich, bioavailable sources of a range of micronutrients 
including iron and zinc (Lobstein et al., 2015; Allen, 2012). Studies in LMICs have shown 
that children who consume more animal protein foods are taller, heavier and have better 
cognitive outcomes than those who consume smaller amounts (Allen, 2012).  Iron rich food 
intake at 6 months was positively associated with HAZ at 18 months in a Zambian birth 
cohort study (Mallard et al., 2014). In addition to iron, adequate zinc intake is important 
for prevention of stunting (Krebs, 2007; Black et al., 2013). Complementary feeding diets 
in developing countries are typically high in grains that are not only poor food sources of 
zinc but also contain large amounts of phytates which inhibit its absorption (Krebs, 2007; 
Stewart et al., 2013).  
 
Dairy products are also associated with better linear growth. Milk is a poor source of iron 
but a good source of calcium and zinc as well as bioactive factors. It stimulates insulin-like 
growth factor and insulin and contains growth stimulating peptides (Allen, 2012). An 
Indonesian study found a link between iron-fortified infant food consumption at 9 months 
and linear growth at 12 months. The iron fortified foods (formula, cereals and rusks) also 
contained significant amounts of milk powder. In contrast, consumption of iron rich flesh 
foods was not associated with linear growth, although this could be due to the fact that 
meatballs and sausages with a high cereal content were the main sources of meat. The 
authors postulated that the association of the iron-fortified foods rather than flesh foods 
with LAZ could be due to the growth promoting effect of the milk powder (Diana et al., 
2017). Intake of animal protein foods is often very low in poor communities due to the cost 
and lack of refrigeration facilities in the home. Additional factors limiting inclusion in the 
diet of infants and toddlers may be cultural or religious beliefs (Allen, 2012). 
 
2. Inadequate practices: includes feeding too little food, not feeding often enough or feeding 
overly diluted foods which have low energy density. It also includes lack of responsive 
feeding or not feeding during and after illness (Stewart et al., 2013). This aspect is also 
linked to lack of care and will be discussed in further detail in the next section, 2.5.1.3. 
 
3. Unsafe food and water: includes unsafe food preparation and storage practices as well as 
lack of access to safe water. These factors all increase the risk of diarrhoea, which, as 
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discussed previously, is a major risk factor for stunting  (Stewart et al., 2013). Aflatoxin 
contamination is particularly a problem with maize and groundnuts and has been linked to 
stunting, possibly through a mechanism of gut inflammation (Smith et al., 2012). 
 
Two of the aspects described, namely quality of complementary foods and feeding practices 
are assessed by the WHO Infant and Young Child Feeding Indicators (hereafter referred to as 
the IYCF Indicators) (WHO, 2010) which are based on international guidelines for both 
breastfed and non-breastfed infants (WHO, 2005; PAHO/WHO, 2003). The IYCF Indicators 
use a dietary diversity score, intake of iron rich or iron fortified foods and frequency of feeding 
to assess adequacy of complementary feeding. Breastfeeding indicators are also included 
(WHO, 2010).  
 
The association of the IYCF Indicators with growth outcomes has been evaluated with mixed 
findings. A pooled analysis of data from 14 countries found lower risk of both stunting and 
underweight if the indicators for timely introduction of solid foods, minimum acceptable diet 
(MAD), intake of iron rich foods (IRF) and dietary diversity (MDD) were met (Marriott et al., 
2012). A later review used data from 9 countries but did not pool the data. It found lack of 
consistency across countries with some countries showing a positive relationship between  
MDD indicators  and MAD and HAZ but others showing no association (Jones et al., 2014). 
Both reviews found a negative association with continued breastfeeding at 12-15 months and 
child growth. Possible reasons for this unexpected finding could be reverse causality, that is, 
smaller, more vulnerable infants are breastfed for longer; or overreliance on breastfeeding at 
the expense of complementary diet quality (Marriott et al., 2012; Jones et al., 2014).  
 
A recent analysis of DHS data from 39 countries used the IYCF Indicators 7 food groups to 
assess dietary diversity and also looked at consumption of animal source foods (ASF). It was 
found that increasing dietary diversity and ASF consumption was associated with lower risk of 
stunting and the authors recommended that MDD be set at 5 rather than 4 food groups 
(Krasevec et al., 2017).  The IYCF Indicators have also been used in South African studies, 
but these will be discussed later in this section in section 2.5.3. 
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2.5.1.3 Lack of care 
Lack of care which includes not taking the child for immunisations, neglect or lack of 
psychosocial stimulation has also been linked to stunting and is strongly correlated with 
maternal education (Black et al., 2013).  There is also an overlap with feeding practices, that 
is, responsive feeding, preparation of safe, nutritious foods, and frequency of feeding. Lack of 
maternal education was consistently associated with poor complementary feeding practices in 
five South Asian countries (Senarath et al., 2012). Achieving IYCF Indicators in a study in 
Bangladesh was positively associated with maternal education. Mothers who had no education 
were at higher risk for not achieving any of the IYCF Indicators than those who had secondary 
or higher education (Kabir et al., 2012). The Zambian study mentioned previously found a 
significant effect of maternal education on child growth that was independent of household 
wealth. The effect was mainly seen through the provision of a diverse diet but other ways in 
which maternal education improves child growth include increased autonomy and confidence 
in decision making and better access to and use of health and nutrition information and services 
(Mallard et al., 2014). 
 
  Overweight   
As with stunting, childhood overweight and obesity starts in the womb and a number of studies 
have implicated high pre-pregnancy BMI (Ziyab et al., 2014; Weng et al., 2012) or excessive 
gestational weight gain (Oken et al., 2007) as risk factors for overweight in offspring. This is 
of particular concern in South Africa with a combined overweight and obesity prevalence in 
women of 64% (Shisana et al., 2013). Overweight and obesity during pregnancy as well as 
gestational diabetes result in the foetus developing in an abnormal metabolic environment, 
increasing the risk of adverse metabolic changes and childhood obesity. This can continue into 
adolescence and adulthood thereby continuing obesity through the generations (Black et al., 
2013; Catalano, 2003). Maternal undernutrition has also been linked to later risk of overweight 
due to the “mismatch” pathway. Altered gene expression (epigenetic effects) can occur which 
enables survival in a nutrient poor environment but increases the risk of obesity later when 
there is a plentiful supply of energy dense foods as is typical in many LMICs which are 
undergoing or have undergone a nutrition transition (WHO, 2016a; Barker, 2012; Popkin et 
al., 2011).  
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Maternal smoking has been identified as a risk factor for overweight in the offspring (Ziyab et 
al., 2014; Weng et al., 2012) with a meta-analysis of seven studies showing a 47% increased 
risk of childhood overweight in offspring of mothers who smoked compared to children of non-
smokers (Weng et al., 2012). This could be a result of rapid postnatal weight gain following 
foetal growth restriction but may also be due to the fact that maternal smoking is associated 
with other poor lifestyle choices (Weng et al., 2012).  
 
A prospective cohort study in the United Kingdom found that three year olds who watched 
more than eight hours of television per week and slept for less than 10,5 hours a day were at 
increased  risk of developing obesity at 7 years of age  (Reilly et al., 2005).  A systematic 
review and meta-analysis of thirty prospective studies found that, in addition to maternal 
overweight and smoking, high birthweight and rapid weight gain in the first year of life were 
associated with later childhood overweight and obesity. Feeding practices such as 
breastfeeding and later introduction of solid foods were found to be protective (Weng et al., 
2012).  
 
The interactions of all these potential risk factors for childhood obesity are illustrated in Figure 
2-3, which was developed by Monasta et al. (2010) from a review of systematic reviews on 
early life determinants of obesity. The authors acknowledged that causality was very difficult 
to prove as there are many potential confounders particularly with regards to socioeconomic 
status. They called on researchers to focus their interventions on these potential determinants 
as this could help confirm if there is a real effect and stressed the urgency of developing 
effective interventions to combat the increasing burden of overweight and obesity (Monasta et 
al., 2010).  
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Figure 2-3: The complex web of potential determinants of overweight and obesity in     
children  (Monasta et al., 2010) 
 
This review will now focus on the potential determinants of overweight and obesity that have 
been identified in infancy and early childhood: birthweight, rate of growth and feeding 
practices. 
2.5.2.1 Birth weight 
Systematic reviews have confirmed findings from individual studies of an association between 
high birth weight and risk of overweight in early childhood (Weng et al., 2012; Monasta et al., 
2010). The Avon Longitudinal study found that every 100g increase in birth weight increased 
odds of overweight at 7 years by 1.05 (Reilly et al., 2005). The nationally representative 
Millennium Cohort study, also conducted in the United Kingdom, reported a 1.4 Odds Ratio 
of obesity at 5 years of age for every 1kg increase in birth weight (Brophy et al., 2009). Other 
studies have reported risks related to birth weight categories varying from > 3.85 kg to > 4.25kg 
(Weng et al., 2012). This association can be complicated by the fact that obesity in later 
childhood in developed countries has been linked to rapid postnatal catch up growth in babies 
who have been born small due to intrauterine growth restriction (Monasta et al., 2010; Ong et 
al., 2000). A review of a number of studies concluded that the relationship appears to be U- or 
J shaped with both low and high birthweight associated with later obesity and that low 
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birthweight is more strongly associated with greater fat mass, a risk factor for cardiovascular 
disease (Yang & Huffman, 2013).  
 
2.5.2.2 Rate of growth 
The link between rapid infancy weight gain and adult overweight and obesity and NCD risk 
was discussed previously in section 2.4.2, Consequences of overweight in childhood. Its role 
in the development of childhood overweight and obesity will now be explored. 
 
A meta-analysis using data from 10 birth cohorts totalling nearly 50 000 participants found a 
twofold higher risk of childhood obesity with each +1 increase in weight SD scores between 
birth and 1 year (Druet et al., 2011). Increased risk was also seen with the  >+0.67 SD increase 
that is commonly used to classify rapid growth (Ong & Loos, 2006) but the 21% of infants who 
had very rapid growth in the first year (>+1.33 SDS) had an almost fourfold risk of later 
childhood obesity (Druet et al., 2011). This association was confirmed in a separate systematic 
review which included findings from six studies (Weng et al., 2012). An association of rapid 
weight gain in the first two years with later adiposity was also demonstrated in a South African 
study using a subset of children from the Birth to 20 Cohort. Children who had >0.67 change 
in weight for age Z scores from birth to two years (20% of the sample) had higher BMIs and 
subcutaneous fat stores at nine years (Cameron et al., 2003). A small study of 47 infants found 
that fat mass and central fat distribution at 12 months was more strongly associated with rapid 
weight gain in the first 6 months than in the 6 to 12 month period (Chandler-Laney et al., 2013).  
 
Other studies have looked at changes in weight for length or BMI and have also identified the 
birth to 6 months period as being of greater significance. An American study of 559 infants 
found increased risk of obesity and subcutaneous fat stores at 3 years in children who had 
experienced rapid increases in weight for length between birth and 6 months (Taveras et al., 
2009). Overweight, obese and morbidly obese 5 year olds in another American study had very 
different infant growth patterns compared to normal weight children. Overweight and obese 5 
year olds had consistently higher BMIs than normal weight children from as early as 2-4 
months of age and these BMIs were strongly correlated with BMI at 5 years of age (Ludington-
Hoe et al., 2013). As mentioned previously, a Chilean study found that greater gains in BMI 
starting as early as 6 months were associated with obesity and biochemical markers of CVD 
risk at 4 years of age (Corvalán et al., 2009).  
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The consistent association of early rapid weight gain with later childhood obesity may be due 
either to nutrition or the environment or may be a genetic marker for future weight gain 
trajectory (Druet et al., 2011). The “growth acceleration hypothesis” proposes that early and 
rapid growth, particularly in the first 6 months of life, programs the infant metabolic profile to 
be susceptible to obesity in later childhood and adulthood (Young et al., 2012; Singhal, 2007). 
This association of rapid early growth with later obesity calls for earlier screening to identify 
high risk infants (Ludington-Hoe et al., 2013).  
 
The majority of these birth cohort studies have been conducted in HICs and the findings of an 
increased risk of childhood obesity with early rapid weight gain may not hold true in LMICs 
where there is a need to balance the short and long term risks and benefits of rapid postnatal 
catch up growth (Druet et al., 2011). Analysis of COHORTS data has supported the beneficial 
effects of weight gain in the first two years of life on schooling outcomes, particularly in babies 
with a lower birth weight, but found that later weight gain did not have the same benefits 
(Martorell et al., 2009).  The negative effects of rapid growth in later childhood, but not if the 
growth occurs before the age of two years, on cardio metabolic risk factors has also been 
discussed previously (Adair et al., 2013). Therefore, in LMICs the emphasis should be on 
promoting growth, especially linear growth in the first two years. The Chilean and South 
African studies show  that in LMICs  that are more advanced in the nutrition transition, early 
excessive weight gain that is disproportionate to linear growth can lead to overweight and 
obesity and adverse biochemical markers in later childhood (Corvalán et al., 2009; Cameron 
et al., 2003). 
 
2.5.2.3  Feeding practices 
Feeding practices that have been implicated in the development of childhood obesity are 
formula feeding/lack of breastfeeding, early introduction of solid foods and inappropriate 
complementary foods.   
 
a) Breastfeeding 
The evidence of a protective effect of breastfeeding against childhood overweight has been 
mixed in cohort studies. Systematic reviews of the individual studies have shown that it has a 
moderately protective effect both in childhood and adulthood (Young et al., 2012). A meta-
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analysis of 10 studies found a 15% reduction in the odds of childhood overweight with 
breastfeeding (Weng et al., 2012), similar to the findings of a previous review which found a 
22% reduction (Arenz et al., 2004).  The benefit appears to be linked to duration, although 
again the evidence has been mixed with a number of studies finding no effect (Weng et al., 
2012). There was a  significant reduction in risk of obesity at two years in children in a German 
birth cohort who were breastfed for more than 6 months compared to those breastfed for less 
than 3 months (Weyermann et al., 2006). A systematic review found that for every month of 
additional breastfeeding there was a 4% reduction in risk of overweight (Harder et al., 2005). 
A randomised controlled trial (RCT) in Belarus, the PROBIT trial, however found that 
prolonged duration of breastfeeding had no beneficial effect on height or adiposity at 6.5 years 
(Kramer et al., 2007). 
 
Breastfeeding duration may be particularly important in babies at high risk of obesity due to 
maternal factors such as high BMI or smoking. An American study found that high risk babies 
breastfed for less than 2 months were significantly more likely to gain weight rapidly in the 
first few months than high risk infants who were breastfed for longer periods (Carling et al., 
2015). Although breastfed babies who experience rapid early growth are also at risk for later 
obesity, this risk is less in those “ rapid gainers” who are exclusively breastfed for at least 6 
months (Young et al., 2012).  
 
As most birth cohorts are conducted in developed countries, there has been very little 
information on the association between breastfeeding and later risk of overweight and obesity 
in LMICs. Analysis of data from the previously discussed Pelotas, Brazil, cohort found no 
association between breastfeeding and obesity at 11 years of age. There was a small reduced 
risk of overweight in infants breastfed from 1 to 3 months. A limitation of the study was that 
due to very low levels of exclusive breastfeeding in the study sample in 1993, the effect of 
exclusive versus partial breastfeeding could not be analysed  (Neutzling et al., 2009). A cross-
sectional study conducted in three Mexican cities in infants aged 5-24 months reported a 
protective effect of breastfeeding against overweight and obesity (Jimenez-Cruz et al., 2010). 
In a Chinese study that compared feeding practices in normal weight vs overweight infants and 
young children, breastfeeding rates were significantly lower in the overweight group 
(Jingxiong et al., 2009).  
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Determining the impact of breastfeeding on childhood overweight and obesity is extremely 
difficult as there are many potential confounders such as maternal education and 
socioeconomic status  (Carling et al., 2015; Young et al., 2012). A strength of the Pelotas study 
was that there was very little risk of confounding by socio economic factors because 
breastfeeding duration was not associated with socioeconomic status and maternal education 
as is the case in cohorts in developed countries (Neutzling et al., 2009). The findings of no 
association between  breastfeeding and later adiposity in the PROBIT RCT is further evidence 
that confounding by socioeconomic factors may be responsible for the beneficial effects of 
breastfeeding reported in observational studies in HICs (Kramer et al., 2007). 
 
There is also lack of consistency in the literature regarding the definitions of “exclusive” 
breastfeeding, “predominant” breastfeeding, “some” breastfeeding and “no” breastfeeding 
(Young et al., 2012).  Exclusive breastfeeding for 4-6 months compared to no exclusive 
breastfeeding was found to protect against overweight and obesity in later childhood in a study 
involving children from eight European countries. It is interesting to note that shorter periods 
of exclusive breastfeeding (1-3 months) did not have a statistically significant effect 
(Hunsberger et al., 2012). A large Chinese cohort also found a protective effect of exclusive 
breastfeeding, with children exclusively breastfed for 3-5 months having a 13% reduction in 
risk of  overweight at 4-5 years of age which increased to 27% if exclusive breastfeeding was 
maintained to 6 months (Zheng et al., 2014). 
 
There are a number of potential mechanisms to explain the protective effect of breastfeeding. 
Breastfed infants are better able to self-regulate their intake and tend to consume lower volumes 
than formula fed infants (Yang & Huffman, 2013; Young et al., 2012). This ability to self-
regulate could also extend beyond the breastfeeding period, making children more responsive 
to internal hunger and satiety cues. In contrast, formula fed infants tend to rely on caregivers 
to decide when feeding is over, “finish the bottle”, which can condition them to overeat in later 
life (Moss & Yeaton, 2014). Infants enrolled in the Infant Feeding Practices Study who were 
predominantly fed expressed breastmilk from a bottle showed similar lack of self-regulation to 
those fed formula milk, indicating that it is the act of feeding from the breast that is important 
in establishing self-regulating behaviour (Li et al., 2010). 
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In addition, formula has higher concentrations of most macro- and micro-nutrients compared 
to breastmilk. The combination of increased volume and higher energy density can lead to 
higher energy intake in formula fed infants (Young et al., 2012). Higher energy intake at 4 
months was associated with increased weight gain from birth to 2 years and increased BMI at 
3 and 5 years in the Avon Longitudinal study. Each 420kJ/day increase in energy intake at 4 
months of age was associated with 46% increased risk for being overweight at 3 years and 25% 
increased risk at 5 years of age. This association was only found in formula and mixed-fed 
infants due to the difficulties of assessing energy intake of breastfed infants (Ong et al., 2006). 
The link between formula feeding and faster weight gain was also shown in the UK Millennium 
Cohort Study. Infants breastfed for 4 months or more gained weight slower than infants never 
breastfed or breastfed for less than 4 months (Griffiths et al., 2009).  
 
The higher protein content of formula has been associated with rapid postnatal weight gain in 
both preterm and term infants and higher fat mass in later childhood (Poskitt & Breda, 2012; 
Young et al., 2012; Singhal et al., 2010). A recent review of a number of trials highlighted the 
benefits of feeding a lower protein formula. Infants fed the low protein formula gained weight 
slower and had significantly reduced risk of overweight than infants fed the standard higher 
protein formula. Weight gain in the low protein group was similar to that of the breastfed 
controls and was not inferior to WHO growth standards (Haschke et al., 2016). This has 
implications for formula composition in the future. Cow’s milk protein appears to be 
specifically associated with risk of obesity (Poskitt & Breda, 2012) possibly through increasing 
blood levels of insulin and insulin-like growth factor which can promote synthesis of 
adipocytes (Hoppe et al., 2004). Dairy protein and increased levels of insulin-like growth factor 
was discussed previously as it is also associated with improved linear growth (Diana et al., 
2017; Allen, 2012). Therefore in countries with high rates of stunting and predominantly 
vegetable diets the addition of animal protein, including dairy, to complementary feeding diets 
should be encouraged, provided the dairy does not displace breastmilk (Poskitt & Breda, 2012). 
 
Apart from the differences in macronutrient content between breast- and formula milk, there 
are a number of bioactive factors in breastmilk such as leptin, insulin, ghrelin and adiponectin 
that may elicit endocrine effects and modulate growth (Weng et al., 2012; Young et al., 2012). 
The role of the microbiome in the development of obesity is a relatively new field. Breastmilk 
is a rich source of both probiotics, providing a continuous source of bacteria, and prebiotics, in 
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the form of oligosaccharides. The microbiome of a breastfed infant differs from that of a 
formula-fed infant. It is thought that the microflora of a formula-fed infant may be more 
efficient at extracting energy from carbohydrate and fat thereby contributing to more rapid 
weight gain (Thompson, 2012). 
 
b) Age of introduction of solid foods 
The evidence of a link between the early introduction of solid foods, often defined as < 4 
months of age, is also contradictory with conflicting results in a number of studies. Formula 
fed infants enrolled in Project Viva, a longitudinal birth cohort study, had a six fold increase in 
the odds of being obese at the age of 3 years if solids were introduced before 4 months. There 
was no association with obesity and age of introduction of solids in children who were breastfed 
for at least 4 months (Huh et al., 2011). A large American birth cohort study found that 
introducing solids before 4 months was associated with a 5-10% increased prevalence of 
obesity at 2 years and 4 years of age when compared to introducing solids from 4-5 months or 
6 months. There appeared to be no increased benefit of delaying solid food until 6 months on 
obesity rates (Moss and Yeaton, 2014). However in a much smaller Australian study there was 
a 15% lower prevalence of obesity at 10 years in children who were introduced to solids at 24 
weeks (6 months) vs. at 20 weeks or less (Seach et al., 2010). In LMICs the COHORTs 
collaboration showed an association with early introduction of solid foods and higher weight 
at 2 years and adiposity in adulthood (Fall et al., 2011). In a large Chinese cohort introduction 
of solids before 3 months was associated with higher BMI and overweight, but not obesity, at 
4-5 years of age. It is interesting to note that early introduction of solid foods was very common 
with 65% of infants fed complementary foods before 3 months (Zheng et al., 2015). 
 
Other studies have shown no association between age of introduction of solid foods and later 
overweight. A recent analysis of data from the Infant Feeding Practices Study, an American 
birth cohort study, found that introduction of solid foods before 4 months was not associated 
with increased risk of obesity at 6 years when compared to introduction at 4-6 months. 
Breastfeeding status did not affect the results (Barrera et al., 2016). Early introduction of solids 
was not associated with rate of weight gain from birth to 3 years in the Millennium Cohort 
Study once height at 3 years was taken into account (Griffiths et al., 2009).  The Pelotas birth 
cohort study found no association between starting complementary feeding before 4 months of 
age and obesity at 11 years (Neutzling et al., 2009). In another birth cohort study in a LMIC 
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(Caleyachetty et al., 2013) there was no association between age of introduction of solids and 
adiposity ( measured as sum of skinfold thicknesses) at 5 years in children in the Mysore region 
of  India. The Mexican cross sectional study mentioned previously compared overweight and 
obesity rates in infants started on solid food before 6 months and after 6 months and found no 
significant difference but did not consider the impact of starting before 4 months (Jimenez-
Cruz et al., 2010).  
 
The conflicting evidence from these studies makes it very difficult to draw any conclusions. A 
systematic review on the effect of timing of solid food introduction and risk of later overweight 
concluded that there was no clear association but that very early introduction (≤ 4 months of 
age) may increase the risk (Pearce et al., 2013). Potential mechanisms that could increase the 
risk of obesity include epigenetic modification of metabolic programming by specific foods or 
a hormonal  influence e.g. increased ghrelin levels (Pearce et al., 2013). Infants fed solids early 
tend to have higher energy intakes which leads to rapid weight gain and high weight for length 
(Thompson & Bentley, 2013) and, as previously discussed, higher BMI in later childhood (Ong 
et al., 2006). 
 
c) Type of complementary foods 
There is surprisingly little information on the relationship of nutrition composition of 
complementary foods to subsequent risk of obesity. The focus previously has been on 
breastfeeding duration and timing of introduction of solid foods and there is a need for more 
research into the effect of composition and quality of the complementary feeding diet (Young 
et al., 2012).  
 
A systematic review on the types of food introduced and risk of childhood overweight 
concluded that high energy and protein intake, particularly dairy protein, appear to be 
associated with higher BMI and body fat mass in later childhood. No specific foods or food 
groups were linked to childhood BMI. A varied, balanced diet as advised in national 
complementary feeding guidelines  should be followed as this was associated with greater lean 
mass (Pearce & Langley-Evans, 2013). 
 
The systematic review finding regarding increased risk of later childhood overweight and 
increased energy intake was based on the Ong et al. (2006) study which has been discussed 
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previously. Higher energy intake at 4 months predicted greater weight gain in the first few 
years of life and increased childhood obesity risk. Two other cohorts published subsequent to 
the review provide some further evidence. The U.S. Infant Care and Risk of Obesity birth 
cohort study found that inappropriate complementary feeding practices led to higher energy 
intakes (420kJ/day) and higher weight for lengths throughout the study period (birth-18 
months), putting the infants at high risk for later childhood obesity (Thompson & Bentley, 
2013).  A large Chinese cohort study did not measure energy intake but found an association 
between overweight at 4-5 years and consumption of fish oil in infancy which the authors 
linked to increased energy intake and rapid weight gain in infancy (Zheng et al., 2015). 
Although cross sectional, a Chinese study comparing feeding practices in overweight and 
normal weight infants and young children found that energy intakes were significantly higher 
in overweight children (Jingxiong et al., 2009). 
 
The link between high protein intake and later obesity risk has been demonstrated in a number 
of RCTs comparing high and low protein content infant formulas as discussed previously 
(Haschke et al., 2016). There is also some evidence for a link between high protein content (as 
% of energy) of the complementary feeding diet and later childhood overweight and body 
fatness, although there have been conflicting results (Pearce & Langley-Evans, 2013). A 
German birth cohort study found that high animal protein intake, particularly dairy protein, at 
12 months may be associated with higher fat mass at 7 years (Gunther et al., 2007). The authors 
of the review concluded that higher intakes of protein in the second year of life may be a better 
predictor of obesity in childhood than intakes earlier in life (Pearce & Langley-Evans, 2013). 
It must be noted that the levels of protein associated with higher BMI in the 12-24 month 
period, 2.6-3g/kg/day, are more than double the FAO/WHO recommendations (Yang & 
Huffman, 2013). 
 
 A RCT published subsequent to the above mentioned reviews found that breastfed infants 
allocated to a predominantly meat complementary feeding regimen between 5-9 months of age 
had greater linear growth than infants allocated to the traditional infant cereal based regimen. 
The meat group also had increased WAZ but this was proportional to the gain in length so there 
was no difference in WFL Z scores between the two groups. Body fat percentage was not 
assessed. There was also no difference in insulin like growth factor-1 levels. The protein intake 
of the meat group was double that of the cereal group (2.9 vs 1.4 g/kg/day; 17% of energy vs 
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9% of energy) but caloric intake was virtually identical. These findings provide evidence that 
in breastfed infants in a developed country setting, high meat protein intake can support optimal 
linear growth without increasing adiposity as measured by WFL. The study was, however, very 
small with only 42 infants, but did collect very detailed dietary information. The findings may 
not be applicable to formula fed infants (Tang & Krebs, 2014).  
 
The Pearce & Langley-Evans (2013)  review found no link between carbohydrate and fat intake 
and later BMI or adiposity and these findings were confirmed in  another review on the 
association of early nutrition with later obesity (Yang & Huffman, 2013). There was no 
evidence of a link between early micronutrient status and obesity but this is an area that requires 
more research (Yang & Huffman, 2013). The association of dietary diversity with overweight 
was investigated in a very small Canadian longitudinal study. Breastfed infants who were fed 
homemade complementary foods had greater dietary diversity and reduced adiposity at 12 
months (measured by DEXA) compared to those who received commercial infant foods (Mok 
et al., 2017). Dietary diversity was measured using the WHO IYCF Indicators. 
 
Intake of inappropriate complementary foods such as sugar sweetened beverages (SSBs) and 
high fat snacks (HFS)  has been identified as an increasing problem in LMICS (Contreras et 
al., 2016; Huffman et al., 2014) and was discussed previously in relation to its role in stunting 
by displacing more nutrient dense foods, in the diet and, in the food budget (Huffman et al., 
2014). It can also promote development of overweight through increasing energy intake and 
rapid weight gain in infants as well as the long term development of unhealthy eating habits 
such as preference for sweet and salty foods (Contreras et al., 2016; Huffman et al., 2014). 
These products are also often high in trans fats and sodium which have both been implicated 
in the development of NCDs (Huffman et al., 2014). Inappropriate feeding practices, including 
intake of SSBs, chips and ice-cream were associated with increased energy intakes and weight 
for length in infants in the U.S. Infant Care and Risk of Obesity Study (Thompson & Bentley, 
2013). The Mexican study discussed previously found that consumption of SSBs and HFS 
more than once a week was strongly associated with both overweight and obesity. The 
consumption of these foods was the greatest risk for obesity in the study population; greater 
than maternal BMI, no breastfeeding or early introduction of solid foods. The consumption of 
SSBs and HFS started before 6 months of age and by the second year of life, 60% of children 
were consuming these items at least once a week (Jimenez-Cruz et al., 2010).  
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Fruit juice, which is often considered by caregivers to be a healthy drink for infants and young 
children, has also been linked to childhood obesity. The American Academy of Pediatrics 
recently updated its guidelines to recommend that fruit juice not be given to infants younger 
than one year and limited to not more than 120-180ml per day in children aged 1-6 years 
(Heyman & Abrams, 2017). It appears that fruit juice may act as a “gateway” drink to juice 
and SSB consumption in later childhood. This was demonstrated in the Project Viva cohort; 
higher juice intake at one year was associated with higher juice and SSB consumption and BMI 
Z scores in later childhood. Early juice intake can establish a preference for sweet beverages 
which sets a pattern for later SSB consumption (Sonneville et al., 2015). 
 
Apart from the nutritional content of the complementary diet, responsive feeding practices, 
previously discussed in relation to stunting, have been found to be protective against rapid early 
weight gain. Excess parental control of the amount of food eaten can override the infant’s 
ability to self-regulate which has implications for eating habits beyond the infancy period 
(Redsell et al., 2016; Daniels et al., 2012). 
 
In developed countries childhood overweight is more prevalent in children living in households 
of low SES but this relationship is less clear cut in developing countries. A study using data 
from a large, nationally representative longitudinal survey in America found that much of the 
disparity in obesity rates is due to the clustering of poor infant feeding practices in low SES 
mothers. The three major factors identified were lack of breastfeeding, early (< 4 months) 
introduction of solids and putting the baby to bed with a bottle. Low socioeconomic status 
increased the risk of childhood obesity by 20% but this risk could be reduced to 7% if healthy 
infant feeding practices were followed with predominant breastfeeding being particularly 
important. This emphasises the importance of supporting healthy infant feeding practices in 
low socioeconomic settings in developed countries (Gibbs & Forste, 2013). 
 
  Determinants of stunting and overweight: the South African perspective 
South Africa, as with other LMICs, has a double burden of malnutrition with high levels of 
both stunting and micronutrient deficiencies together with an increasing prevalence of 
overweight in children under five years (Shisana et al., 2013). In LMICs stunting and 
overweight share many determinants. Findings from three prospective cohort studies 
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(Limpopo, Drakenstein and Promise-EBF) and three cross-sectional studies (KZN MRC, 
Mpumalanga and MRC/HST) that explored associations between infant feeding, maternal and 
household factors, and anthropometric status are summarised in Table 2-4. All the studies 
reported high rates of both stunting and overweight with the exception of the Promise-EBF 
study which only reported on overweight. This section will discuss the associations with 
overweight and stunting reported on in the studies presented in Table 2-4 and will include 
additional relevant information from other South African studies. These studies were not 
included in the table as they did not investigate associations with growth outcomes but they 
help to provide a more complete account of IYCF practices in South Africa. 
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Table 2-4: Determinants of stunting and overweight: South African studies 
Study details Description of study Prevalence of stunting and 
overweight  
Determinants of 
stunting 
Determinants of 
overweight 
Central Region Limpopo: 
 2001 
(Mamabolo et al., 2004) 
(Mamabolo et al., 2005) 
Prospective birth cohort 
Rural villages in Limpopo 
n=162 
12 months 
Stunting: 34.6% 
Overweight and obese:12.3% 
36 months 
Stunting: 48% 
Overweight and obese: 46% 
Stunted and overweight: 19% 
Lack of electricity. 
Larger household size. 
Student mother.  
Short maternal stature. 
Lower length at one year.  
Working mother. 
Rapid weight gain in 
first year of life. 
MRC    
(Faber & Benade, 2007) 
Cross sectional survey 
Rural KZN; Valley of a 
Thousand Hills 
6-12 months infants 
n=505 
 
Stunting: 16% 
 
Overweight: 23% 
Increased CRP levels-
may indicate HIV 
infection. 
Home gardens associated 
with increased LAZ. 
 
HST/MRC survey 
2003 
(Lesiapeto et al, 2010) 
 
Cross sectional baseline 
survey 
0-60 months children 
OR Tambo and Alfred 
Nzo districts,, Eastern 
Cape; Umkanyakude and 
Zululand districts, KZN 
n=2485 
Stunting: 28.6% 
 
Overweight: 16.1% 
Male gender. 
Household wealth index 
was protective against 
stunting. 
Maternal education not 
associated. 
Higher maternal BMI. 
Household has no 
regular source of 
income. 
Low maternal 
education- protective 
against overweight but 
increased odds of 
underweight. 
Agincourt ; 2007 
(Kimani-Murage et al, 
2010) 
(Kimani-Murage, 2013) 
Cross sectional survey 
Agincourt sub district, 
Mpumalanga Province 
Rural. Children 1-4 years 
n=671 
Stunting: 18% 
 
Overweight: 8% 
HIV infected infant. 
Low birthweight. 
Young maternal age. 
Mozambican origin. 
 
Older maternal age. 
Less than secondary 
certificate of household 
head. 
Higher SES. 
Adequate food security. 
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Table 2.4 continued. 
 
Study; date of study; 
authors 
Description of study Prevalence of stunting 
and overweight 
Determinants of  
stunting 
Determinants of 
overweight 
Promise-EBF trial 
2006-2008 
(Ramokolo et al., 2015) 
 
Longitudinal birth cohort 
Data from 3 sites (Paarl, 
Rietvlei and Umlazi)  
Anthropometric status 
assessed at 2 years 
n=641 
 
 
Overweight: 30% 
 
Obesity 8.7% 
 
  
 
 
Not breastfeeding at 12 
weeks associated with 
increased risk of rapid 
weight gain 12-24 weeks 
and increased overweight 
and obesity at 2 years. 
 
Drakenstein Child Health 
Study  
2012-2014 
(Budree et al., 2017 a; 
Budree et al., 2017 b) 
Longitudinal birth cohort  
Multi ethnic population, 
low resource district 
surrounding Paarl, 
Western Cape Province 
12 months old infants 
n= 342 
 
Stunting: 13% 
 
Overweight: 9% 
Birthweight. 
Alcohol and tobacco use 
in pregnancy. 
SES.  
Mixed race ethnicity. 
 
Longer duration of 
exclusive breastfeeding 
was associated with lower 
HAZ score. 
Poor infant feeding 
practices but no 
association with stunting. 
 
Poor infant feeding 
practices but no 
association with 
overweight. 
Higher prevalence in 
black African infants. 
No association with 
birthweight. 
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2.5.3.1 Sociodemographic factors 
Although there were no consistent findings, low birthweight and indicators of low SES tended 
to be associated with stunting. Higher SES was associated with overweight in the Agincourt 
study but not in others and in the MRC/HST study lack of regular source of income was 
associated with increased risk of overweight. Maternal alcohol use and smoking were 
particularly high in the Drakenstein cohort; 18% and 31%% respectively and were associated 
with both lower birthweight and poor infant growth postnatally (Budree et al., 2017b). 
 
2.5.3.2 HIV exposure 
HIV infection was associated with stunting in the Agincourt study (Kimani-Murage, 2013) and 
was suspected as a cause of the high CRP levels associated with stunting in the rural KZN 
MRC study (Faber & Benade, 2007); both studies were conducted prior to ARV programme 
accessibility. 
 
Growth failure is well documented in untreated HIV infection (Venkatesh et al., 2010) but 
infant HIV infection is less of a factor in stunting in the current era of reduced mother to child 
transmission and early detection and treatment of infected children as part of the Prevention of 
Mother to Child Transmission (PMTCT) programme (DoH, 2015a). The growth of HIV 
uninfected but exposed children was compared to that of HIV unexposed children in the 
Vertical Transmission Study (VTS) conducted in KZN province. Growth patterns of the HIV 
exposed but uninfected children were as good as those of HIV unexposed children. This is an 
important finding as up to 40% of children are HIV exposed in Southern Africa (Patel et al., 
2010). However, there were  high rates of exclusive breastfeeding in the study as mothers were 
supported to practise exclusive breastfeeding for 6 months and those few who were formula 
feeding were carefully counselled and were living in conditions that allowed for safe formula 
feeding (Patel et al., 2010). Of concern is the fact that outside of the research setting described 
in the VTS, many HIV positive mothers choose to formula feed their infants. A small study 
conducted in 2011 in Worcester in the Western Cape reported that none of the HIV positive 
mothers (self- reported) had initiated breastfeeding (Goosen et al., 2014). 
 
The Drakenstein study conducted between 2012-2015, also in the Western Cape, found that 
less than half of HIV positive mothers initiated breastfeeding (Budree et al., 2017 a).  Exclusive 
formula feeding was practised by 50% of HIV positive mothers in the Gert Sibande district of 
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Mpumalanga province with only 35% exclusively breastfeeding at 3-6 months of age (Ladzani 
et al., 2011). These feeding practices may reflect prior Department of Health policy that 
provided free infant formula to HIV positive mothers (DoH, 2007). Since 2011, as part of the 
Tshwane Declaration for the support of breastfeeding in South Africa, free supply of formula 
was discontinued and exclusive breastfeeding for 6 months and continued up until one year 
together with provision of maternal ARVs was advised (DoH, 2013b; Tshwane Declaration, 
2011). Subsequent guidelines recommend continued breastfeeding up to 2 years, in line with 
guidelines for HIV uninfected mothers (DoH, 2017a). 
 
The effect of exposure to maternal anti-retroviral treatment on infant growth has been 
investigated. A systematic review of trials investigating potential effects of maternal ARV 
therapy on HIV exposed but uninfected children found mixed results. Some studies reported 
increased rates of prematurity and low birthweight while others did not find an effect. Lower 
LFAZ were reported in some studies but the authors of the review concluded that the effects 
were transient.  They also pointed out the difficulty of determining whether any effects  are due 
to the drugs themselves or to exposure to the virus in utero (Heidari et al., 2011). A later study 
investigating the use of Tenofovir (TDF), which is one of the anti-retrovirals used in the South 
African PMTCT programme, found no increased risk of low birthweight or SGA. There was a 
slightly lower mean head circumference and LAZ at 12 months in infants exposed to a TDF 
regimen (Siberry et al., 2012).  
2.5.3.3 Breastfeeding practices 
Inappropriate breastfeeding practices have been linked to both stunting and overweight. The 
Promise-EBF prospective cohort study found that infants who were not breastfed at 12 weeks 
had increased rates of rapid weight gain from 12-24 weeks which predicted increased 
prevalence of overweight and obesity at 2 years (Ramokolo et al., 2015).  This link between 
rapid weight gain in the first 6 months of life and subsequent childhood obesity was discussed 
previously as well as the increased risk of rapid weight gain in formula fed infants. The only 
other study from Table 2.4 to explore the association of breastfeeding practices with 
anthropometric outcomes was the Drakenstein study which found that longer duration of 
exclusive breastfeeding was associated with lower HAZ at one year (Budree et al., 2017 a). It 
is not clear whether this reflected exclusive breastfeeding beyond six months. 
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The other studies describe a similar pattern of breastfeeding practices in many different regions 
of South Africa. Typically there are high breastfeeding initiation rates, ranging from 86% in 
the Drakenstein study to 96% in the rural KZN MRC study (Faber & Benade, 2007), followed 
by early introduction of other fluids and/or solid foods. Breastfeeding is commonly practised, 
with over 80% of infants in both the Limpopo and KZN studies still breastfed at 9-12 months 
of age, but exclusive breastfeeding under 6 months of age is the exception. The South African 
Infant and Young Child Feeding (IYCF) Policy recommends exclusive breastfeeding for the 
first 6 months, followed by introduction  of complementary foods and continued breastfeeding 
up to 2 years (DoH, 2013b), but there appears to be little adherence to them. The Limpopo 
study reported rates of exclusive breastfeeding at 3 months of age of only 10% and by 1 month 
64% of infants were already receiving formula and/or solids in addition to breastmilk 
(Mamabolo et al., 2004). The rural KZN MRC study had similar results with exclusive 
breastfeeding rates of 11 % at 4 months (Faber & Benade, 2007) while in the Drakenstein study 
13% of infants were exclusively breastfed for 6 months or longer with higher rates (26%) in 
those HIV positive mothers who had initiated breastfeeding (Budree et al., 2017a).  
 
These findings of low exclusive breastfeeding rates in the studies in Table 2-4, echo those of 
other studies documenting feeding practices in South African infants  (MacIntyre et al., 2005; 
Goosen et al., 2014). The MacIntyre et al. (2005) study conducted in Gauteng in 1997-1998 
found almost universal breastfeeding, with 99% of infants under 9 weeks of age receiving 
breastmilk, but less than 5% were exclusively breastfed. When comparing this earlier study 
with more recent ones, there does appear to be an increase in exclusive breastfeeding rates;  the 
most recent DHS conducted in 2016 reported rates of 32% (DoH et al., 2017) which is similar 
to the 38.5% of infants in the Breede Valley study (du Plessis et al., 2016), although the authors 
felt that this reflected over-reporting.  
 
Formula use, apart from being associated with rapid weight gain in early life and increased risk 
of childhood obesity, can also contribute to poor infant growth. This is particularly a risk in 
poor communities where over dilution of formula is common due to cost constraints. In the 
MacIntyre et al. (2005) study, 10% of mothers over diluted infant formula while this practise 
was much higher in the Goosen et al. (2014) study at 45% and even higher at 66% in a study 
conducted in rural and urban KZN (Faber et al., 2016). Apart from the risk for stunting from 
decreased nutrient intake, formula fed infants are also at increased risk of diarrhoea from 
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bacterial contamination of formula feeds. The role of repeated episodes of diarrhoea in the 
development of stunting has been discussed previously. Unsafe preparation practices were 
documented in the Goosen et al. (2014) study, with some mothers reporting that night feeds 
were stored in a flask and one big bottle was mixed for the whole day. High levels of faecal 
bacteria as well as significant over dilution of feeds were found in an urban/ peri-urban setting 
in KZN (Andresen et al., 2007). 
 
2.5.3.4 Complementary feeding practices 
Complementary feeding practices in South Africa are also often poor with early introduction 
of solid foods, lack of dietary diversity and regular consumption of inappropriate high fat/ salt/ 
sugar snacks and sugar sweetened beverages (du Plessis et al., 2013). These feeding practices 
have been implicated in the development of both stunting and overweight. 
 
Age of introduction of solid foods 
By 1 month of age 44% of infants in the Limpopo study had received solid foods, increasing 
to 80% of 3 month old infants. Force feeding of infants by pushing food down the infant’s 
mouth was practised by close to 30% of mothers which is completely contrary to the principles 
of responsive feeding and encouraging self-regulation of intake. This study reported 
exceptionally high overweight and obesity rates in three year old children (Mamabolo et al., 
2004; Mamabolo et al., 2005).  Similar patterns of very  early introduction of complementary 
foods were reported by MacIntyre et al. (2005) with 37% of infants younger than 9 weeks 
having already received solids, most of them before they were 7 weeks old. This study was 
conducted in 1997-1998 but in the Promise-EBF study conducted 10 years later almost two 
thirds of infants were receiving cereal by the age of 12 weeks and 28% had already received it 
by 3 weeks of age (Ramokolo et al., 2015) while  Faber & Benadé, (2007) reported that 61% 
of infants had received solid foods before the age of 4 months.  The Faber et al., (2016) study 
conducted in 2011 reported average age of introduction of solids of 3.5 months in rural areas 
and 4.2 months in urban areas. The more recent Drakenstein study which reported on data 
collected between 2012 and 2014 found lower rates of early introduction of solid foods; 19% 
before 4 months (Budree et al., 2017a). This may indicate a recent trend towards later 
introduction of solid foods, corresponding with the increase in EBF rate reported in the DHS 
(DoH et al., 2017) 
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Nutritional adequacy of complementary foods 
Lack of dietary diversity with poor micronutrient intake has been widely reported with soft 
maize meal and other starchy foods making up the bulk of the typical complementary feeding 
diet in South Africa (du Plessis et al., 2013). Although maize meal in South Africa is fortified 
with a range of micronutrients, including iron, zinc and folate, the amounts eaten by infants 
and young children are too small to have a significant impact on micronutrient intake and to 
improve micronutrient status (Faber, 2005). 
 
The Limpopo study analysed nutrient intakes at 1 and 3 years and found that the diet was energy 
dense but lacking in micronutrients, particularly iron, zinc and calcium. Carbohydrate 
comprised 70% of energy intake while only 20% of energy came from fat. Although protein 
intake was adequate it was mainly in the form of plant protein and therefore low in iron, zinc 
and lacking some essential amino acids. The high phytate content of the diet also contributes 
to lower absorption of iron and zinc. This poor nutritional intake is reflected in the nutritional 
status of the children; apart from the high stunting and overweight prevalence previously 
discussed, biochemical deficiencies of both iron (33%) and folate (20%) were present 
(Mamabolo et al., 2006).   
 
This combination of poor micronutrient intake, high rates of stunting (16%) and overweight 
(23%) at 6-12 months of age, and biochemical deficiencies of iron (35% iron deficiency 
anaemia), zinc (32%) and vitamin A (20%) was also reported by Faber & Benadé (2007) and 
Faber (2005)  in rural KZN. As with the Limpopo study, intakes of calcium, iron and zinc were 
particularly low, reflecting the poor intakes of animal and dairy products. In the 24 hour dietary 
recall period only 17% of infants had consumed animal products, 26% dairy products and 18 
% vitamin A rich fruit or vegetables. In contrast, 82% of infants had consumed maize meal 
porridge. The addition of high energy foods e.g. sugar, margarine, peanut butter to the porridge 
was common and probably inappropriate given the high rates of overweight in the study 
population. Intake of micronutrients was significantly higher in infants consuming infant 
products i.e. infant cereals, jarred foods and infant formula powder, with infant cereal 
contributing 51% of the iron intake of infants that consumed them. Jarred foods contributed far 
less to micronutrient intake than cereals.  
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IYCF Indicators 
Four more recent studies have assessed complementary feeding practices using the Infant and 
Young Child Feeding Indicators that have been discussed previously. The Breede Valley study 
found that only 44% of children aged 6-23 months achieved adequate dietary diversity; 71% 
were fed the appropriate number of times in a day and 44% received a minimum adequate diet. 
Iron rich foods were consumed by 55% of infants and 89% received iron either in the form of 
food or a supplement (du Plessis et al., 2016).  The Drakenstein study had much higher rates 
of adequate dietary diversity with 75% of infants consuming foods from 4 or more groups by 
12 months of age although this figure was much lower at 6 and 9 months. Data on feeding 
frequency was not collected so the minimum adequate diet indicator could not be assessed. 
Dairy intake was good with 92% of infants consuming dairy daily at 12 months. Animal food 
intake was also much higher than in previous studies at 77% but of concern was that this was 
mainly in the form of processed meats, high in fat and sodium (Budree et al., 2017a). The Faber 
et al. (2016) study found that less than 25% of infants achieved adequate dietary diversity. This 
study also assessed nutrient intake and once again confirmed that iron, calcium and zinc are 
problem nutrients but they also reported low intakes of niacin. Higher dietary diversity scores 
were associated with higher nutrient density of protein and a number of micronutrients as was 
discussed previously. The nationally representative DHS also used the IYCF Indicators and 
found that only 23% of infants aged 6-23 months received a minimum adequate diet (DoH et 
al., 2017). 
 
Consumption of inappropriate foods 
The last aspect to consider when discussing the complementary feeding diet is the intake of 
inappropriate foods. As was discussed previously, this can impact both on stunting, by 
displacing micronutrient rich foods in the diet, and on overweight, by increasing energy intake 
and establishing unhealthy taste preferences that track into childhood and later life. The 
Limpopo study reported that by 3 years of age sweets and crisps were the third and fourth most 
commonly consumed items, milk did not make it into the top 20 with tea being more often 
consumed. This is of concern given the inhibitory effect of tannins in Ceylon tea on iron 
absorption (Mamabolo et al., 2006). The rural KZN study found that savoury snacks were 
consumed by 42% of 6-12 months old infants most days of the week and biscuits by 27%. 
Carbonated drinks were consumed on most days by 12% of infants with a further 26% having 
them once a week. Tea consumption was also common (Faber & Benadé, 2007). The Faber et 
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al. (2016) study highlighted the early introduction of chips/savoury snacks with over 50% of 
infants already consuming them at least once a week from 6-12 months of age, rising to over 
80% in the second year of life. Carbonated beverage, tea and cakes/ biscuits were also regularly 
consumed from 12 months of age. The Drakenstein study found high intake of inappropriate 
food consumption. At 6 months 13% of infants were drinking fruit juice daily. By the age of 
one year over half of infants were drinking carbonated beverages or eating refined sugary foods 
daily while a third consumed crisps daily (Budree et al., 2017a). 
 
The poor nutritional status of South African children is not surprising when considering the 
poor breastfeeding and complementary feeding practices described. There is little adherence to 
the South African IYCF Policy which recommends that mothers exclusively breastfeed their 
children for the first six months, followed by the introduction of adequate safe and appropriate 
complementary foods with continued breastfeeding up to two years and beyond (DoH, 2013b).  
 
The determinants of both childhood stunting and overweight in LMICs are rooted in underlying  
socioeconomic conditions, food systems and health care systems and therefore tackling these 
issues requires comprehensive interventions that address more than the immediate causes of 
inadequate feeding practices.  
 Prevention strategies for childhood stunting and overweight in LMICs 
 Global context 
Interventions to promote optimal growth are vital due to the difficulty of reversing early growth 
faltering (Dewey & Begum, 2011) and of treating overweight and obesity in childhood and 
beyond (Lobstein et al., 2015). Both stunting and overweight also have serious consequences 
in childhood and adulthood and into the next generation making prevention even more 
imperative. The Lancet 2008 Maternal and Child Undernutrition Series introduced the concept 
of focusing nutrition interventions on the crucial first 1000 days, from conception to two years 
of age, as this is the period during which irreversible and lasting damage is done and when 
interventions can have the greatest impact  (Black et al., 2008). While the 2008 Series only 
addressed undernutrition, including stunting, the Lancet 2013 Maternal and Child Nutrition 
Series acknowledged the increasing problem of overweight and obesity in LMICs; the double 
burden of malnutrition. It re-emphasised the importance of focusing interventions on the first 
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1000 days, even extending it to encompass female adolescence, and highlighted the importance 
of this time period for prevention of both stunting and overweight (Black et al., 2013). 
 
The double burden of malnutrition was also recognised in the WHO 2025 Global Nutrition 
Targets. Target number 1 calls for a 40% decrease in the prevalence of stunting while target 
number 4 is no increase in childhood overweight (WHO, 2012). The recognition of the global 
problem of childhood overweight and obesity led to the establishment in 2014 by the WHO of 
the Commission on Ending Childhood Obesity (ECHO). The final recommendations were 
released in 2016 and have three strategic objectives. The first is to tackle the obesogenic 
environment and norms. The second is to adopt a life cycle approach to obesity prevention and 
the third is to provide effective treatment for overweight children (WHO, 2016a).   The second 
objective emphasises the importance of interventions focused on three critical time periods 
namely preconception and pregnancy; infancy and early childhood (these two time periods 
therefore encompass the first 1000 days); and later childhood and adolescence (WHO, 2016a). 
All these global recommendations therefore reinforce the importance in LMICs of 
interventions in the first 1000 days that promote linear growth while preventing obesity.  
 
Given the complex web of determinants of both stunting and overweight that was described 
previously, it is obvious that nutrition specific interventions alone will not solve the 
malnutrition problems in LMICs. The 2013 Lancet series emphasised the importance of 
including nutrition sensitive programmes for example: water and sanitation; agriculture and 
food security; female empowerment and access to health care; as well as creating an enabling 
environment  through legislation and  policies (Black et al., 2013). This is illustrated in Figure 
2-4. 
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.  
Figure 2-4:  Framework for actions to achieve optimum foetal and child nutrition and      
development  (Black et al., 2013) 
 
Brazil is an example of a country that has successfully reduced stunting rates through nutrition 
sensitive programmes as well as nutrition specific interventions such as breastfeeding 
promotion (de Onis et al., 2011). Stunting rates decreased from 34% in 1986 to 6% in 2006 
and the success can be attributed to four main reasons: increased purchasing power of low-
income families; improved educational level of mothers; improvements in water and sanitation; 
and virtually universal basic health care. Mexico achieved similar results through a programme 
of expanded and better targeted cash grants to poor families and improved access to health care 
(de Onis et al., 2011). 
 
Nutrition specific interventions aimed at IYCF practices include breastfeeding and 
complementary feeding. As was discussed previously, while breastfeeding is important for 
child survival and lays the foundation for appropriate timing of complementary feeding, it does 
not significantly improve stunting rates  (Giugliani et al., 2015; Black et al., 2013). There is 
mixed evidence regarding the role of breastfeeding in the prevention of overweight/ obesity.  It 
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appears to have a small benefit in observational studies (Weng et al., 2012) and a systematic 
review and meta analyses of breastfeeding promotion intervention studies also reported a 
modest but significant reduction in BMI z scores (Giugliani et al., 2015).  In contrast, a 
systematic review of randomised controlled trials of interventions aimed at reducing risk of 
overweight and obesity in infancy and early childhood found no positive effect of breastfeeding 
(Redsell et al., 2016).  
 
Complementary feeding interventions have also had modest effects on stunting. A systematic 
review on the topic (Lassi et al., 2013) confirmed the findings of a previous review (Dewey & 
Adu-Afarwuah, 2008). The most effective interventions were: providing educational messages 
about feeding animal source foods, in areas where they are available and affordable; provision 
of food supplements and increasing energy density of foods in areas where the traditional 
complementary food has a low energy density. Micronutrient fortification alone had little or no 
impact on linear growth (Dewey and Adu-Afarwuah, 2008) although more recent research has 
found that the use of micronutrient powders appears to improve complementary feeding 
practices and micronutrient intake (Siekmans et al., 2017). Nutrition specific interventions on 
their own are unlikely to have a large effect on stunting and there is a need for studies 
examining an integrated approach; combining nutrition specific interventions with nutrition 
sensitive interventions such as water, sanitation and hygiene as well as care for mothers and 
children (De Onis et al., 2013). The need for integrated interventions to address the complexity 
of linear growth faltering in impoverished children was well illustrated in a trial conducted in 
four countries with high stunting prevalence (Krebs et al., 2012). Infants were randomised to 
receive either meat or a micronutrient fortified cereal, starting at 6 months and continued 
through 18 months. There was no difference in length gain between the two groups but what 
was most striking was that neither intervention prevented the increase in stunting rates from 
~30% at 6 months to ~50% at 18 months (Krebs et al., 2012). The lack of an effect of nutrition 
supplementation interventions on stunting outcomes, together their potential to increase the 
risk of overweight, was acknowledged by the WHO in guidelines aimed at addressing stunting 
and wasting in the context of the double burden of malnutrition (WHO, 2017). The guidelines 
recommend that caregivers of stunted children receive general nutrition counselling, applicable 
to all children under 5 years, but advise against routine provision of nutrition supplementation. 
This recommendation has also been incorporated into the KZN DoH Standard Operating 
Procedures on the Prevention and Management of Malnutrition in KZN (KZN DoH, 2018). 
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The previously mentioned systematic review on obesity prevention interventions found that 
complementary feeding interventions, specifically those that included responsive feeding 
aspects showed some promise in reducing the risk of obesity. Use of lower protein formulas,  
had a positive effect on weight outcomes as was discussed previously (Redsell et al., 2016).  
 
The ECHO report also highlighted the need for an approach to childhood obesity prevention 
that goes beyond nutrition specific interventions with its first strategic objective: tackling the 
obesogenic environment and norms. It recommends that governments need to take action i.e. 
through food, agriculture and trade policies that ensure availability of healthy, affordable foods; 
taxation of unhealthy food and beverages (SSB Tax in particular); restriction of marketing and 
advertising of unhealthy foods to young children and their parents; and taking steps to ensure 
that the built environment is conducive to physical activity. Other aspects include nutrition 
education and food labelling (WHO, 2016a). In a paper for the 2015 Lancet Obesity Series, 
by? (Lobstein et al., 2015), the authors call for stricter controls on promotion of commercially 
prepared complementary foods. They caution against the increasing use of these foods which 
replace family foods in the diet and accustom infants’ taste buds to highly processed foods and 
sweetened juices.   
 
 South African policies and strategies 
The South African Roadmap for Nutrition (DoH, 2013a) and the Strategy for the Prevention 
and Control of Obesity in South Africa (DoH, 2015b) provide the framework for policies that 
address both stunting and overweight. 
 
The Roadmap is aligned with the nutrition specific interventions outlined in Figure 2-7  and 
includes interventions to promote healthy weight gain in pregnancy; optimal infant and young 
child feeding practices through the IYCF Policy; micronutrient supplementation and 
fortification programmes for pregnant women and children; and treatment of acute malnutrition 
(DoH, 2013a). South Africa has focused much attention on breastfeeding promotion. The 
Tshwane Declaration affirmed that South Africa is a country that protects, promotes and 
supports breastfeeding (Tshwane Declaration, 2011). Over 70% of public hospitals are MBFI 
accredited and the Code of Marketing of Breastmilk Substitutes in South Africa was legislated 
in 2012 (DoH, 2012). 
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The Strategy for Prevention and Control of Obesity in South Africa incorporates many aspects 
included in the ECHO Report. It aims to tackle the obesogenic environment through a number 
of strategies including legislation e.g. the newly introduced tax on SSBs; norms and standards 
for sugar and fat content of processed foods; nutrition content of foods displayed at restaurants; 
restrictions on marketing and advertising of unhealthy foods to children as well as taking action 
to increases access and availability of vegetables and fruits. There is also a goal to facilitate 
physical activity. As with the ECHO report, a life cycle approach to obesity prevention is an 
integral part of the Strategy. The maternal, infant and young child nutrition interventions 
described in the Roadmap are incorporated, namely healthy weight gain during pregnancy, 
breastfeeding promotion and healthy complementary feeding practices with an explicit focus 
on obesity prevention. The draft Paediatric Food Based Dietary Guidelines for South Africa 
were recently field tested and contain clear messages aimed at promoting optimal growth in 
the complementary feeding period and beyond (du Plessis, 2018).  In addition, early detection 
of overweight at routine growth monitoring visits and inclusion of obesity prevention messages 
in the updated Road to Health booklet are further strategies along with healthy eating at Early 
Child Development centres (DoH, 2015b). 
 
Nutrition sensitive interventions include high rates of access to safe water of 93%, although 
improved sanitation figures are much lower at 66% (WHO, 2016b). Health care is free for 
pregnant women and children (Chopra et al., 2009). There is a widely accessed social grant 
system, with the most commonly accessed grant being the Child Support Grant, which has been 
found to have a positive impact on HAZ (Heinrich et al., 2012). 
 
As can be seen, South Africa has a comprehensive set of both nutrition specific and nutrition 
sensitive interventions and yet stunting rates remain stubbornly high and overweight and 
obesity continue to increase. High rates of poverty and unemployment no doubt play a role, 
with SANHANES-1 reporting that less than half the population (45.6%) is food secure. The 
nutritional quality of the diet was also poor with 40% of the population having a DDS less than 
4 (Shisana et al., 2013).  As a result of the nutrition transition there has been a shift away from 
traditional diets based on unrefined grains and legumes to a diet high in sugar, refined grains 
and cheap vegetable oils (Popkin et al., 2011).  Energy dense but nutrient poor, highly 
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processed foods are widely available and cheap while healthier foods such as vegetables, fruit, 
lean meats and fish are expensive and often not available in rural areas (Igumbor et al., 2012). 
 
An independent report evaluating the implementation of nutrition interventions found that 
nutrition policies are often poorly implemented due to staff shortages and lack of staff training 
on nutrition. Breastfeeding and complementary feeding both scored very poorly on 
implementation effectiveness. Poor inter sectoral collaboration between the Departments of 
Health, Agriculture and Social Development was reported. KwaZulu-Natal was singled out in 
the report for its significant improvements in stunting rates. It is the only province where 
nutrition is managed at a Directorate level, giving it a higher profile. Nursing staff in the 
province had significantly better knowledge on key nutrition messages when compared to other 
provinces and there was a more appropriate budget for nutrition (du Plessis, 2015; DoH et al., 
2014). A recent review of South African interventions aimed at reducing maternal, neonatal 
and child morbidity and mortality, including some nutrition interventions for example 
breastfeeding, KMC and Vitamin A supplementation, also came to the conclusion that although 
policies were good and evidence based they were often poorly implemented and practised 
(English et al., 2017). The Obesity Strategy was only published fairly recently with the SSB 
tax finally implemented on 1 April 2018, so evaluation of the effectiveness will take a number 
of years. 
 
Therefore, poor nutritional outcomes despite good policies can be explained by lack of effective 
policy implementation against a backdrop of extremely high levels of unemployment, poverty 
and food insecurity in a country that has undergone a rapid nutrition transition. 
 Conclusion 
Childhood stunting and overweight are prevalent throughout LMICs and South Africa is no 
exception. Stunting has both short-term and long-term consequences. Stunted children have 
increased morbidity and mortality and in the long term, the evidence of the negative effect of 
childhood stunting on development of human capital is unequivocal. The risks for later 
development of obesity and NCDs are less clear-cut. Childhood obesity also has short-term 
consequences, but the long-term risk of increased adult obesity and NCD development is the 
most serious threat especially in a LMIC setting with limited health budgets and resources.  
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The determinants for both are complex and begin even before conception. This review, 
however, focused on the period from birth to two years. Being born too big or too small; rapid 
weight gain that is disproportionate to length gain, particularly after two years of age; and poor 
infant feeding practices result in poor growth outcomes. Stunting is closely linked to poor 
socioeconomic circumstances, lack of access to health care and basic services such as water 
and electricity. In HICs childhood obesity also affects the poor disproportionately while in 
LMICs this relationship is less clear but appears to be moving in a similar direction in some 
countries, including South Africa.  
Both stunting and overweight require nutrition specific as well as nutrition sensitive 
interventions in order to address the underlying determinants. Regarding nutrition specific 
interventions, feeding practices that promote linear growth in the first two years are important 
for both stunting and overweight prevention. Breastfeeding is vital for child survival and, while 
it has little impact on stunting, it is modestly protective against overweight. High protein 
formulas have been shown to increase rapid weight gain in the first year, which is a risk for 
later obesity. Dietary diversity and intake of iron rich foods are important aspects of 
complementary feeding for prevention of stunting. Dairy protein appears to have specific 
growth promoting effects, however high protein intake in the complementary feeding diet, 
especially dairy protein, increases the risk for overweight. Intake of energy dense but 
micronutrient poor foods such as SSBs, chips, sweets, biscuits is increasingly common in 
infants and young children in LMICs because of the nutrition transition and is a risk for both 
stunting and overweight. The same optimal IYCF practices, that is: exclusive breastfeeding for 
6 months; introduction of diverse, micronutrient-rich foods at six months with continued 
breastfeeding to two years are important aspects of both stunting and overweight prevention.   
Information on the determinants of childhood stunting and overweight is usually obtained from 
longitudinal birth cohort studies. The majority of these studies have been conducted in HICs 
and investigate the determinants of overweight only. There have been very few conducted in 
LMICs such as South Africa which experience high rates of both stunting and overweight. The 
MACE longitudinal birth cohort study provides an opportunity to investigate the association of 
socioeconomic conditions, infancy growth patterns and feeding practices with stunting and 
overweight at 12 months of age. 
  
67 
 
 
 METHODOLOGY 
 Introduction 
This study aimed to identify risk factors for overweight/obesity and stunting at 1 year of age in 
infants enrolled in the Mother and Child in the Environment (MACE) longitudinal birth cohort 
study, Durban. As discussed previously, both overweight and stunting are prevalent amongst 
South African children (Shisana et al., 2013). Identifying risk factors is important for 
developing effective prevention strategies and longitudinal birth cohort studies provide 
opportunities to investigate the association of a wide range of exposures in early life with 
growth outcomes at a later stage (Lawlor et al., 2009). The purpose of this chapter is to describe 
both the MACE and the MSc (Dietetics) study design. The study population is described as 
well as the methods and materials used in the collection of anthropometric and questionnaire 
data. The statistical tests used to analyse the data are discussed. Furthermore, steps taken to 
address issues of reliability, validity and bias, together with ethical considerations are 
described. 
 
 Study Design 
This MSc (Dietetics) study performed secondary data analysis using anthropometric and 
questionnaire data collected in the MACE study. This section will therefore firstly describe the 
MACE study and the strengths and limitations of longitudinal birth cohorts followed by a 
description of the MSc (Dietetics) study. 
 
 MACE study design 
The MACE study is an ongoing longitudinal birth cohort study designed to determine the effect 
of ambient and environmental pollution exposure on childhood respiratory development. A 
detailed protocol is attached (Appendix A, p140) and only the aspects relevant to this study 
will be described. The MACE study is monitoring the health and development of a cohort of 
pregnant women and their offspring attending public sector antenatal clinics in the north and 
south of Durban, KwaZulu-Natal. It plans to enrol 2000 women and their infants, with follow 
up of the children until the age of six years. The priority outcomes will be indicators of 
respiratory development as well as adverse respiratory outcomes.  
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3.2.1.1 Longitudinal birth cohort studies  
Longitudinal birth cohort studies are increasingly used for epidemiological research into early 
life determinants of later disease (Lawlor et al., 2009). A longitudinal birth cohort study follows 
the same individuals from birth, or pregnancy in some cases, taking repeated measures over 
time (Western et al., 2015). The individuals are usually born around the same time, but this 
may stretch over a few years, and follow up typically continues for years and often decades 
(Batty et al., 2007).   
Pregnancy and birth cohort studies provide one of the most powerful research methods for 
medical and social research (Western et al., 2015). Their advantages include being able to 
investigate a wide range of exposures and outcomes; and providing longitudinal data, which 
enables researchers to identify associations between exposures and outcomes. This is in 
contrast to cross sectional studies which only provide information about subjects at one point 
in time, making it difficult to determine if the exposure preceded the outcome (Western et al., 
2015). 
Birth cohort studies are however extremely costly to set up and maintain, with many of the 
more recent cohorts aiming to enrol 100 000 subjects (Lawlor et al., 2009). Further, retention 
of subjects over long periods of time can be difficult, resulting in large numbers lost to follow 
up. If this loss of subjects is not random it can skew the results (Song & Chung, 2010; Batty et 
al., 2007).  As with other observational studies, cohort studies cannot confirm causality and are 
limited to identifying associations (Reilly et al., 2005).  One of the barriers to confirming 
causality of a given exposure is that confounding by a number of factors, particularly 
sociodemographic factors can occur. Confounding is when a variable has an independent effect 
on both the independent and dependent variable and can lead to false conclusions of causality 
between the independent and the dependent variable. While these factors are usually controlled 
for, residual confounding can still occur (Lawlor et al., 2009). Cross cohort comparisons can 
be useful to determine if an association is confounded by comparing results from cohorts 
conducted under different social conditions. An example is breastfeeding, which has been 
shown in some cohorts in HICs to have a protective effect against childhood overweight. 
However, it is uncertain whether this finding is confounded by the fact that in HICs 
breastfeeding is more common in women of higher SES, which is in itself protective against 
overweight (Lawlor et al., 2009). In comparison to the findings from birth cohorts conducted 
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in HICs, a birth cohort conducted in Brazil, a LMIC where breastfeeding rates were not linked 
to SES, found no association between breastfeeding and overweight (Neutzling et al., 2009). 
This indicates that the relationship observed in HIC cohorts was probably due to confounding 
by SES. 
Birth cohorts in LMICs are rare compared to those in HICs and tend to be smaller and run for 
shorter periods of time. This is due to a number of factors including the high cost of maintaining 
the cohort, the fact that many births occur at home and not in hospital and difficulties in 
retaining participants because of greater internal migration in LMICs compared to HICs (Batty 
et al., 2007).  
 
 MSc (Dietetics) study design 
For the purpose of this MSc (Dietetics) study, the researcher extracted questionnaire and 
anthropometric data that were collected in the MACE study from 2013 to 2017. The variables 
of interest were determined, following a review of the literature on the determinants of 
childhood stunting and obesity. An additional questionnaire, adapted from the WHO IYCF 
Indicators, was administered by the researcher to caregivers attending the 12 month follow up 
visit from March 2016 to March 2017. The study had two aims: 
1) To determine the prevalence of stunting and overweight/obesity in the study infants at 
12 months 
2) To determine risk factors for stunting and overweight in the study infants. 
 
Although not included in the original objectives, 24 month anthropometric data became 
available for 144 infants during the year it took to collect infant feeding data from 94 12 months 
old infants. This 24 month data was included in the study results in order to report on the change 
in anthropometric status from 12 months to 24 months. 
 
 Study population 
Pregnant women in their first trimester, were enrolled in the MACE study. These women were 
attending public sector ante natal clinics in the south (Austerville, Merebank, Bluff, 
Lamontville and Wentworth Hospital antenatal clinic) and north (Newlands East, Newlands 
West and Kwa-Mashu Clinic B) of Durban. Enrolment started in 2013 and is currently ongoing.  
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The women were followed up at the clinics and at home during pregnancy, and the infants were 
followed up at 6 months and 12 months at the MACE study clinics at King Dinizulu Hospital 
and King Edward Hospital. The MACE study continues to follow up children until 6 years of 
age but due to time constraints, the MSc (Dietetics) study investigated outcomes at 12 months 
of age. Anthropometric data at 24 months of 144 infants was included as described in the 
previous section. 
 Study methods and materials 
The MSc Dietetics study used anthropometric and questionnaire data collected by the eight 
MACE study fieldworkers and clinical staff. The researcher collected additional infant feeding 
information at the 12 month clinic visit from a sub set of infants. This section will describe the 
methods in more detail. 
 Anthropometry 
Hospital birth weight and lengths were taken from the infants’ Road to Health booklets. Infants 
were weighed and measured at the 6 and 12 month mark by trained MACE study fieldworkers. 
Weights were taken using an electronic baby scale (Seca 354) and lengths were measured in a 
supine position using an infantometer (Seca 416). Weight was measured to the nearest 10 g and 
length to the nearest 0.1 cm. The 24 month data was collected using a Seca 786 mechanical 
column scale and measuring rod (Seca 224). Children who were less than 24 months were 
measured in a supine position using the infantometer. 
 
Date of birth, gender, date of clinic visit, weight and length were entered into the WHO Anthro 
computer programme, version 3.2.2 (WHO, 2011), which generated z scores for weight for age 
(WAZ), length for age (LAZ) and weight for length (WFLZ) for each child at birth, 6 months, 
12 months and 24 months.  BMI for age z scores (BAZ) were also generated for 12 and 24 
month data.  The LAZ and BAZ at 12 and 24 months were used to determine the prevalence of 
stunting and overweight/obesity in the study. Infants were classified using the WHO 
guidelines: stunted < -2 LAZ, severely stunted < -3 Z score; overweight >+2 BAZ, obese >+3 
BAZ (WHO, 2006).  Children with 24 month data were also classified using the IOTF age 
specific BMI cut offs if they were two years or older at the 24 month visit as the IOTF cut offs 
can only be used from the age of 2 years (Cole et al., 2000). There is lack of consensus 
regarding which classification method to use for childhood overweight so both the WHO 
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guidelines and IOTF cut offs were used in order to allow comparisons to be made with other 
studies (Rolland-Cachera, 2011).  
 
Anthropometric data were additionally used to determine the association of birth weight and 
length, and patterns of growth, with growth outcomes at 12 and 24 months. Birth WAZ and 
LAZ were used in the analyses together with patterns of growth from 0-6, 6-12 and 12-24 
months.  Rapid growth was defined as ≥0.67 change in WAZ or WFLZ between two time 
points; normal growth was <0.67>-0.67 change and slow or catch down growth as a ≤-0.67 
change (Ong & Loos, 2006). This change is equivalent to the crossing of one significant 
percentile band for example from the 2nd to the 10th centile (Ong & Loos, 2006).  Change in 
LAZ was also measured in the same way in order to determine associations with stunting 
outcomes. 
 
All flagged z scores were first checked with the original data collection forms and corrected if 
there had been a capturing error. Out of range measurements that remained were excluded as 
per the WHO recommendations (WHO, 2011).  
 
 Questionnaire data 
3.4.2.1 Maternal and household sociodemographic characteristics 
MACE study questionnaires were used to collect maternal and household sociodemographic            
information. Carefully selected fieldworkers drawn from the study area communities were 
trained and supervised to conduct baseline interviews with participants. The fieldworkers were 
all matriculated and had undergone training in HIV and TB counselling. They were volunteers 
at their respective clinics before recruitment into the MACE study. Training included providing 
techniques and practice in conducting interviews in a consistent and neutral manner. The 
questionnaires consisted of standardised questions extracted from past and current European 
birth cohorts, as well as environmental health studies conducted by the MACE research team 
previously. Questionnaires were tested in a pilot study, conducted in 2011 among 100 women, 
and revised where necessary. The questionnaires can be found in Appendices B to G (pp170-
183). 
 
Selected maternal and household sociodemographic information of interest in the MSc 
Dietetics study was extracted from the MACE data set for descriptive purposes. From these 
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variables a number of exposure variables were identified, following a review of the literature, 
as potential risk factors for stunting and/or overweight. These variables were included in further 
analysis to test their association with the outcome variables.  Further details of these exposure 
variables are now presented. 
 
Socioeconomic status 
Information on income, housing type and number of household members was used from the 
MACE Enrolment Questionnaire, an abridged version of which is presented in Appendix B 
(p170), and was captured as categorical data. 
 
Access to tap water and electricity 
Information regarding access to water and electricity was obtained from the MACE Enrolment 
questionnaire (Appendix B, p170). 
 
Maternal education 
Information on level of education was obtained from the MACE Enrolment Questionnaire 
(Appendix B, p170) and captured in categories ranging from having a highest education level 
of primary school or less up to the level of degree or diploma. 
 
Maternal smoking 
Information on antenatal smoking and alcohol consumption was obtained from the MACE 3rd 
Trimester; Part 2 Questionnaire, an abridged version of which is presented in Appendix C 
(p174), and was captured as either a “yes” or “no” variable. 
 
Infant HIV exposure 
HIV status in the MACE study mothers was recorded in the Clinical data at Trimester 3 
questionnaire (Appendix D, p176) and recorded as “positive”, “negative” or “unknown”. 
Mothers were tested by DoH staff with a rapid HIV test during routine antenatal clinic visits as 
per South African PMTCT Guidelines (DoH, 2015a). Confirmation of maternal status was 
obtained from the Labour/Postnatal questionnaire (Appendix E, p178) and, if there was 
discordance between the two questionnaires, maternal HIV status was verified by asking the 
relevant field worker. 
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3.4.2.2 Infant feeding practices 
The MACE medical staff recorded limited information on infant feeding practices at 6 months 
(n=233) and 12 months (n=290). An additional questionnaire using the WHO Indicators for 
Assessing Infant and Young Child Feeding (hereafter referred to as the WHO Indicators) 
(WHO, 2010) was adapted for use in the South African context. It was administered by the 
researcher to provide more detailed information on feeding practices at 12 months in a sub set 
of 94 infants; this being the number of infants who had attended the 12 month visit during the 
data collection period from March 2016 to March 2017. 
 
MACE questionnaire information 
The MACE 6 month follow up questionnaire, an abridged version of which is presented in 
Appendix F (p181), included questions about type of milk feeds and age of introduction of 
complementary foods. The information on type of milk feeds was classified as exclusively 
breast fed (EBF), exclusively formula fed (EFF), fresh milk, or mixed feeds (MF). The age of 
introduction of complementary foods was captured both as a continuous variable and as 
categories; < 4 months; 4-5.9 months; 6 months and > 6 months. Information on the type of 
introductory food was categorised as porridge or infant cereal. Commercial jarred food intake 
was also recorded. All of these variables were used to describe infant feeding practices at 6 
months of age. The 6 month feeding variables were further analysed to determine their 
association with growth outcomes at 12 months.  
 
The 12 month MACE follow up questionnaire, an abridged version of which is presented in   
Appendix G (p183), also included a question regarding the type of milk feeds which were 
categorised in the same way as for 6 month milk feeds. As with the 6 month feeding practices 
information, 12 month data were used both for descriptive purposes and to test their association 
with growth outcomes. 
 
Feeding practices at 12 months 
The 12 month Nutrition questionnaire was adapted by the researcher for the South African 
context from the WHO Indicators (WHO, 2010).  The questionnaire is attached in Appendix H 
(p185). The researcher administered the questionnaire to the mothers of children attending the 
12 month visits at the study sites at King Edward and King Dinizulu hospitals. The WHO 
Indicators were selected as they are a tested valid and reliable tool (WHO, 2008a). They are 
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fairly quick to administer which was an important consideration as there was limited time to 
conduct the interviews. A further advantage is that the relative simplicity of the tool meant that 
the MACE fieldworkers could be trained in administering them in the future.   
Although the WHO Indicators are made up of eight indicators that include both breastfeeding 
and complementary feeding, for the purposes of this study, only four of the core indicators 
were assessed.  These core indicators were (i) Minimum Dietary Diversity; (ii) Minimum Meal 
Frequency; (iii) a composite measure of MDD and MFF, Minimum Adequate Diet; and (iv) 
Iron Rich Food Consumption. A 24 hour dietary recall was used to collect the data as per the 
WHO (2010) guidelines. Information on milk feeds (breast, formula or fresh milk/maas) was 
also collected as it was required in the MDD, MMF and MAD calculations.  
 
The Dietary Diversity Score was calculated by allocating 1 point for any food consumed out 
of the following seven food groups: 
1. Grains, roots and tubers; 
2. Legumes and nuts; 
3. Dairy products; 
4. Flesh foods; 
5. Eggs; 
6. Vitamin A rich fruit and vegetables; 
7. Other fruits and vegetables. 
The Minimum Dietary Diversity (MDD) indicator was calculated based on having consumed 
at least four of the seven food groups in the previous 24 hours (WHO, 2010). Data were 
captured as a continuous score as well as categorical “met MDD” or “did not meet MDD”. 
According to the WHO Indicators, the Minimum Meal Frequency (MMF), for infants aged 12 
months is the consumption of solid, semi solid or soft foods three times in the previous 24 
hours for breastfed infants and four times for non-breastfed infants (WHO, 2010). Milk feeds 
are included in the MMF calculation for non-breastfed infants, but not for breastfed infants. 
Both continuous and categorical data were captured. 
 
The Minimum Acceptable Diet (MAD) Indicator is a combination of the MDD and MMF 
Indicators. Breastfed infants must have had the MDD and MMF the previous day. Non- 
breastfed infants must have had the MDD (not including milk feeds) and MMF the previous 
day as well as two milk feeds (WHO, 2010). Data were captured as having an “adequate” or 
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“inadequate” diet. Iron Rich Food (IRF) consumption included flesh foods, infant formula and 
infant cereal. It was captured as a “yes” or “no” variable. 
 
The WHO advises that in countries that are experiencing a nutrition transition, where childhood 
obesity is a problem, indicators of high sugar and high fat food consumption should be included 
(WHO, 2010). Therefore, an unquantified food frequency questionnaire formed part of the 12 
Month Nutrition Questionnaire (Appendix H, p181) and was used to collect data on fruit juice, 
sugar sweetened beverage (SSB) and high fat snack (HFS) consumption; hereafter referred to 
as inappropriate food consumption. The percentage of infants consuming each of the three 
categories once a week or more was determined for descriptive purposes. This enabled 
comparison with other South African studies that had collected similar data (Budree et al., 
2017; Faber et al., 2016) A daily consumption score was calculated and entered as continuous 
data in order to determine the association with growth outcomes. An unquantified food 
frequency questionnaire was used to collect the high sugar/high fat foods information as it 
could be missed with a 24 hour dietary recall. 
  
The 12 month Nutrition Questionnaire was used to describe complementary feeding practices 
in the study infants. It also provided an opportunity to test the association of the WHO 
complementary feeding indicators, together with inappropriate food intake, with child 
anthropometric status in a setting where both stunting and overweight prevalence is high. 
 Data analysis 
The MACE study data of interest in the MSc Dietetics study were extracted from a number of 
different data sheets and incorporated into a master Microsoft Excel spreadsheet. 
Anthropometric data was entered into the WHO Anthro programme (WHO, 2011) to generate 
Z scores for birth, 6 month, 12 month and 24 month data. The Z scores and the 12 Month 
Nutrition questionnaire data were entered into the master spreadsheet. 
 
Once the data had been checked for errors, it was analysed using the Statistical Package for 
Social Sciences (SPSS) version 21. Descriptive tests were used to describe maternal and 
household characteristics, anthropometric status of the study infants, patterns of growth and 
feeding practices. 
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Further analysis of the data was conducted to explore associations of the exposure variables 
with the outcome variables, namely stunting and overweight / obesity at 12 months.  Chi square 
tests of independence were performed to test if any significant associations existed between 
selected household and maternal factors, and infant feeding practices, and the outcome 
variables.  
 
The association of birth anthropometric status, and patterns of growth, with growth outcomes 
at 12 months was explored using both categorical growth outcomes and continuous data. Mean 
birth and growth pattern data in relation to LFA and BMI categories at 12 months was 
investigated using analysis of variance (ANOVA). The LFA categories were normal length, 
stunted and severely stunted. The BMI categories were “wasted”, “normal”, “at risk of 
overweight”, “overweight” and “obese”. Linear regression analysis was applied to explore the 
relationship using continuous data. The aims of these analyses were: 
 
a) To identify differences in mean birth WAZ and LAZ, and growth patterns, between those 
of normal height and BMI at 12 months and those who were not. 
b) To explore the causal relationship between birth WAZ and LAZ,  and growth patterns, and 
12 month LAZ and BAZ  
c)   To identify the time period during which growth most strongly predicts LAZ and BMIZ at            
12 months.   
 
Significance was set at a p value of less than 0.05. Table 3-1 provides further details about each 
objective; the variables relevant to each objective; and the combination of statistical methods 
applied. 
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Table 3-1: Data analysis of objectives 
Research Objective Variable Method of analysis 
1. To determine the anthropometric 
status of the study infants at 12 
months.  
 
1.1 To describe the prevalence of 
stunting and overweight in the 
cohort. 
1.2 To determine the outcome 
variables, namely stunting and 
overweight in the study infants. 
12 month weight and 
length. 
Additional information 
required: 
Date of visit, gender, date 
of birth. 
 
Data entered into WHO Anthro 
programme; WAZ, LAZ, WFLZ, BAZ 
generated.  
Report generated from WHO Anthro of 
prevalence in cohort of stunting, wasting, 
overweight and obesity. 
2.1 To describe maternal/ household 
characteristics of the cohort. 
 
2.2 To determine if 
maternal/household characteristics 
are associated with stunting and 
overweight. 
Household income 
Number of household 
members 
Type of housing 
Number of rooms 
Access to tap water 
Access to electricity 
Maternal smoking 
Maternal alcohol intake 
Maternal level of 
education 
Maternal HIV status 
2.1 Descriptive statistics. 
2.2 Chi square tests of independence. 
3.1 To describe infant anthropometric 
status at birth and growth patterns 
from birth to 6 months and from 6 
months to 12 months. 
3.2 To determine if birth weight and 
length and patterns of growth from 0- 
6 and 6 to 12 months are associated 
with growth outcomes at 12 months. 
 
Birth, 6 month and 12 
month weights and lengths. 
 
3.1 Data entered into WHO Anthro 
programme; WAZ, LAZ, WFLZ generated. 
Change in WAZ, LAZ and WFLZ from 
birth to 6 months and 6 months to 12 
months calculated. 
3.2 ANOVA; Linear regression analysis. 
4.1 To describe infant feeding 
practices at 6 months and 12 months. 
 
4.2 To determine if infant feeding 
practices are associated with growth 
outcomes at 12 months. 
6 months (MACE) 
BF/FF/mixed. 
Age intro of CF.  
Type of food     (porridge, 
cereal, Purity). 
 
12 months (MACE) 
BF/FF/milk. 
12 month Nutrition Q 
Adequacy of CF. 
Intake of SSB/HFS.  
4.1 Descriptive statistics. 
4.2 Chi square tests of independence. 
 
 
 
 
 
 
 
 
  Reliability and validity 
In order for research to produce trustworthy results it is important that the instruments used to 
collect data are both reliable and valid (Roberts et al., 2006). Reliability is the ability of an 
instrument or test to consistently give the same measurement while validity is the ability of the 
instrument or test to accurately measure what it is intended to measure (Roberts et al., 2006).  
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The reliability and validity of the anthropometric data collected in the MACE study was 
addressed by training fieldworkers in standard procedures for weighing and measuring children 
using the WHO guidelines (WHO, 2008b) and by calibration of the electronic scales. The WHO 
Growth Standards, which were used to classify stunting and overweight, are internationally 
recognised. They were developed using rigorous methodology and are a technically robust tool 
that can be used to assess children regardless of ethnicity, socioeconomic status or type of 
feeding. (WHO, 2006). The growth standards were externally validated through field-testing 
in four countries, chosen to provide representative samples of both under- and over-nutrition 
(Onyango et al., 2007).    
                  
The sociodemographic questionnaire used to collect baseline data was adapted from 
questionnaires used by the MACE study team in previous studies in the same community. They 
were pilot tested in 100 subjects and changes made where necessary. Fieldworkers were trained 
in asking questions in a consistent and neutral manner. MACE medical doctors collected the 
feeding practices information in the MACE 6 and 12 month follow up questionnaires. 
 
The 12-month Nutrition questionnaire used the WHO Indicators. These are simple, valid and 
reliable indicators to assess infant and young child feeding practices, developed through testing 
in 10 countries over a 5-year period (WHO, 2008a). They have been used in a number of recent 
South African studies (Budree et al., 2017; DoH et al., 2017; du Plessis et al., 2016) which 
allows for comparison across studies. Collection of consistent and accurate information was 
ensured as the researcher administered all the questionnaires personally, asking the questions 
exactly as specified (WHO, 2010).  
 
 Reduction of bias 
Bias in research is “any trend or deviation from the truth in data collection, data analysis, 
interpretation and publication which can cause false conclusions” (Simundic, 2013). In 
longitudinal birth cohort studies the two main sources of bias are selection bias and 
confounding bias. 
 
Selection bias can occur at recruitment if the subjects volunteering to participate in the study 
are not representative of the population.  Golding & Birmingham (2008) recommend a number 
of strategies to maximise recruitment including personal contact of study staff with potential 
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participants; providing clear information about the study, the benefits and any risks as well as 
any cost implications; assurance of confidentiality; and the voluntary nature of the study. The 
MACE study followed all of these recommendations as study fieldworkers were stationed at 
all the participating clinics, all eligible women were invited to participate and the informed 
consent form was explained to the mothers in their home language before signing. The 
informed consent form explained the purpose of the study, what would be required of 
participants, benefits and risks, confidentiality, reimbursement of travelling costs, and the 
voluntary nature of the study. This consent form is presented in Appendix K (p189).    
                    
Selection bias can also occur if large numbers of participants were lost to follow up and the 
characteristics of these participants differs significantly from those who remained in the study 
(Song & Chung, 2010). Retention of participants is always a problem in longitudinal studies, 
and is particularly difficult in birth cohorts in LMICs (Batty et al., 2007).  Strategies to enhance 
retention in the MACE study included regular follow up by field workers, covering of transport 
costs, meals provided at clinic visits and occasional gift packs.  
 
An important limitation to determining causation between exposure and outcome in any cohort 
study is potential confounding (Lawlor et al., 2009). Socioeconomic status and maternal 
education are well documented confounding factors in the relationship between feeding 
practices and growth outcomes (Lawlor et al., 2009; Reilly et al., 2005).  Information on 
income and maternal education was collected in the MACE baseline questionnaire. 
 
 Roles of the researcher 
The researcher identified the variables of interest from the MACE datasets. Data required to 
measure the variables were extracted from eight separate data sheets and incorporated into one 
master datasheet. Weights and lengths of each child at birth,. 6 months, 12 months and 24 
months were entered into the WHO Anthro programme and the Z scores were then entered into 
the master data sheet. The researcher coded 6 month nutrition information from the MACE 6 
month questionnaires. The 12 month Nutrition Questionnaire was developed by the researcher; 
using the WHO IYCF Indicators and adding a section on inappropriate foods consumption. 
The questionnaire was administered to mothers attending the 12 month clinic visit by the 
researcher. This data collection period ran from March 2016 to March 2017.  Mothers received 
feedback on their child’s growth and complementary feeding advice from the researcher after 
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the questionnaire was completed. Information collected in the questionnaire was used to 
calculate DDS, MF and determine if MDD,. MMF and MAD indicators were met. This data 
were entered into the master spreadsheet together with inappropriate food consumption scores.  
 
 Ethical considerations  
Ethical clearance for the MACE study was obtained from the Biomedical Research Ethics 
Committee (BREC) of the University of KwaZulu-Natal; Reference: BF 263/12 (Appendix I, 
p187) and the KwaZulu-Natal Department of Health (Appendix J, p188). Women enrolled in 
the MACE study signed individual consent forms (Appendix K, p189). Additional ethical 
approval for the MSc (Dietetics) study was also obtained from BREC; Reference: BE 479/15 
(Appendix L, p193). Confidentiality was maintained through the use of codes for each 
participant and no names were recorded. 
 
 Summary 
This chapter described the MACE longitudinal birth cohort study, which provided most of the 
data used in the MSc (Dietetics) study. The strengths of longitudinal birth cohort studies as a 
research tool were discussed together with the limitations. The chapter briefly reviewed the 
literature supporting the choice of exposure variables. The methodology used to collect and 
analyse the anthropometric and questionnaire data used in the MSc (Dietetics) study was 
described.  Aspects related to the quality of the data namely, reliability and validity of the tools 
used, and the steps taken to avoid bias were outlined. The next chapter describes the results of 
the study. 
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 RESULTS 
The results of the study research objectives outlined in Chapter 1 are now presented. The 
household and maternal characteristics are outlined to provide context to the study population. 
The anthropometric status of the study population at 12 months of age is described. The 
associations of selected household and maternal characteristics with the outcome variables of 
stunting and overweight at 12 months are presented. The infant factors that could potentially 
be associated with the outcome variables, namely growth patterns and feeding practices, are 
described together with their association with the outcome variables. 
 
 Maternal and household characteristics of the study population    
Data were available for 288 mothers. The mean maternal age was 26.0 years (range 15-43 
years; SD 6.0) and level of education was relatively high where 55% (n=160) had a matric 
certificate and a further 15% (n= 43) had a degree or diploma. HIV prevalence was 35.3% 
(n=102). Participants’ primary language were predominantly indigenous African languages: 
65.7% (n=189) spoke Zulu or Xhosa at home and 32.5% (n=94) spoke English or Afrikaans. 
Income levels were low with 66.8% (n=192) of mothers and 30.4% (n=88) of fathers reporting 
that they had no income or earned less than R2000.00 per year.  Less than 5% (n=13) of mothers 
reported that they had smoked or consumed alcohol during pregnancy. While the average 
household size ranged between 2 and 18 members, the average size was six. Access to tap 
water was universal and only three households did not have electricity.  Less than 10% (n=25) 
of the sample lived in informal housing.  Details of the maternal and household characteristics 
are reported in Table 4-1.      
  
82 
 
 
Table 4-1: Maternal and household sociodemographic information (n=288) 
Variable n % 
Maternal education: 
Primary school or less 
Some high school 
Matric 
Degree/diploma 
 
4 
81 
160 
43 
 
1.3 
28.4 
55.4 
14.9 
Lived with spouse 80 28.1 
HIV prevalence 102 35.3 
Alcohol intake during pregnancy 13 4.5 
Smoked during pregnancy 11 3.8 
Home language: 
Zulu 
English 
Xhosa 
Afrikaans 
 
173 
93 
16 
1 
 
60.2 
32.2 
5.5 
0.3 
Type of housing: 
Detached/ semi-detached house 
Flat/ apartment 
Informal house 
 
199 
64 
25 
 
69.1 
22.2 
8.7 
Access to tap water 288 100 
Access to electricity 285 98.9 
Annual Income   
 
 
No income  
<R2000,00 
R10 000-R30 000 
R30 001- R75 000 
R75 001-R150 000 
>R150 000 
Refused to answer 
Maternal Paternal 
n % n % 
133 
59 
53 
24 
9 
0 
10 
46.4 
20.4 
18.3 
8.3 
3.1 
0 
3.5 
62 
26 
72 
54 
39 
10 
26 
21.5 
9 
24.9 
18.7 
13.5 
3.5 
9 
 
 The anthropometric status of the study infants at 12 months  
The sample consisted of 290 infants; 157 (54.1%) males and 133 (45.9%) females. Two study 
infants had anthropometric data at 12 months but maternal data was missing. The 
anthropometric status of the study infants, classified using WHO criteria for length for age 
(LFA) and BMI for age, is presented in Table 4.2. The prevalence of overweight was 14.5% 
(n=42) and obesity 7.2% (n=21) with a further 22% (n=64) classified as being at risk of 
overweight according to WHO criteria. The mean BMI for age Z score (BAZ) was 0.81 (SD 
1.42). Stunting prevalence was far lower at 5.9 % (n=17) with a mean length for age Z score 
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(LAZ) of -0.01 (SD 1.24), while four children (1.4%) were wasted. Only one child (0.35%) 
was both stunted and overweight. Chi square tests revealed no relationship between gender and 
either stunting (p=0.897) or overweight/obesity (p=0.222).  
 
Table 4-2: Anthropometric classification of study population at 12 months (n=290*) 
 
* Anthropometric data at 12 months was available for an additional 2 infants who had no maternal data 
**Mean LAZ = -.01 (SD 1.24) 
***Mean BAZ =.81 (SD 1.42)   
  
The LAZ and BAZ for each child, which were used to determine the prevalence of stunting 
and overweight categories, were also used to generate the outcome variables of stunting and 
overweight/obesity in the study population. They are used in the analyses that follow in sections 
4.3, 4.4, 4.5 and 4.6. 
 Association of maternal and household characteristics with stunting and 
overweight at 12 months  
Chi square tests of independence were used to determine if there was an association between 
maternal and household characteristics and stunting and/or overweight. There was a significant 
relationship between type of housing and stunting (Fisher’s exact=8.321, p=0.048). 
Significantly more than expected of those who lived in a flat/apartment compared to houses 
were stunted and of those who lived in informal housing were severely stunted. Type of housing 
was also associated with BMI outcomes (Fisher’s exact = 15.014, p=0.040). Significantly more 
than expected of those who lived in informal housing compared to those who lived in houses 
or flats were at risk of overweight, overweight or wasted. The other variables had no significant 
association with either stunting or overweight categories or wasting. Table 4-3 presents the 
cross-tabulation of selected maternal and household characteristics across LFA and BMI 
categories.  
 
 n % 
LFA ** 
Normal  
Stunted (<-2 SD) 
Severely stunted (<-3 SD) 
 
273 
15 
2 
 
94.1 
5.2 
0.7 
BMI *** 
Normal 
At risk of overweight(>+1SD) 
Overweight (> +2 SD) 
Obese (> +3 SD) 
Combined overweight and obesity 
Wasted  (<-2 SD) 
 
159 
64 
42 
21 
63 
4 
 
54.8 
22.1 
14.5 
7.2 
21.7 
1.4 
84 
 
 
Antenatal smoking was not associated with birthweight (p=0.226) or length (p=0.910).  There 
was also no association between antenatal alcohol intake and birthweight (p=0.183) or length 
(p=0.449). 
 
Table 4-3: Maternal and household characteristics across LFA and BMI categories at 
12 months  
 
*p<0.05 
  
 
 
LFA Categories BMI Categories 
Stunted 
 
Severely 
stunted 
 
Wasted 
 
At risk of 
overweight 
 
Overweight 
 
Obese 
 
n     % n % n % n % n % n % 
Annual Income: 
<R10 000(maternal)n=192 
<R10 000(paternal)n=88 
 
>R10 000(maternal)n=86 
>R10 000(paternal)n=174 
 
12 
4 
 
2 
9 
 
6.3 
4.5 
 
2.3 
5 
 
2 
0 
 
0 
2 
 
1 
0 
 
0 
1.1 
 
1 
2 
 
3 
2 
 
0.5 
2.3 
 
3.5 
1.1 
 
43 
13 
 
17 
42 
 
22.4 
14.8 
 
19.8 
24.1 
 
31 
13 
 
10 
26 
 
16.1 
14.8 
 
11.6 
14.9 
 
16 
7 
 
5 
11 
 
8.3 
7.9 
 
5.8 
6.3 
Type of housing: 
House (n=198) 
Flat/apartment (n=64) 
Informal housing (n=25) 
 
8 
7 
0 
 
4 
10.9* 
0 
 
1 
0 
1 
 
0.5 
0 
4* 
 
1 
1 
1 
 
0.5 
1.6 
4* 
 
40 
15 
8 
 
20.3 
23.4 
32* 
 
32 
3 
6 
 
16.2 
4.7 
24* 
 
16 
4 
1 
 
8.1 
6.3 
4 
Maternal education: 
Some secondary (n=85) 
Matric (n=160) 
Degree or diploma (n=43) 
 
7 
7 
1 
 
8.2 
4.4 
2.3 
 
1 
1 
0 
 
1.1 
0.6 
0 
 
0 
3 
1 
 
0 
1.9 
2.3 
 
15 
38 
10 
 
17.5 
23.8 
23.3 
 
15 
19 
7 
 
17.5 
11.9 
16.3 
 
4 
10 
7 
 
4.7 
6.3 
16.3 
Home language: 
Zulu/ Xhosa (n=190) 
English/ Afrikaans (n=93) 
 
7 
7 
 
3.7 
7.5 
 
2 
0 
 
1 
0 
 
2 
2 
 
1 
2.2 
 
39 
23 
 
20.5 
24.7 
 
30 
8 
 
15.7 
8.7 
 
16 
5 
 
8.4 
5.4 
Maternal HIV status: 
HIV positive (n=99) 
HIV negative (n=186) 
 
5 
10 
 
5 
5.4 
 
1 
1 
 
1 
0.5 
 
2 
2 
 
2 
1.1 
 
24 
39 
 
24.2 
21 
 
14 
27 
 
14.1 
14.5 
 
7 
14 
 
7.1 
7.5 
Antenatal smoking: 
Yes (n=11) 
No (n=277) 
 
2 
13 
 
18.2 
4.7 
 
0 
2 
 
0 
0.7 
 
0 
4 
 
0 
1.5 
 
3 
56 
 
27.3 
20.8 
 
1 
39 
 
9.1 
14.5 
 
0 
21 
 
0 
7.6 
Antenatal alcohol:  
Yes (n=13) 
No (n=276) 
 
1 
14 
 
7.7 
5.1 
 
0 
2 
 
0 
0.7 
 
0 
4 
 
0 
1.5 
 
3 
60 
 
23.1 
21.8 
 
4 
38 
 
30.8 
13.8 
 
0 
21 
 
0 
7.6 
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    Birth anthropometric data and patterns of growth in the first 12 months 
This section presents birth anthropometric data and data on rate of growth from birth - 6 months 
and 6-12 months, followed by an analysis of the association of this data with the outcome 
variables. 
 
 Description of birth anthropometric status and rate of growth from birth-6 
months and 6-12 months  
a) Birth data 
The mean birthweight was 3173 g and the prevalence of term, low birthweight (<2500 g) was 
8.2% (n=23). Detailed birth anthropometric data of the sample can be found in Table 4.4. Mean 
birth weight for age Z score (WAZ) of - 0.2299 was below the WHO reference mean while 
mean birth LAZ of 0.3461 was above it.  
Table 4-4: Birth anthropometric data of study sample (n=288) 
 Mean SD Minimum Maximum 
Birthweight 3173.39 g 479.76 1910 g 4570 g 
WAZ -0.2299 1.03678 -4.18 2.25 
LAZ 0.3461 1.42780 -4.16 4.7 
*Birth/maternal data was missing for two subjects 
 
b) Growth  from birth to 6 months 
Change in WAZ, LAZ and weight for length Z score (WFLZ)  between birth and 6 months was 
calculated and classified as “slow” (≤-0.67); “normal” (-0.67 to +0.67) and “rapid” (≥+0.67) 
growth. The prevalence of each category of growth in the study sample is presented in Table 
4-5. 
Table 4-5: Prevalence of growth categories: 0-6 months 
 Slow growth Normal growth Rapid growth 
n % n % n % 
WAZ (n=233)* 26 11.2 84 36.1 123 52.7 
LAZ (n=226)** 92 40.9 73 32.4 60 26.7 
WFLZ (n=226)** 28 12.4 30 13.3 168 74.2 
* 50 infants did not attend 6 month visit and an additional 7 had missing/out of range weights at birth or 6 months 
**7 additional infants who attended 6 month visit had missing or out of range lengths at birth or 6 months  
 
Rapid gains in weight occurred in over 50% (n=123) of the sample in the first 6 months of life. 
Linear growth on the other hand was more evenly distributed across the growth categories with 
“slow” growth being the most predominant category. This disproportionate weight gain in 
relation to linear growth is reflected in the almost 75% (n=168) prevalence of “rapid” gain in 
weight for length in the study sample. 
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c) Growth from 6-12 months 
Change in WAZ, LAZ and WFLZ between 6 and 12 months was calculated and classified as 
“slow”, “normal” and “rapid” growth as before. The prevalence of each category of growth in 
the study sample is presented in Table 4-6. 
 
Table 4-6: Prevalence of growth categories: 6-12 months 
 Slow growth Normal growth Rapid growth 
n % n % n % 
WAZ (n=233)* 29 12.5 158 67.8 46  19.7 
LAZ (n=232)** 64 27.6 98 42.2 70 30.2 
WFLZ (n=232)** 64 27.6 107 46.1 61 26.3 
* 50 infants did not attend 6 month visit and an additional 7 had missing/ out of range weights at 6 or 12months 
**An additional 1 infant who attended 6 month visit had missing length data at 6 or 12 months 
 
Prevalence of “rapid” gain in WAZ decreased considerably in the 6-12 month period, compared 
to the 0-6 month period, with more than two thirds of infants falling into the “normal” growth 
category. Change in LAZ was once again spread more evenly among the categories but “slow” 
growth was now the least common category. The decrease in rapid weight gain accompanied 
by increased linear growth resulted in a sharp decrease in the prevalence of “rapid” WFLZ gain 
from over 75% in the 0-6 month period to 26% (n=61).  The difference in growth patterns 
tween birth to 6 months and 6 to 12 months is illustrated in Figure 4-1. 
 
Figure 4-1: Percentage of infants in each growth category: 0-6 and 6-12 months 
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WAZ  (0-6m) WAZ  (6-12m) LAZ  (0-6m) LAZ  (6-12m) WFLZ  (0-6m) WFLZ  (6-
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Slow Normal Rapid
87 
 
 
 The association of birth anthropometric data and growth patterns with growth 
outcomes at 12 months 
This sub-section first presents mean birth and growth pattern data in relation to LFA and BMI 
categories at 12 months using analysis of variance (ANOVA). The LFA categories are normal 
length, stunted and severely stunted. The BMI categories are wasted, normal, at risk of 
overweight, overweight and obese. The second part of the sub-section reports the results of the 
linear regression analysis. 
4.4.2.1 Difference in growth patterns across 12 month growth outcome categories  
Mean birth WAZ and LAZ and the mean change in LAZ for each LFA category; and change 
in WAZ, LAZ and WFLZ for each BMI category, at 12 months was determined. Analysis of 
variance (ANOVA) was applied to test for significant differences in means across categories. 
Results are reported for LFA categories first, and BMI categories second, for birth, 0-6 and 6-
12 months data. 
a) Birth data 
Mean birth WAZ and LAZ for each LFA category and BMI category together with the results 
of the ANOVA are presented in Tables 4-7 and 4-8 respectively.    
There was a significant difference in mean birth WAZ and LAZ for the different LFA 
categories. Children who were classified as normal height at 12 months had a significantly 
higher birth WAZ on average than those classified as stunted (p=0.002). Mean birth LAZ was 
also significantly higher in children classified as normal height at 12 months compared to those 
classified as stunted (p=0.002).  
Table 4-7: Mean birth WAZ and LAZ across LFA categories at 12 months 
 Mean birth WAZ 
(SD) 
Mean Birth LAZ 
(SD) 
LFA categories at 12 months: 
Normal  
Stunted 
Severely stunted 
Total 
 
-0.1766 (1.0078) 
-1.1260 (1.2160) 
-0.7000 (0.5374) 
-0.2299 (1.0368) 
 
0.4189 (1.4062) 
-0.7127 (1.3316) 
-1.4350 (1.2374) 
0.3461 (1.4278) 
 df 2:284 2:281 
F-statistic 6.397 6.251 
p value p=0.002 p=0.002 
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 Table 4-8: Mean birth WAZ, birthweight and LAZ across BMI categories at 12 
months 
 Mean birth WAZ 
(SD) 
Mean Birthweight 
(SD) 
Mean birth LAZ 
(SD) 
BMI categories at 12 months: 
Wasted  
Normal  
At risk of overweight 
Overweight 
Obese 
Total 
 
-2.215 (1.210) 
-0.4112 (0.9756) 
-0.798 (1.1969) 
0.1968 (0.7743) 
0.1514 (0.6441) 
-0.2337 (1.0366) 
 
2325 g (413.32) 
3088 g (435.80) 
3235 g (576.78) 
3396 g (392.64) 
3338 g (306.44) 
3173 g (479.76) 
 
-1.5367 (1.5366) 
-0.3768 (1.3247) 
0.2253 (1.5672) 
0.3762 (1.6269) 
0.5814 (1.1410) 
0.3384 (1.4245) 
df 4:281 4:283 4:278 
F-statistic 8.508 8.357 1.599 
p value p<0.0005 p<0.0005 p=0.175 
 
There was a significant difference in mean birth WAZ for the different BMI categories. 
Children who were classified as wasted at 12 months had a significantly lower birth WAZ and 
birthweight on average than all other BMI categories. The specific p values for each category 
are as follows: normal (p=0.012); at risk of overweight (p=0.002); overweight (p<0.0005; 
obese (p<0.001). Children classified as overweight at 12 months had a significantly higher 
mean WAZ (p=0.014) and weight (p<0.0005) at birth than those classified as having a normal 
BMI. There was no significant difference in mean LAZ at birth across BMI categories at 12 
months (p=0.175). 
 
b) Change in LAZ, WAZ and WFLZ: 0-6 months                                                                
Data were analysed to determine if mean change in Z score between birth and 6 months differed 
across LFA and BMI for Age categories at 12 months. Results for LFA categories are presented 
in Table 4-9 and those for BMI categories in Table 4-10. 
Table 4-9: Mean change in LAZ 0-6 months across LFA categories at 12 months  
 Mean change LAZ:      
0- 6 months (SD) 
LFA categories at 12 months: 
Normal  
Stunted 
Severely stunted 
Total 
 
-0.2770 (1.6387) 
-0.8878 (1.7676) 
-0.3450 (0.9405) 
-0.2958 (1.6392) 
 df 2:223 
F-statistic 0.752 
p value. p =0.473 
 
89 
 
 
There was no significant difference in the mean birth to 6 month change in LAZ across LFA 
categories at 12 months (p=0.473). Mean change in Z score for all categories except stunting 
was within in the range for “normal” growth (-0.67 to +0.67 change). 
 
Table 4-10: Mean change in WAZ, LAZ and WFLZ across BMI categories at 12 
months 
  Mean change 
WAZ: 0-6 mths 
(SD) 
Mean change 
LAZ: 0-6 mths 
(SD) 
Mean change 
WFLZ: 0-6 mths 
(SD) 
BMI categories at 12 months: 
Wasted 
Normal 
At risk of overweight 
Overweight 
Obese 
Total 
 
0.5050 (0.6537) 
0.4487 (1.1256) 
0.9308 (1.1818) 
1.0374 (1.070) 
2.0011 (1.120) 
0.7555 (1.1988) 
 
0.2167 (0.8594) 
-0.3810 (1.5014) 
-0.1331 (1.8790) 
-0.6103 (1.5929) 
0.2683 (1.9403) 
-0.2958 (1.6392) 
 
0.8750 (0.0354) 
1.5047 (1.9736) 
1.8813 (2.2377) 
2.2494 (2.0505) 
2.6747 (1.9038) 
1.7802 (2.0551) 
df 4:228 4:221 4:226 
F-statistic 8.732 1.093 2.039 
p value p<0.0005 p =0.361 p =0.090 
 
There was only a significant difference in the mean change in WAZ across BMI categories. 
The mean change in WAZ from 0-6 months was significantly greater in those children who 
were classified as obese at 12 months than in those classified as normal (p<0.0005) or at risk 
of overweight (p=0.019). Mean change in WAZ was above +0.67 for the sample in total at 
+0.7555 with only children classified as being wasted or normal at 12 months having a mean 
change in WAZ in the “normal” growth range. 
Change in LAZ was in the “normal” growth range for all BMI categories while all BMI 
categories had a mean change in WFLZ in the “rapid” growth category. Children classified as 
overweight or obese at 12 months had a mean change in WFLZ greater than + 2. 
c) Change in LAZ, WAZ and WFLZ: 6-12 months  
Data were again analysed to determine if mean change in Z score between 6 and 12 months 
differed across LFA and BMI for age categories at 12 months. Mean change in LAZ in each 
LFA category is presented in Table 4-11. Change in WAZ, LAZ and WFLZ is shown in relation 
to BMI categories in Table 4-12. 
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Table 4-11 Mean change in LAZ across LFA categories at 12 months 
 Mean change LAZ:       
6 -12 months (SD) 
LFA categories at 12 months: 
Normal  
Stunted 
Severely stunted 
Total 
 
0.1191 (1.2974) 
-0.3633 (1.1263) 
-1.9680 (0.3606) 
0.0826 (1.3011) 
 df 2:230 
F-statistic 3.150 
p value p=0.045 
 
Infants who were classified as normal at 12 months of age had a significantly greater mean 
change in LAZ between 6 and 12 months than infants classified as severely stunted at 12 
months (p=0.024). 
Table 4-12: Mean change in WAZ, LAZ and WFLZ across BMI categories at 12 
months  
 Mean change 
WAZ:6-12 months 
(SD)  
Mean change 
LAZ:6-12 months 
(SD) 
Mean change 
WFLZ:6-12 months 
(SD) 
BMI categories at 12 months: 
Wasted 
Normal 
At risk of overweight 
Overweight 
Obese 
Total 
 
-0.3400 (0.7918) 
-0.1373 (0.6726) 
0.3206 (0.5798) 
0.5019 (0.7878) 
1.0817 (1.1240) 
0.1406 (0.8015) 
 
1.0375 (0.1611) 
0.1052 (1.1955) 
0.0231 (1.4263) 
-0.0106 (1.4112) 
0.0422 (1.5987) 
0.0826 (1.3011) 
 
-1.6175 (0.8611) 
-0.3821 (0.9011) 
0.2779 (1.0053) 
0.5445 (1.4683) 
1.4228 (1.3510) 
0.0067 (1.1952) 
df 4:228 4:228 4:228 
F-statistic 15.882 0.615 17.779 
p value p<0.0005 p=0.652 p<0.0005 
 
As with the 0-6 month results there were no significant differences in mean change in LAZ 6-
12 months between BMI categories at 12 months (p=0.652). There were, however, significant 
differences in mean change of both WAZ and WFLZ. Infants classified as obese (p=0.003), 
overweight (p=0.002) and at risk of overweight (p<0.0005) at 12 months had significantly 
greater mean gains in WAZ between 6-12 months than infants classified as normal BMI at 12 
months.   Change in WFLZ also differed: infants classified as obese (p<0.0005), overweight 
(p=0.018) and at risk of overweight (p=0.001) at 12 months had significantly greater mean 
gains in WFLZ between 6-12 months than infants classified as normal BMI at 12 months. Mean 
change in WAZ and WFLZ fell within the “normal” rate of growth category (-0.67 to +0.67) 
for all BMI categories except for obese. Additional analysis showed a mean change in WAZ 
between birth and 12 months of + 2.97 in infants classified as obese at 12 months. Infants 
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classified as wasted at 12 months had “slow” WFLZ growth. Overweight (p<0.0005) and obese 
(p=0.007) infants had significantly greater mean change in WFLZ than wasted infants.  
4.4.2.2 Linear regression analysis 
Regression analysis was performed to explore the relationships between the independent 
variables birth anthropometric status; rate of growth from 0-6 months; and rate of growth from 
6 to 12 months, and the dependent variables LAZ and BAZ at 12 months. The results of the 
analysis are presented in Table 4-13 for stunting (LAZ) outcomes and 4-14 for overweight 
(BAZ) outcomes.  
Table 4-13: The relationship between LAZ at 12 months and birth WAZ and LAZ, and 
change in LAZ 
 Beta 
coefficient 
Model summary 
R square 
df F-statistic p value 
WAZ 
Birth 
 
0.394 
 
0.106 
 
1:285 
 
33.800 
 
p<0.0005 
LAZ 
Birth 
Change 0-6 
Change 6-12 
 
0.191 
0.154 
0.412 
 
0.047 
0.041 
0.193 
 
1:282 
1:224 
1:231 
 
13.939 
9.555 
55.193 
 
p<0.0005 
p=0.002 
p<0.0005 
 
All the independent variables were significantly associated with LAZ at 12 months. Lower 
birth WAZ and LAZ, and smaller change in LAZ between 0-6 and 6-12 months were associated 
with lower Z scores at 12 months and vice versa. The higher the value of the coefficient B the 
stronger the predictive relationship. This shows that birth WAZ and change in LAZ from 6-12 
months were the strongest predictors of 12 month LAZ with values of the coefficient B of 0.394 
and 0.412 respectively. 
Table 4-14: The relationship between BAZ at 12 months and birth WAZ and LAZ, and 
change in WAZ, LAZ and WFLZ 
 Beta 
coefficient 
Model summary 
R square 
df F-statistic p value 
WAZ 
Birth 
Change 0-6 
Change 6-12 
 
0.390 
0.579 
0.906 
 
0.075 
0.208 
0.227 
 
1:285 
1:231 
1:231 
 
22.977 
60.571 
67.933 
 
p<0.0005 
p<0.0005 
p<0.0005 
LAZ 
Birth 
Change 0-6 
Change 6-12 
 
0.048 
0.063 
-0.064 
 
0.002 
0.005 
0.003 
 
1:282 
1:224 
1:231 
 
0.621 
1.071 
0.689 
 
p=0.431 
p=0.302 
p=0.407 
WFLZ 
Birth 
Change 0-6 
Change 6-12 
 
0.149 
0.182 
0.625 
 
0.034 
0.061 
0.241 
 
1:280 
1:229 
1:231 
 
20.674 
32.005 
73.296 
 
p=0.002 
p<0.0005 
p<0.0005 
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None of the LAZ variables was significant predictors of BAZ at 12 months while both WAZ 
and WFLZ were significant predictors. Higher birth WAZ and WFLZ and higher change in 
WAZ and WFLZ during both time periods were associated with higher BAZ at 12 months. The 
strongest predictor was change in WAZ from 6 to 12 months, with the highest value of the 
coefficient B of 0.906. 
 Feeding practices 
Information on feeding practices was collected at 6 months and 12 months. The findings at 
both time periods will be presented in this section. This will be followed by an analysis of the 
association between feeding practices and growth outcomes. 
 Description of feeding practices at 6 months 
MACE clinical staff collected the following feeding information as part of the 6 month follow 
up questionnaire: type of milk feed the child was receiving; age of introduction of 
complementary food; and type of complementary food introduced, which is porridge, infant 
cereal or jarred foods, or a combination. 
 
Results are presented in Table 4-15. In summary, approximately 50% (n=116) of study infants 
were still receiving some breastmilk at 6 months; either as the sole milk feed or in combination 
with infant formula. Very early introduction of solids seemed uncommon with only 10% 
(n=16) of study infants mothers reporting having given complementary foods before 4 months 
and almost half reporting waiting until the recommended age of 6 months. Use of commercial 
infant cereals and jarred foods was common.  
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Table 4-15: Feeding practices at 6 months 
 n % 
Milk feeds at 6 months (n= 233)*: 
Breastmilk only 
Formula milk only 
Breast and formula 
Fresh milk 
 
70 
116 
46 
1 
 
29.9 
49.9 
19.8 
0.4 
Age of introduction of complementary foods (n=148)**: 
<4  months 
4-6 months 
6 months 
Later than 6 months 
 
16 
63 
63 
6 
 
10.7 
42.6 
42.6 
4.1 
Type of starchy food introduced (n=233)*: 
Porridge  
Infant cereal 
No porridge/cereal 
 
60 
146 
26 
 
25.9 
62.8 
11.3 
Use of commercial jarred foods (n=223)*** : 
Yes 
-jarred food only 
-jarred food and infant cereal 
-jarred food and porridge 
No 
 
111 
11 
70 
30 
112 
 
49.8 
4.9 
31.4 
13.5 
50.2 
*57 infants did not attend 6 month visit 
** Missing data, 85 infants-original MACE 6 month questionnaire did not include this question *** Missing data 
for 10 infants 
 
 Description of feeding practices at 12 months 
Information on type of milk feed was collected at the 12 month visit by MACE clinical staff. 
The WHO IYCF Indicators questionnaire on complementary feeding practices, adapted to 
include a question on intake of inappropriate foods, was administered by the researcher to a 
sub sample of 94 mothers. These were the mothers of infants who came to the clinic for their 
12 month follow up visits between March 2016 and August 2017.  
4.5.2.1 Milk feeds at 12 months 
A little over a third of study infants were still receiving breast milk at 12 months while almost 
two thirds were receiving infant formula. Only four infants (1.4%) were receiving fresh milk 
or maas as a milk feed. More detailed information is provided in Table 4-16. 
Table 4-16: Milk feeds at 12 months: n=290 
12 month milk feeds n % 
Breastmilk only 
Infant formula only 
Breast and formula 
Fresh milk or maas 
63 
183 
40 
4 
21.6 
63 
13.7 
1.4 
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4.5.2.2 Adequacy of complementary feeding practices 
Complementary feeding practices were assessed using the WHO IYCF Indicators 
questionnaire based on a 24-hour dietary recall. The following components were assessed; 
dietary diversity (a dietary diversity score (DDS) greater than 4, out of a possible 7, is 
considered adequate) and frequency of feeding (at 12 months at least 3 meals per day for 
breastfed infants; 4 meals per day, including formula feeds, for formula fed infants). Both the 
adequate dietary diversity and minimum meal frequency (MMF) indicators must be met in 
order to achieve minimum adequate diet (MAD) classification. The seven food groups used to 
assess dietary diversity were: starches, grains and tubers; Vitamin A rich fruit and vegetables; 
other fruit and vegetables; iron rich foods; eggs; legumes and nuts; and dairy.   
 
Complementary feeding practices were poor with a mean DDS of 3.56 (range 1-6), below the 
adequate diversity score cut off of 4. Just under half of the infants (n=45; 48%) achieved a 
score above 4 and only one third (n=31; 33%) achieved the MAD indicator. The discrepancy 
between the number of children achieving adequate DDS and MAD is due to the fact that 
formula fed infants require a DDS of 4, excluding milk feeds to achieve the MAD indicator. 
Only one child did not achieve the MMF score. Iron rich food intake was good with 87.4% 
(n=82) of infants receiving some form of iron rich food in the previous 24 hours; over half, 
59.3% (n=56), in the form of flesh foods. Of those who did not consume flesh foods, a further 
28.1% (n=26) consumed iron fortified infant formula or cereals. Processed meat consumption 
was low with 5.7% (n=5) of infants consuming polony. 
 
The percentage of infants consuming foods from each of the seven food groups, as well as 
some additional foods of interest, in the previous 24 hours is depicted in Figure 4-2.  
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Figure 4-2: Percentage of children receiving foods from the 7 food groups in the 
previous 24 hours (n=94) 
The starch group was the most commonly consumed followed by dairy and meat. Less than 
half of the infants had consumed fruit or vegetables the previous day. Eggs were the least 
consumed group with only 4.6% (n=4) of infants having consumed them. Nearly one quarter 
of infants (23.8%; n=22) had received instant noodles the previous day.  
 
4.5.2.3 Consumption of inappropriate foods and drinks 
A question on intake over the previous month of fruit juice, SSBs, sweets and high fat snacks 
was included in the IYCF Indicators questionnaire. Mean intake is presented in Table 4-17. 
 
Table 4-17: Mean daily intake of inappropriate foods and drinks (n=94) 
 Mean daily intake Minimum Maximum 
Fruit juice 0.4499 ( ± 3 times a week) 0 3 
Sugar score (SSB, juice, sweets) 0.2922 (  ± twice a week) 0 3 
High fat snacks (crisps, vetkoek) 0.5182 ( ± 4 times a week) 0 3 
Total  1.2602 0 4.14 
 
High fat snacks were the most commonly consumed type of food, followed by fruit juice, which 
is often considered by mothers to be a healthy choice for their infants. Mean total consumption 
of inappropriate foods was more than once a day.  The percentage of infants in the study 
population consuming each category of inappropriate foods at least once a week was as follows: 
fruit juice, 51% (n=48); SSBs, 45% (n=42) and HFS, 72% (n=68). 
 
98
43 49
81
60
4.6 18 6 23
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  Association of feeding practices with stunting and overweight at 12 months 
The association of feeding practices with stunting and overweight in the study infants at 12 
months of age was investigated.  Chi square tests of independence were performed to test if 
any significant associations existed between infant feeding practices and the outcome variables 
(stunting and overweight/obesity) in the infants at 12 months of age. There were no significant 
associations between any of the infant feeding practices investigated and the outcome variables. 
The cross tabulation of feeding practices across LFA and BMI for age categories at 12 months 
is presented in Table 4-18. 
Table 4-18: Infant feeding practices across LFA and BMI for age categories at 12 
months 
 LFA Categories BMI Categories 
Stunted 
 
Severely 
stunted 
Wasted 
 
At risk of 
overweight 
Overweight 
 
Obese 
 
n % n % n % n % n % n % 
6 month milk feeds: 
Breast milk only (n=71) 
Formula only (n=116) 
Breast & formula (n=46) 
 
3 
4 
2 
 
4.2 
3.3 
4.2 
 
2 
0 
0 
 
2.8 
0 
0 
 
1 
1 
2 
 
1.4 
0.8 
4.2 
 
16 
27 
9 
 
22.5 
22.5 
18.8 
 
6 
23 
3 
 
8.5 
19.2 
6.3 
 
6 
10 
2 
 
8.5 
8.3 
4.2 
Age of introduction of 
complementary foods: 
<4 months (n=16) 
4-6 months (n=63) 
6 months (n=63) 
>6 months (n=2) 
 
 
1 
3 
1 
1 
 
 
6.3 
4.8 
1.6 
50 
 
 
0 
0 
2 
0 
 
 
0 
0 
3.2 
0 
 
 
0 
3 
1 
0 
 
 
0 
4.8 
1.6 
0 
 
 
1 
17 
12 
0 
 
 
6.3 
27 
19 
0 
 
 
3 
9 
12 
0 
 
 
18.8 
14.3 
19 
0 
 
 
2 
3 
7 
0 
 
 
12.6 
4.8 
11.1 
0 
Type of 
complementary food  
(6 months): 
Porridge (n=60) 
Infant cereal (n=146) 
Jarred food- Yes(n=112) 
Jarred food-No (n=110) 
 
 
 
1 
7 
4 
3 
 
 
 
1.7 
4.8 
3.6 
2.7 
 
 
 
0 
1 
1 
1 
 
 
 
0 
0.7 
0.9 
0.9 
 
 
 
2 
2 
2 
2 
 
 
 
3.3 
1.4 
1.8 
1.8 
 
 
 
13 
30 
25 
21 
 
 
 
21.7 
20.7 
22.3 
19.1 
 
 
 
11 
16 
11 
18 
 
 
 
18.3 
11 
9.8 
16.4 
 
 
 
6 
10 
8 
10 
 
 
 
10 
6.9 
7.1 
9.1 
12 month milk feed: 
Breast milk only (n=62) 
Formula only (n=183) 
Breast & formula (n=40) 
Fresh milk/maas (n=4) 
 
3 
8 
3 
0 
 
4.8 
4.4 
7.5 
0 
 
1 
1 
0 
0 
 
1.6 
0.5 
0 
0 
 
1 
1 
2 
0 
 
1.6 
0.5 
5 
0 
 
15 
42 
6 
1 
 
24.2 
23 
15 
25 
 
7 
30 
4 
1 
 
11.3 
16.4 
10 
25 
 
4 
14 
2 
1 
 
6.5 
7.7 
5 
25 
12 month 
complementary diet: 
DDS≥4 (n=42) 
DDS< 4 (n=45) 
MAD  (n=28) 
No MAD (n=59) 
IRF (n=76) 
No IRF (n=11)  
 
 
1 
3 
1 
3 
3 
1 
 
 
2.4 
6.7 
3.6 
5.1 
3.9 
9.1 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
- 
- 
 
 
- 
- 
- 
- 
- 
- 
 
 
8 
10 
5 
13 
15 
3 
 
 
19 
22.2 
17.9 
22 
19.7 
27.3 
 
 
10 
11 
5 
16 
18 
3 
 
 
23.8 
24.4 
17.9 
27.1 
23.7 
27.3 
 
 
3 
4 
1 
6 
7 
0 
 
 
7.1 
8.9 
3.6 
10.2 
9.2 
0 
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 Additional findings 
An interesting association between maternal HIV status and infant feeding practices was 
identified and is presented in this section. The prevalence of stunting and overweight/obesity 
in the study infants at 24 months is also presented together with further analyses of growth 
patterns in relation to 24 month outcomes. 
 HIV and infant feeding practices 
Prevalence of breastfeeding, formula feeding and mixed breast and formula feeding in HIV 
positive and HIV negative mothers is shown in Table 4-19. Results from a chi–square tests of 
independence show that there is a significant relationship between maternal HIV status and 
formula feeding/breastfeeding practices at 6 months (Fisher’s exact=30.330, p<0.0005). 
Mothers who were HIV positive were significantly more likely to be giving only infant formula 
at 6 months as a milk feed than mothers who were HIV negative. HIV negative mothers were 
far more likely to be giving both breastmilk and infant formula. There was also a significant 
relationship between maternal HIV status and initiation of breastfeeding at birth (Fisher’s 
exact=21.431, p<0.0005). The IYCF Indicators questionnaire, which was administered to a sub 
sample of 87 mothers, included a question that asked whether the child had ever been breastfed. 
HIV positive mothers were significantly less likely to have initiated breastfeeding than HIV 
negative mothers. 
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Table 4-19: Maternal HIV status and infant feeding practices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*50 mothers did not attend 6 month visit 
** Sub sample of mothers who had completed the IYCF Indicators questionnaire 
 
 Anthropometric data at 24 months 
Due to time constraints associated with collecting longitudinal data, the original objectives used 
12 month overweight and stunting as the outcome variables. However, during the 12 months it 
took to collect the 12 month IYCF Indicators data, 145 children with 12 month data reached 
the age of 24 months. It was decided to include their anthropometric data in this report. This 
section presents these anthropometric data at 24 months and data on rate of growth in the 
second year of life, followed by analysis of the association of this data with growth outcomes. 
 
4.6.2.1 Anthropometric status 
The results are presented in Table 4-20 together with the 12 month data as a comparison. Both 
the IOTF classification and WHO reference were used to classify overweight and obesity. The 
Cole classification can only be used in children two years and older. 
 
  
 Mother HIV 
positive 
Mother HIV 
negative 
n % n % 
6 month milk feeds (n=240) * 
Breast milk only 
Infant formula only 
Breast and formula milk 
Total 
 
22 
58 
2 
82 
 
26.8 
70.7 
2.4 
 
50 
62 
46 
158 
 
31.6 
39.2 
29.1 
Ever breastfed (n=87)** 
Yes 
No 
Total 
 
16 
14 
30 
 
53.3 
46.7 
 
54 
3 
57 
 
94.7 
5.3 
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Table 4-19: Comparison of anthropometric status at 12 and 24 months 
 
* One child had missing length data 
** Not all the children attending the 24 month visit had reached 24 months of age 
 
While direct comparisons cannot be made, as 24 month data was only available for a subset of 
the 12 month sample, the prevalence of both stunting and overweight however, increased from 
12 to 24 months. Using the IOTF classification resulted in more infants being classified as 
overweight or obese compared to the WHO reference. The mean LAZ decreased while the 
mean BMIZ increased. 
 
4.6.2.2 Description of rate of growth from 12 to 24 months  
Change in WAZ, LAZ and WFLZ between 12 and 24 months was calculated and classified as 
“slow” (≤0.67); “normal” (-0.67 to +0.67) and “rapid” (≥+0.67) growth. The prevalence of 
each category of growth in the study sample is presented in Table 4-21. 
 
Table 4-20: Prevalence of growth categories: 12-24 months 
 Slow growth Normal growth Rapid growth 
n % n % n % 
WAZ (n=145) 46 31.7 82 56.6 17  11.7 
LAZ (n=144)* 72 50 49 34 23 16 
WFLZ (n=144)* 48 33.3 59 41 37 25.7 
*missing length data for 1 subject 
 12months(n=291) 
 
24 months 
(n=144*) 
Stunting 
Stunting (LFA Z < -2 ≥ -3) 
Severe stunting (LFA Z < -3) 
Total 
Mean LAZ; SD 
 
5.2% 
0.7% 
5.9% 
- 0.01; 1.24 
 
8.3% 
2.1% 
10.4% 
-0.51; 1.16 
Overweight and Obesity 
WHO Classification (n= 291 at 12 
months; 144 at 24 months) 
Overweight (BAZ > +2 ≤ +3) 
Obese (BAZ > +3) 
Combined overweight and obesity 
Mean  BAZ ; SD 
Mean WAZ;SD 
 
IOTF Classification (n=139)** 
Overweight 
Obese 
Combined overweight and obesity 
 
 
14.5% 
7.2% 
21.7% 
0.81; 1.42 
0.6; 1.33 
 
 
18.9% 
7.7% 
26.6% 
0.95; 1.45 
0.35; 1.3 
 
 
20.8% 
10.8% 
31.6% 
100 
 
 
The percentage of children in the “rapid” growth category declined further from the 6-12 month 
time period while “slow” growth was the most common category for LAZ. The prevalence of 
each category compared to the 0-6 and 6-12 months data is shown in Figure 4-3.  
 
 
Figure 4-3: Percentage of infants in each growth category: 0 - 6, 6 - 12 and 12 - 24 
months 
 
4.6.2.3 The association of birth anthropometric data and growth patterns with growth 
outcomes at 24 months 
Regression analysis was performed to explore the causal relationships between the independent 
variables birth anthropometric status; rate of growth from 0-6 months; 6 to 12 months; and 12 
to 24 months and the dependent variables LAZ and BAZ at 24 months. The results related to 
LAZ and BAZ are presented in Table 4-22 and 4-23 respectively. 
 
  
11 13
32
41
28
50
12
28 33
36
68
57 32
42
34
13
46.1 41
52.7
19.7
11.7
26.7 30.2
16
74.2
26.3 25.7
Slow Normal Rapid
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Table 4-21: The relationship between LAZ at 24 months and birth LAZ, and change in 
LAZ. 
 Beta 
coefficient 
Model summary 
R square 
df F-statistic p value 
LAZ 
Birth 
Change 0-6 
Change 6-12 
Change 12-24 
 
0.178 
0.145 
0.097 
0.344 
 
0.198 
0.216 
0.120 
0.319 
 
1:141 
1:125 
1:127 
1:142 
 
5.726 
6.117 
1.844 
16.100 
 
p=0.018 
p=0.015 
p=0.177 
p<0.0005 
 
Birth LAZ and change in LAZ between birth and 6 months remained significant predictors of 
LAZ at 24 months. Change in LAZ from 6-12 months was no longer significant. The strongest 
predictor of 24 month LAZ was change in LAZ from 12 to 24 months with a value of the 
coefficient B of 0.344. 
 
Table 4-22: The relationship between BAZ at 24 months and birth WAZ, and change 
in WAZ, and WFLZ. 
 Beta 
coefficient 
Model summary 
R square 
df F-statistic p value 
WAZ 
Birth 
Change 0-6 
Change 6-12 
Change 12-24 
 
0.265 
0.528 
0.627 
0.501 
 
0.033 
0.170 
0.106 
0.082 
 
1:143 
1:128 
1:128 
1:143 
 
4.877 
26.243 
15.141 
12.694 
 
p=0.029 
p <0.0005 
p <0.0005 
p<0.0005 
WFLZ 
Birth 
Change 0-6 
Change 6-12 
Change 12-24 
 
0.207 
0.102 
0.325 
0.492 
 
0.255 
0.140 
0.212 
0.400 
 
1:141 
1:126 
1:127 
1:142 
 
9.767 
2.523 
5.976 
27.114 
 
p=0.002 
p=0.115 
p=0.016 
p<0.0005 
 
Change in WAZ from 6-12 months remains the strongest predictor of BAZ at 24 months with 
a value of the coefficient B of 0.627. The strongest predictor of BAZ at 24 months when looking 
at change in WFLZ was the 12-24 month period, value of the coefficient B, 0.492. 
In order to determine whether being overweight or obese at 12 months was a significant 
predictor of overweight or obesity at 24 months further analysis was performed. The results of 
the linear regression analysis are presented in Table 4-24. 
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Table 4-23: The relationship between BAZ at 24 months and BAZ at 24 months 
 
 Beta 
coefficient 
Model summary 
R square 
df F-statistic p value 
BAZ 12 months 
 
0.606 0.398 
 
1:142 
 
93.865 
 
p<0.0005 
 
 
BAZ at 12 months is strongly predictive of 24 month BAZ as can be seen by the high value of 
the coefficient B of 0.606. The higher the BAZ at 12 months the higher the BAZ at 24 months. 
This is further demonstrated by the fact that all the infants who were obese at 12 months were 
either obese or overweight at 24 months. 
 
 Summary of results 
The following are the most noteworthy findings: 
The sample consisted of 290 infants at 12 months, 54.1% were males and 45.9% females. The 
prevalence of stunting at 12 months was 5.9% while combined overweight and obesity 
prevalence was 21.7% with a further 22.1% classified as being at risk of overweight. 
Anthropometric analysis of 144 of these children at the age of 24 months showed that their 
nutritional status had deteriorated in the second year of life. Stunting rates had nearly doubled 
to 10.4%. Combined overweight and obesity prevalence had increased to 26.6%. This 
prevalence was even higher at 31.6% when using the Cole classification.  
 
Maternal average age was 26.0 and the majority of mothers had completed matric. Maternal 
HIV prevalence was 35%. Average household size was 6 members and a large proportion of 
households reported having either no income or less than R2000 per annum. Access to tap 
water was universal and 98.9 % had electricity, while 8.7% lived in informal housing. Apart 
from type of housing, there was no association between sociodemographic variables and 
growth outcomes at 12 months. Infants living in flats were more likely to be stunted than those 
living in houses. Infants living in informal housing were more likely to be severely stunted, 
wasted, at risk of overweight and overweight than those living in formal housing. 
 
Analysis of growth patterns revealed a very high proportion of infants with rapid gains in 
weight and weight for length in the first 6 months that decreased thereafter. The analysis of the 
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relationship between birth anthropometric status and patterns of growth, and growth outcomes 
at 12 and 24 months showed: 
- Children classified as stunted at 12 months had lower mean birth WAZ and LAZ, while 
overweight children had higher mean birth WAZ. Linear regression analysis showed a 
similar pattern using continuous data with both birth LAZ and WAZ significant 
predictors of LAZ and BAZ at 12 months and 24 months. 
- Children obese at 12 months had a pattern of more rapid weight gain than infants with 
normal BMI at 12 months starting in the first 6 months of life and continuing thereafter. 
Their higher BAZ at 12 months persisted into the second year with all children who were 
obese at 12 months being either obese or overweight at 24 months.  
- Change in LAZ from 6 to 12 months was most predictive of 12 month LAZ while change 
in WAZ from 6-12 months was the strongest predictor of both 12 and 24 month BAZ.  
- Higher BAZ at 12 months is strongly predictive of high BAZ at 24 months.  
 
Infant feeding practices in the study infants were described. Breastfeeding rates at 6 months 
were 30% with a further 20% receiving a combination of breastmilk and infant formula. 
Breastfeeding rates were significantly lower amongst HIV positive mothers compared to HIV 
negative mothers, who were also more likely to give both infant formula and breastmilk. Half 
of the mothers fed their infants solid foods before the age of 6 months and only one third of 
infants met the WHO IYCF MAD indicator. Consumption of instant noodles was common as 
was intake of inappropriate foods such as SSBs and high fat snacks. There were no significant 
associations of feeding practices with growth outcomes at 12 months. 
 
The relationship of patterns of growth in the first year of life, in particular the 6 to 12 month 
period, with BMI outcomes at both 12 and 24 months was the most significant finding of this 
study. These results will be discussed in the next chapter. 
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 DISCUSSION 
This study aimed to determine the prevalence of stunting and overweight at 12 months in the 
MACE study infants; describe potential risk factors identified from the review of the literature; 
and determine their association with growth outcomes. The results that were presented in the 
previous chapter will now be discussed. 
 
  Prevalence of stunting and overweight 
The prevalence of stunting and overweight in the MACE study infants at 12 and 24 months 
compared to other South African studies from the last 10 years is presented in Table 5-1.         
The other studies in Table 5-1 included children in the same age range and used the WHO 2006 
growth standard, unless otherwise indicated. The importance of comparing studies with similar 
age categories and using the same growth reference was highlighted previously. The prevalence 
of stunting was far lower than other South African surveys of children in the same age range, 
while that of overweight was higher than most. By 24 months of age both stunting and 
overweight had increased and this was in line with other studies, however the stunting 
prevalence remained comparatively low. The low stunting rates could be partly explained by 
the exclusion of pregnant women with diabetes and hypertension. 
 
Table 5-1: Comparison of the prevalence of stunting and overweight in MACE and 
other studies 
 Stunting Combined overweight and obesity 
 WHO IOTF 
 Age n % Age n % n % 
MACE 12 mths 
24 mths 
290 
144 
5.9 
10.4 
12 mths 
24 mths 
290 
144 
21.7 
26.6 
 
139 
 
31.6 
Drakenstein 
Budree et al 2017a; 2017b 
12 mths 342 13 12 mths 342 8 - - 
Breede Valley 
du Plessis et al., 2016 
0-23 mths 218 28.8 0-23 
mths 
218 21.8 - - 
Agincourt 
(Kimani-Murage, 2010) 
12 mths 
24 mths 
137 
160 
32 
20 
12 mths 
24 mths 
- 
- 
- 
- 
 
160 
 
10 
SANHANES-1 
Shisana et al., 2013 
0-3 yrs 1090 26.5 2-5 yrs - 
 
- 1291 23.8 
 
Interestingly, combined overweight and stunting was only present in one infant at 12 months 
in the MACE study and increased to 4 children at 24 months (3%). This is in contrast to the 
Limpopo study which reported a very high prevalence of combined stunting and overweight of 
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19% at 36 months (Mamabolo et al., 2005), and a number of other studies which found that 
stunting was a significant risk factor for being overweight (Steyn et al., 2005; Popkin et al., 
1996). Given the increasing prevalence of concurrent stunting and overweight from 12 to 24 
months this trend should be monitored in follow up studies in this cohort. A Mexican study 
reported rates of 5-10% in children aged 2 to 6 years (Fernald & Neufeld, 2007) which is only 
slightly higher than the 3% at 24 months in MACE study infants. 
 
There were no gender differences in stunting and overweight prevalence in line with other 
studies in younger children (Kimani-Murage, 2013; Shisana et al, 2013). Gender differences 
only become apparent in older childhood and adolescence when boys have higher rates of 
stunting while overweight is more prevalent in older girls (Kimani-Murage, 2013; Shisana et 
al, 2013). An exception to this was the MRC/HST study which found higher rates of stunting 
amongst boys under the age of 5 years (Lesiapeto et al., 2010). The low stunting and high 
overweight prevalence in the MACE study infants indicates that in this urban population the 
nutrition transition may be fairly advanced and over nutrition is more of a problem than 
undernutrition, although the previously discussed issue of exclusion of hypertensive and 
diabetic mothers must be kept in mind.  
 Maternal and household characteristics 
Low stunting prevalence can be explained when considering the maternal and household 
characteristics of the cohort. This was an urban population with almost universal access to tap 
water and electricity. Lack of water and sanitation is associated with increased episodes of 
diarrhoea, a significant contributor to stunting (Danaei et al., 2016; Black et al., 2013). The 
MRC/HST study, conducted in 2003 in rural areas of KwaZulu-Natal and the Eastern Cape, 
that had a stunting prevalence of 28%, reported that 75% of the population accessed water from 
dams and rivers while only 26% had electricity (Lesiapeto et al., 2010).  
 
Maternal education levels in the MACE study were relatively high with 70% of mothers having 
a matric or tertiary qualification and only 1% having primary school education or less. The fact 
that virtually all the mothers had at least some secondary education probably explains the lack 
of an association between education and growth outcomes. Stunting has been linked to poor 
maternal education in both international and local studies. Mothers with low levels of education 
are more likely to have poor caring practices such as not accessing health care services, for 
example immunisations; as well as neglect or lack of psychosocial stimulation (Black et al., 
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2013). Poor complementary feeding practices, particularly lack of dietary diversity were also 
associated with maternal education in Asian studies (Kabir et al., 2012; Senarath et al., 2012 ;) 
and a study in Zambia (Mallard et al., 2014). Both the rural Limpopo study and the Agincourt 
study in South Africa found an association between stunting and young or student mothers 
(Kimani-Murage, 2013; Mamabolo et al., 2005).  
 
Access to water and electricity, and relatively high levels of maternal education may have 
ameliorated the effect of SES on stunting, considering that reported household income was 
predominantly very low. In the MACE cohort the only sociodemographic factor that had any 
association with growth outcomes was the type of housing. Living in a flat, rather than a house, 
was associated with stunting; while living in informal housing was associated with both severe 
stunting and overweight, indicating that both these growth outcomes are associated with low 
SES. This is in line with the 2016 South African DHS which found that stunting and overweight 
were both more prevalent in the lowest quintile of SES (DoH et al., 2017). A number of other 
South African studies that investigated determinants of stunting and overweight also found an 
association between stunting and low SES (Budree et al., 2017b; Lesiapeto et al., 2010; 
Mamabolo et al., 2005) but the relationship with overweight was mixed. The Agincourt study 
found that higher SES was associated with overweight (Kimani-Murage, 2013) while in the 
HST/MRC study overweight was associated with lack of a regular source of income (Lesiapeto 
et al., 2010). In HICs, childhood overweight is more prevalent in children of low SES (Skinner 
et al., 2018; Olds et al., 2011) and it would appear that this is becoming the trend in South 
Africa. 
 
HIV exposure was neither associated with stunting nor overweight at 12 months in the MACE 
infants. The effect on birth outcomes was not explored, as infants born preterm were excluded 
from this study. While the negative impact of untreated HIV infection on infant growth is well 
documented (Venkatesh et al., 2010), there has been mixed evidence on the effects of HIV 
exposure and/or maternal ARV therapy (ART) on growth outcomes in HIV exposed but 
uninfected (HEU) children. A systematic review on the topic found that some trials 
investigating birth outcomes reported an increased prevalence of preterm birth while others 
found no effect (Heidari et al., 2011). The recently published results from the 2012-2013 South 
African PMTCT evaluation showed that HEU infants had a greater risk of preterm birth, SGA 
and LBW; and of being underweight for age at 6 weeks compared to HIV unexposed infants. 
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Preconception ART also increased the odds of preterm delivery compared to post conception 
ART initiation (Ramokolo et al., 2017).  
 
The systematic review on the effect of maternal ART on infant outcomes also reviewed studies 
investigating later growth outcomes. Some studies found lower LAZ but they appeared to be 
transient (Heidari et al., 2011). Infants in an American study exposed to Tenofovir (TDF) had 
slightly lower mean head circumference and LAZ at 12 months than infants on a non TDF 
regimen (Siberry, et al., 2012). The authors highlighted that while the difference was small, 
<0.5 cm on average, and of uncertain significance, further monitoring of longer term growth 
outcomes in HEU infants was recommended (Siberry et al., 2012). The MACE study finding 
of no difference in growth outcomes at 12 months between term HIV exposed and unexposed 
infants, is particularly welcome in view of the high antenatal prevalence of HIV in South Africa 
and in KZN in particular. The sample size is, however, relatively small so the findings should 
be interpreted with caution. 
 
It must be noted that the fact that the MACE study excluded pregnant women with hypertension 
and diabetes could have contributed to the low stunting prevalence. These women would have 
been more likely to have experienced the double burden of malnutrition themselves, placing 
their offspring at greater risk for LBW and subsequent stunting. 
 
It is interesting to compare the MACE study stunting prevalence to another current longitudinal 
birth cohort study, the Drakenstein study in the Western Cape. Stunting prevalence in the 
Drakenstein cohort at 12 months, although lower than other national and regional surveys at 
13%, was a little over double that of the MACE cohort at 5.9% (Budree et al., 2017b).  Stunting 
in the Drakenstein cohort was associated with low birthweight, which was linked to very high 
rates of antenatal smoking at 54%, and alcohol intake of 26%, in mothers of mixed race 
ethnicity. Birthweight and linear growth were both lower in mixed race infants. The MACE 
cohort mothers in contrast, had rates of antenatal smoking and alcohol intake below 5% and 
they were not associated with either birthweight or 12 month growth outcomes. The small  
numbers in each group however mean that these results should be interpreted with caution. The 
MACE cohort has a similar ethnic mix to the Drakenstein cohort, comprised mainly of Black 
African and mixed race subjects. Although data on ethnicity was not collected in the MACE 
study, home language was used as a proxy for ethnicity and there were no differences in growth 
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outcomes between the two groups. This suggests that lifestyle factors, rather than ethnicity, are 
responsible for the disparities in growth outcomes between ethnic groups in the Drakenstein 
study. Clear messaging regarding the harmful effects of alcohol and smoking on the developing 
fetus and community initiatives aimed at supporting mothers to make healthy choices are some 
potential interventions although a long term solution requires addressing the underlying poor 
socioeconomic conditions. 
 The relationship between birth weight and length and growth patterns; and 
growth outcomes at 12 and 24 months 
There was congruence between the findings using both categorical outcomes (ANOVA) and 
continuous data (linear regression analysis). Both analytical methods found links between birth 
anthropometrics and 12 month growth outcomes, and additionally identified the 6-12 month 
period as being of greatest significance. They also found no link between birth LAZ and linear 
growth, and BMI categories or BAZ at 12 months. 
 
 Birth weight and length 
In the MACE study, both birthweight and length of the infants were associated with stunting 
and LAZ at 12 month and 24 months. Overweight at 12 months and BAZ at 12 and 24 months 
were also associated with birthweight, but not birth length. This emphasises the importance of 
the maternal aspect of the first 1000 days. As was discussed previously, 20-25% of childhood 
stunting has its roots in poor foetal growth (Danaei et al., 2016; Black et al., 2013) while 
childhood overweight is also thought to start in utero (Black et al., 2013).  
 
The association of low birthweight with increased risk of stunting was reported in the 
Drakenstein and Agincourt studies (Budree et al., 2017b; Kimani-Murage, 2013). A link 
between high birthweight and risk of obesity at 9-11 years of age was reported by the 
International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE), which 
included South African schoolchildren (Qiao et al., 2015). Of interest was the finding that 
infants from LMICs were at increased risk of obesity at lower birthweights, >3500 g, than 
infants in HICs, whose risk only increased above 4000 g. The authors suggested that this could 
be partly attributed to differences in maternal nutritional status between LMICs and HICs (Qiao 
et al., 2015). This is demonstrated in the MACE study where infants classified as overweight 
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at 12 months had a mean birthweight of 3396 g, which is 300 g heavier than infants of normal 
BMI at 12 months, although not exceptionally high.  
 
This finding of a positive relationship between birthweight and later BAZ is similar to results 
from a number of international birth cohort studies, however they used growth outcomes in 
older children, typically aged 5 to 7 years (Weng et al., 2012).  The Millennium Cohort study 
and the Avon Longitudinal study both reported increasing risk of childhood overweight with 
increasing birth weight (Brophy et al., 2009; Reilly et al., 2005).  Higher birthweight remained 
a predictor of higher BMI at 24 months in the MACE study infants, but follow up at the age of 
5 years is recommended to determine if this association remains significant in later childhood. 
Considering the relationship of lower birthweight with stunting, optimal nutrition and health 
care during pregnancy is important to ensure a healthy birthweight that protects against both 
stunting and overweight.  
 Patterns of growth 
There were four main findings from the analysis of growth patterns: 
- The first 6 months was characterised by rapid weight gain in more than 50% of study 
infants. 
- Growth in the 6-12 month period was most strongly predictive of both growth outcomes at 
12 months 
- Obese infants at 12 months had significantly greater gains in weight starting from the first 
6 months and continued to be either overweight or obese at 24 months. 
- There was disproportionate weight gain in relation to linear growth in the cohort. 
These findings will now be discussed in more detail. 
 
There was a marked difference in rate of growth between the first and second 6 months of life 
in the MACE study infants. In the first 6 months, over half the study infants had gains in WAZ 
≥+0.67, placing them in the “rapid” growth category. The mean change in WAZ was +0.777 
for the study sample, similar to the +0.7 change reported in the Drakenstein study (Budree et 
al., 2017b). This was not accompanied by gains in LAZ, resulting in 75% of the infants falling 
into the “rapid” growth category for WFL. Growth patterns changed in the second 6 months 
with most of the study infants falling into the “normal” growth category for WFA and LFA. A 
similar pattern of rapid weight gain in the first 6 months, followed by slowing in the 6-12 month 
period was reported in the Drakenstein study (Budree et al., 2017b).  Rapid weight gain in the 
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first 1 to 2 years of life has been associated with risk of obesity in later childhood in a number 
of studies (Druet et al., 2011; Ong & Loos, 2006), including one using data from the South 
African Birth to 20 cohort (Cameron et al., 2003).  
 
The birth to 6 month period has been identified in some studies as being particularly significant 
for later obesity risk (Chandler-Laney et al., 2013; Taveras et al., 2009) whereas in the MACE 
study the change in LAZ and WAZ in the 6-12 month period was the most predictive of 12 
month LAZ and BAZ respectively. Change in LAZ in the second 6 months of life was most 
strongly predictive of 12 month LAZ, while change in both WAZ and WFLZ during that time 
period was most strongly predictive of BAZ at 12 months. ANOVA results confirmed the 
importance of the 6-12 month period: Infants classified as obese, overweight and at risk of 
overweight at 12 months had significantly greater mean change in WAZ and WFLZ than those 
classified as having normal BMI.  
Change in LAZ from 6-12 months was no longer significant when using 24 month LAZ as the 
outcome while 12 -24 month change in LAZ was the most predictive. Change in WAZ, 
however, during the 6-12 month period, remained most predictive of BAZ at 24 months. The 
consistent association of early rapid weight gain with later childhood obesity may be due either 
to nutrition, or the environment, or may be a genetic marker for future weight gain trajectory 
(Druet et al., 2011). Follow up of the study infants at 4-5 years is recommended to determine 
whether rapid weight gain in the 6-12 month period remains the most significant predictor of 
later overweight and obesity. 
 
The finding that infants obese at 12 months of age had already started on a rapid weight gain 
trajectory in their first 6 months, and that their increased BMI persisted into the second year of 
life, has been demonstrated in other studies. An American study found that overweight and 
obese 5 year olds had consistently higher BMIs than normal weight children starting from 2-4 
months of age (Ludington-Hoe et al., 2013), similar to the findings of a Chilean study 
(Corvalan et al., 2009). The “growth acceleration hypothesis” proposes that early and rapid 
growth, particularly in the first 6 months of life, programs the infant metabolic profile to be 
susceptible to obesity in later childhood and adulthood (Young et al., 2012; Singhal, 2007). 
The Isle of Wight study discussed previously had identified four different growth trajectories 
in children from birth to 18 years, two of which are relevant to the MACE findings. The first 
one was early, transient overweight where infants were overweight at 1 year, however BMI 
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decreased thereafter. The second one was early, persistent obesity where infants were obese by 
4 years and BMI never decreased (Ziyab et al., 2014). In the MACE study, all of the infants 
who were obese at 12 months and who had 24 month data, remained either obese or overweight 
at 24 months; indicating that they were probably on the persistent obesity trajectory.  
Additionally, their mean change in WAZ from birth to 12 months was +2.97. This puts them 
at an extremely high risk for later obesity when one considers the results of the meta-analysis 
by Druet et al (2011) which showed that infants with a change in WAZ >+1.33 in the first year 
had an almost fourfold risk of later childhood obesity.  
 
The necessity in LMICs of balancing prevention of overweight with promotion of healthy 
growth, in particular linear growth, was discussed at length in the literature review. The general 
consensus was that, unlike in HICs, rapid weight gain in the first 24 months, particularly if 
accompanied by gain in length, may be desirable in terms of human capital outcomes and does 
not appear to pose a long term risk for later obesity or cardio metabolic outcomes. In contrast, 
rapid weight gain after this time, has no positive effects and does increase the risk of later 
obesity and NCDS (Adair et al., 2013).  The finding therefore of a disproportionate gain in 
weight in relation to length in the MACE cohort from birth to 24 months, is a cause for concern. 
Mean birth WAZ of -0.23 was below the WHO reference and had increased to +0.35 by 24 
months while LAZ decreased from +0.34 to -0.51. This is very similar to the Drakenstein study 
findings at 12 months where mean WAZ increased from -0.7 to +.01, while LAZ decreased 
from +0.1 to -0.5 (Budree et al., 2017). 
 
 Infant feeding practices and growth outcomes 
Breastfeeding practices, age of introduction of solid foods and the quality of the complementary 
feeding diet were assessed. Despite poor feeding practices, there were no associations with 
growth outcomes at 12 months, echoing the findings of the Drakenstein study (Budree et al., 
2017a).  The hypotheses of the study, namely that poor breastfeeding practices, and lack of 
dietary diversity were associated with both stunting and overweight, are therefore rejected. 
 
 Breastfeeding practices 
Information on initiation of breastfeeding was only collected from the sub sample of mothers 
who completed the IYCF Indicators questionnaire. The findings were similar to other South 
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African studies, with high initiation rates of 95% in HIV unexposed infants, comparable to the 
rural KZN MRC study with 96% (Faber & Benade, 2007). Initiation rates were significantly 
lower, just over 50%, in HIV exposed infants.  The Drakenstein study reported initiation rates 
of 86% in the cohort but less than 50% in HIV exposed infants (Budree et al., 2017a) while in 
another Western Cape study, in Worcester, none of the HIV positive mothers initiated 
breastfeeding (Goosen et al., 2014). The Worcester study was conducted in 2011, while the 
Drakenstein study collected data from 2012-2015 and the findings probably reflected prior 
Department of Health policy that provided free infant formula to HIV positive mothers (DoH, 
2007). Following the Tshwane Declaration (Tshwane Declaration, 2011), the Department of 
Health IYCF Policy changed in 2013 and free formula was discontinued,  HIV positive mothers 
were advised to exclusively breastfeed for 6 months then introduce complementary foods and 
continue breastfeeding to 12 months (DoH, 2013b).  In KZN the free formula supply to HIV 
positive mothers was discontinued two years earlier, from January 2011 (KZN DoH, 2010). 
Therefore, it is surprising that breastfeeding initiation rates were not higher in HIV exposed 
infants in the MACE study. 
 
The difference in feeding practices between HIV positive and HIV negative mothers was also 
apparent at 6 months and 12 months. At 6 months 73% of HIV positive mothers were giving 
formula milk as the only milk feed and this increased to 87% of mothers by 12 months. The 
corresponding figures in HIV negative mothers were 39% and 51%. Mixed feeding of both 
breastmilk and formula at 6 months was significantly more common in HIV negative mothers 
at 29.5% compared to HIV positive mothers at only 2.5%.  In the Drakenstein study, exclusive 
breastfeeding rates at 6 months in those HIV positive mothers who had chosen to breastfeed 
were 26%, double those of the HIV negative mothers, at 13% (Budree et al., 2017a). This 
indicates that the message regarding the importance of exclusive breastfeeding in the first 6 
months has perhaps been misinterpreted to apply to HIV positive mothers only. It could also 
reflect the fact that HIV positive mothers may receive more detailed breastfeeding counselling 
from nursing staff and lay counsellors. 
 
By the age of 6 months, half of the MACE mothers had discontinued breastfeeding completely, 
while only 35% of infants were still receiving breastmilk at 12 months. These rates are far 
lower than the Drakenstein study, which reported breastfeeding rates of 58% at 12 months 
(Budree et al. 2017a), but similar to those in the Breede valley study, with rates of 32.5% in 
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infants aged 12-15 months (du Plessis et al., 2016). Breastfeeding rates at 12-17 months in the 
urban mothers in the Faber et al. (2016) KZN study were also fairly low at 44%. All of these 
figures reflect poor adherence to the South African IYCF Policy which recommends 
breastfeeding up until two years and beyond, including for HIV positive mothers (DoH, 2017a). 
The low rates in both the MACE and the Faber et al (2016) studies, which were both conducted 
in KZN, are unexpected as the province has been singled out for its commitment to, and support 
of, breastfeeding promotion (DoH et al., 2014).  The effect of maternal HIV status on feeding 
choice, as discussed previously, may be a contributory factor when considering that KZN is 
the province with the highest antenatal HIV prevalence, at 44% (DoH, 2017b). 
 
The lack of an association between breastfeeding and growth outcomes is not unexpected. 
Breastfeeding is vital for child survival in LMICs (Jones et al., 2003) but it has not been shown 
to decrease stunting (Black et al., 2013). Continued breastfeeding at 12 months was in fact 
associated with lower LAZ in the Drakenstein study as well as in a review of DHS data from 9 
countries (Budree et al., 2017a; Jones et al., 2014).  Breastfeeding has been shown to be 
moderately protective against childhood overweight in a number of birth cohort studies in HICs 
(Weng et al., 2012) but this association may be confounded by maternal education or SES as a 
RCT in Belarus failed to find a protective effect (Kramer et al., 2007). Results from a birth 
cohort study conducted in Brazil, which is a LMIC, found no association between duration of 
breastfeeding and obesity at 11 years of age (Neutzling et al., 2009). A strength of the Brazilian 
study was that there was very little risk of confounding by socio economic factors because 
breastfeeding duration was not associated with socioeconomic status or maternal education. 
The Promise EBF study in contrast, found that infants who were not breastfed at 12 weeks were 
at greater risk of rapid weight gain between 12 and 24 weeks and of being overweight or obese 
at 24 months (Ramokolo et al., 2015). The potential mechanisms for a protective effect of 
breastfeeding include nutritional composition factors, particularly lower protein content 
(Poskitt & Breda, 2012); bioactive factors, such as leptin or ghrelin that may elicit an endocrine 
effect (Weng et al., 2012; Young et al., 2012); and behavioural factors, namely enhanced 
ability to self-regulate intake, leading to lower energy intake (Yang & Huffman, 2013; Young 
et al., 2012). 
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 Age of introduction of complementary foods 
There appears to be a positive trend towards introducing complementary foods at a later age, 
when looking at the findings from MACE and other recent studies, compared to studies 
conducted 10-15 years ago. In the MACE study the mean age of introduction of complementary 
foods was 5.1 months (SD 1.14) with only 10% of infants receiving solids before 4 months of 
age. The Drakenstein study reported that 19% of infants had received solid food before 14 
weeks of age, of which 8% had received it by 6-10 weeks (Budree at al., 2017a). These figures 
are considerably lower than those of studies conducted in the early 2000s. In the Limpopo birth 
cohort, 80% of infants had received solid foods by the age of 3 months, 44% of them by 1 
month (Mamabolo et al., 2004), while in a rural KZN study 61% of infants had received solids 
by 4 months of age (Faber & Benade, 2007).  The Promise-EBF trial which collected data 
between 2006 and 2008, found that almost two thirds of infants had received infant cereal by 
the age of 3 months, 28% of them by 3 weeks of age (Ramokolo et al., 2015). Previous advice 
given to mothers was to introduce complementary foods between 4-6 months. The South 
African IYCF Policy of 2007 (DoH, 2007) adopted the 2001 WHO guideline of exclusive 
breastfeeding until 6 months of age, followed by the introduction of complementary food. 
There appears to be greater awareness amongst mothers of this recommendation in recent years.  
Both the MACE and Drakenstein study found no association between the age of introduction 
of solid foods and either stunting or overweight. There has been conflicting evidence from 
international studies with a systematic review concluding that while there was no clear 
evidence, very early introduction, before 4 months of age, may increase the risk (Pearce et al., 
2013). Potential mechanisms include either increased energy intake, resulting in early rapid 
weight gain (Thompson & Bentley, 2013); or a hormonal effect, for example, by increasing 
ghrelin levels (Pearce et al., 2013). 
 
 Complementary feeding practices 
5.4.3.1 Feeding practices at 6 months 
The limited data that was available on feeding practices at 6 months in the MACE study infants 
indicates that commercial infant foods, particularly infant cereals, were the predominant 
choice. Nearly two thirds of the sample received infant cereal, with only a quarter receiving 
porridge while half the sample received commercial jarred foods. Approximately one third of 
the sample received both infant cereal and jarred foods. The Drakenstein cohort had an even 
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higher daily consumption of infant cereal at 6 months of almost 90% (Budree et al. 2017a). 
The Faber & Benade (2007) study reported a greater consumption of porridge than infant cereal 
with 52% of infants receiving infant cereal on most days while 88% of infants received 
porridge.  This probably reflects the fact that this was a rural population. A later study 
conducted in both a rural and an urban setting in KZN found that the consumption of infant 
cereal was more common in the urban setting (Faber et al. 2016).  
 
Infant cereal, although unaffordable for many, has been found to make an important 
contribution to iron intake, with the rural KZN study reporting 51% of total iron intake coming 
from infant cereals (Faber, 2005).  A beneficial effect of iron fortified commercial infant foods, 
including cereal, on LAZ was reported in an Indonesian study (Diana et al. 2017). In South 
Africa there is mandatory fortification of maize meal and bread flour with a range of 
micronutrients, including iron and zinc, but the amounts consumed by infants are too small to 
have a significant impact on micronutrient intake (Faber et al. 2016). South African 
complementary feeding guidelines, while recognising that infant cereals can improve 
micronutrient intake and are convenient, also emphasise the importance of improving dietary 
diversity and specifically intake of animal protein foods (du Plessis et al., 2013). These are also 
expensive but are required in only small amounts and cheaper sources such as chicken livers 
can provide high levels of micronutrients for far less money than commercial infant foods. As 
an example, three tablespoons of chicken livers (45 ml) provides 4.5 mg of iron and 2.3 mg of 
zinc (FoodFinder®), compared to the 6 mg of iron and 2 mg of zinc in 150 ml of Nestlé 
Cerelac® infant cereal, for less than half the price3. 
 
While infant cereals are high in micronutrients, commercial jarred foods make little 
contribution to micronutrient intake and are far costlier (Faber, 2005).  A review of the 
nutritional value of commercial compared with home prepared meals, highlighted the 
conflicting findings on the topic but advised that, provided caregivers followed infant feeding 
guidelines, home prepared foods had a number of advantages including: the ability to vary 
texture; greater control over ingredients, and cheaper cost (Lockyer, 2016).  Lobstein et al 
(2015) in the 2015 Lancet Obesity series raised the issue of the rapidly increasing processed 
infant foods market which may be preventing the transition from breastmilk to family foods. 
                                                 
3 June 2018 prices: chicken livers R10.99/250g=R2.43 per 45ml serving;  Cerelac® R32.99/ 250g= R6.60 per 50g 
serving (150ml) 
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The concern is that they accustom infants to highly processed foods from an early age and these 
taste preferences then continue into later childhood and beyond. 
 
5.4.3.2 Feeding practices at 12 months 
Complementary feeding practices were assessed using the WHO IYCF Indicators for infants 
from 6-23 months, with some adaptions made for local conditions and the inclusion of a section 
on the intake of inappropriate foods and beverages. The questionnaire, administered by the 
researcher to a sub set of 94 caregivers, revealed poor dietary diversity with a mean DDS of 
3.56, below the cut off for an adequate DDS of 4. This is similar to the mean DDS of 3.26 for 
children 6-13 months old in the Breede Valley study (du Plessis et al. 2016).  The association 
of dietary diversity with micronutrient adequacy was demonstrated by Faber et al. (2016), 
where a complementary diet with a DDS ≥4 provided significantly greater amounts of protein 
and a number of micronutrients, including calcium, iron and zinc than a diet with a DDS <4.  
Less than half the sub set of MACE infants achieved MDD while only one third achieved the 
MAD indicator. These results are comparable to other South African studies that have reported 
on complementary feeding practices using the IYCF Indicators; two of the studies reported that 
less than half of infants achieved MDD (du Plessis et al., 2016; Faber et al., 2016). The 
Drakenstein study reported much higher rates with 75% of infants achieving MDD, but the 
MAD indicator could not be assessed as information on frequency of feeding was not collected 
(Budree et al. 2017a). The MAD Indicator was assessed in the Breede Valley study and the 
2016 DHS; both reporting less than 50% of infants achieving MAD, with the DHS particularly 
low at only 21% (DoH et al., 2017; du Plessis et al., 2016). To put the findings into a global 
context, a recent analysis using UNICEF data from 101 countries found that, in infants aged 
12-17 months, only 31.5% achieved the MDD indicator and this figure decreased to 18% for 
the MAD indicator (White et al., 2017). 
 
Iron rich food consumption was fairly high at 87%, including infant cereal and formula; very 
similar to that reported in the Breede Valley study at 89%. The intake of flesh foods was also 
similar, 60% in MACE compared to 55.6% in Breede Valley (du Plessis et al. 2016). 
Consumption of animal protein foods is recommended as they are good sources of iron and 
zinc which are typically problem nutrients in the complementary diet and, together with 
calcium, are associated with linear growth (Krasevec et al., 2017).  There was a high meat 
consumption in the Drakenstein study with 77% of infants  consuming animal protein but 55% 
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was in the form of polony (Budree et al., 2017a), while only 5% of infants in the MACE study 
had consumed polony in the previous 24 hours. Polony and other processed meat consumption 
is not recommended because of the high sodium and saturated fat content. Of concern in the 
MACE study was the fact that almost a quarter of infants had consumed “two minute” noodles, 
which are also very high in sodium. Consumption of high levels of sodium in infancy has been 
linked to higher blood pressure in later life (Huffman et al., 2014). Additionally, noodles are 
purely a source of refined carbohydrate with very little nutritional value and replace more 
nutrient dense foods in the diet. 
 
The high levels of consumption of inappropriate infant foods such as SSBs and HFS, for 
example crisps, in the MACE study have also been reported in the Drakenstein study (Budree 
et al., 2017a) and in two KZN studies (Faber et al., 2016; Faber& Benade, 2007).   There seems 
to be an increasing trend towards the consumption of crisps in more recent times. In the earlier 
rural KZN study, crisps were consumed once a week by 35% of 6-12 month old infants (Faber 
& Benade, 2007); this figure had nearly doubled in the more recent KZN study (Faber et al., 
2016) and was even higher, at 72%, in the MACE sub set. This trend is not limited to South 
Africa; increasing consumption in LMICS of inappropriate high fat and high sugar snacks and 
beverages has been reported with implications for both stunting and overweight and longer 
term NCD risk (Contreras et al., 2016; Huffman et al., 2014). This is due to their combination 
of high energy- but low nutrient-density and high contents of sugar, salt and fat, particularly 
trans fats. In a LMIC context setting these foods also displace healthier, more nutrient dense 
options in the food budget (Huffman et al., 2014).   
 
Fruit juice is often seen as a healthy option by mothers but the American Academy of Pediatrics 
does not recommended this for infants below 12 months (Heyman & Abrams, 2017) as it is 
thought to act as a gateway drink to SSBs in later childhood (Sonneville et al., 2015). It is 
therefore concerning to note  that in South Africa there is a fruit juice specifically marketed for 
infants from 6 months.  Fruit juice was consumed at least once a week by 51% of 12 month old 
infants in the MACE subset and daily by 83% in the Drakenstein cohort (Budree et al., 2017a). 
   
Despite the poor complementary feeding practices in MACE study infants, such as low dietary 
diversity and the frequent consumption of inappropriate foods and beverages, there was no 
association with either stunting or overweight. This could be due to the small sample size of 
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87 infants. These findings are however very similar to those of the Drakenstein study which 
also used the WHO IYCF Indicators but had a larger sample size and collected data at different 
time points.  Poor feeding practices were also identified in the Drakenstein study but there was 
no association with growth outcomes except that longer duration of exclusive breastfeeding 
was associated with lower LAZ at 12 months (Budree et al., 2017a).  
 
The WHO Indicators are a useful tool to assess feeding practices and make comparisons across 
studies, both nationally and internationally, but their association with growth outcomes has 
been mixed. A pooled analysis of data from 14 countries found lower risk of both stunting and 
underweight if the indicators for timely introduction of solid foods, MAD, intake IRF and MDD 
were met (Marriott et al., 2012). A later review used data from 9 countries but did not pool the 
data. It found lack of consistency across countries with some countries showing a positive 
relationship between MDD indicators and MAD and HAZ, but others showing no association 
(Jones et al., 2014). The authors suggested that this may be due to the fact that at a cut off of 
four food groups the Indicators lack specificity, meaning they will often misclassify an 
adequate diet as inadequate. However, a recent analysis of DHS data from 39 countries found 
that increasing dietary diversity and animal source food consumption, was associated with 
lower risk of stunting. The authors recommended that MDD be set at five rather than four food 
groups (Krasevec et al., 2017). While they were developed for use in large scale surveys such 
as DHS, it was envisaged that the Indicators could prove useful in smaller surveys (WHO, 
2008a). A small 2017 Canadian longitudinal study used the Indicators to investigate the 
association of dietary diversity with overweight and found that infants fed homemade 
complementary foods had greater dietary diversity and reduced adiposity at 12 months 
(measured by DEXA) compared to those who received commercial infant foods (Mok et al., 
2017).  
 
It must be noted that a number of birth cohorts conducted in HICs, using different dietary 
assessment tools, have also failed to make conclusive findings on the association between 
feeding practices and overweight  (Smithers et al., 2011; Brophy et al., 2009; Reilly et al., 
2005).  A systematic review on the types of food introduced and risk of childhood overweight 
concluded that high energy and protein intake, particularly dairy protein, appear to be 
associated with higher BMI and body fat mass in later childhood; although the evidence was 
not definitive. No specific foods or food groups were linked to childhood BMI (Pearce & 
119 
 
 
Langley-Evans, 2013).  Given the association in some studies between energy and protein 
intake and overweight, follow up studies in MACE children should include a more detailed 
dietary assessment that allows for the determination of energy, macronutrient and 
micronutrient intake.  
  
 Summary 
The prevalence of stunting in MACE study infants at both 12 and 24 months was considerably 
lower than other South African studies in infants of the same age range while levels of 
overweight and obesity were generally higher. The low levels of stunting can be explained by 
the urban/peri-urban nature of the cohort with virtually all households having access to tap 
water and electricity. Another socioeconomic contributing factor is the relatively high levels 
of maternal education, as lack of maternal education has been linked to stunting mainly through 
its impact on caring and feeding practices. The exclusion of mothers with hypertension and 
diabetes from the MACE study was another potential contributing factor to the low stunting 
prevalence. The association of stunting with low SES has been fairly well documented but the 
MACE study adds to evidence from the most recent South African DHS that both stunting and 
overweight are linked to low SES. 
 
The finding of an association between lower birthweight and length, and stunting; and higher 
birthweight and overweight; emphasises the need for optimal nutrition and care during 
pregnancy to ensure a healthy birthweight. Early identification of infants gaining weight 
exceptionally fast from as early as the first 6 months is important as this was strongly predictive 
of being overweight or obese at 24 months in the MACE study and evidence from other studies 
suggests that they are at markedly increased risk of obesity in later childhood. The 6 to 12 
months period appears to be particularly important as rapid weight gain during this time was 
the most strongly predictive of higher BAZ at both 12 and 24 months. This is in contrast to 
other studies that found the first 6 months to be more significant.  
 
Infant feeding practices were very similar to those reported in other South African surveys with 
high levels of breastfeeding initiation, which were not sustained by 6 months; and generally 
poor complementary feeding practices, characterised by low dietary diversity and high intake 
of inappropriate foods. Breastfeeding practices of HIV positive mothers were also similar to 
those reported in other surveys with lower rates of breastfeeding initiation and mixed feeding 
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compared to HIV negative mothers and higher rates of formula feeding. There is poor 
compliance with the South African IYCF policy. Despite poor infant feeding practices they 
were not associated with growth outcomes at 12 months, in line with the findings of the 
Drakenstein study.  
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 CONCLUSION 
South Africa, as with other LMICs, has a double burden of malnutrition, with high rates of 
stunting and overweight in young children. A number of sociodemographic factors, together 
with sub optimal nutrition during the first 1000 days from conception to two years of age, have 
been implicated in the development of poor growth outcomes.  This study used longitudinal 
data collected between 2013 and 2017 from 290 mothers and infants enrolled in the MACE 
birth cohort study, Durban, to investigate early life risk factors for stunting and overweight in 
a LMIC setting. 
This study had the following objectives:  
 To describe the prevalence of stunting and overweight at 12 months of age in infants 
enrolled in the MACE study. 
 To describe the maternal and household characteristics of the study infants and to 
determine their association with the growth outcomes of stunting and overweight at 12 
months. 
 To describe birth anthropometrics, and patterns of growth from 0-6, and 6-12 months, 
and to determine their associations with growth outcomes at 12 months. 
 To describe infant feeding practices at 6 and 12 months and to determine their 
association with growth outcomes at 12 months. 
This chapter concludes the findings of the study in relation to the objectives described above. 
It discusses the limitations of the study and makes recommendations for future research. 
 Conclusions of the study findings 
 The prevalence of stunting and overweight in the MACE study infants 
The study found that at 12 months of age MACE study infants had a lower prevalence of 
stunting and a higher prevalence of overweight compared to other South African surveys. Data 
was also available for half the study infants at 24 months of age and both stunting and 
overweight prevalence increased in the second year of life although stunting prevalence 
remained relatively low. The findings indicate that, in this urban setting, over nutrition is now 
a greater problem than undernutrition. 
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 Maternal and household characteristics and their association with growth 
outcomes 
Households were predominantly low income but with relatively high levels of maternal 
education and universal access to tap water and electricity. Antenatal HIV prevalence was 
35.3% and HIV exposure had no effect on growth outcomes at 12 months of age. The only 
household factor associated with growth outcomes was type of housing; both stunting and 
overweight were associated with children living in informal housing or flats as opposed to 
formal houses. This indicates that low SES is linked not only to stunting, which has been well 
documented, but also to overweight. This is a less well established association in LMICs. The 
low stunting rates documented in the survey can be explained by the access to basic services 
such as water and electricity as well as the good level of education in the MACE survey 
mothers.  This emphasises the importance of nutrition sensitive interventions that address the 
underlying social determinants of stunting. 
 
 Growth patterns and their association with growth outcomes 
Stunting and overweight start in utero with lower birthweight associated with lower HAZ at 12 
and 24 months while higher birthweight is associated with higher BAZ. This emphasises the 
need for optimal nutrition and care during pregnancy to ensure a healthy birth weight. When 
looking at patterns of growth, the 6-12 month period is the most significant for prediction of 
later overweight; rapid weight gain during that time should be detected early through routine 
growth monitoring to allow for intervention. Furthermore, infants obese at 12 months were 
already gaining weight significantly faster from birth than infants of normal BMI at 12 months. 
They remained overweight or obese at 24 months, indicating that very rapid gains in weight in 
the first 6 months of life were the beginning of a growth trajectory that placed the infant at high 
risk for later obesity and should not be regarded as a transient stage that the child will grow out 
of. The 12-24 month period seems to be most important for stunting prevention as it was most 
predictive of 24 month LAZ and stunting prevalence doubled in the second year of life. The 
disproportionate increase in weight in relation to linear growth in the study sample is of concern 
and if the trend continues it could lead to even higher prevalence of overweight at a later age. 
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 Infant feeding practices and their association with growth outcomes 
Feeding practices were similar to those reported in other South African surveys with low levels 
of breastfeeding by 6 months; introduction of solid foods before 6 months in half of the sample; 
and a poor quality complementary feeding diet that lacked dietary diversity. Furthermore, the 
consumption of inappropriate foods and beverages was high. Despite this there was no 
association between poor feeding practices and growth outcomes. This finding was perhaps not 
surprising in relation to the breastfeeding practices as many other studies have shown no 
association with stunting and found mixed results with overweight. The fact that the 6-12 
month period was most significant in predicting overweight indicates that complementary 
feeding practices are implicated however, the small sample size of infants with 12 month IYCF 
Indicators data probably prevented the detection of any significant associations. The finding 
that HIV positive mothers were significantly less likely to breastfeed than HIV negative 
mothers, shows that there was a lack of awareness of DoH guidelines and that misperceptions 
regarding the risk of transmission may persist. 
 
 Study limitations 
Although the MACE study had collected data on household income and maternal education, in 
a country like South Africa, with a large informal economy, it is recommended that assessment 
of SES includes a greater number of variables. The South African Stress and Health Study 
(SASH) used a composite score of four aspects: maternal education; employment status; 
household income, including social grants; and a household asset and market access score. 
(Myer et al., 2008). Some of this information was not collected in the MACE study and, as the 
study is still ongoing, should be incorporated into follow up questionnaires to allow for accurate 
determination of SES. In particular, income from grants and more detailed information on the 
type of housing, including RDP housing should be included The association of informal 
housing with overweight and stunting indicates that there is a link that was not identified with 
the income data currently collected. 
 
Pregnant women with hypertension and diabetes were excluded from the MACE study which 
aims to determine the association of environmental pollution with respiratory outcomes at 5 
years. The exclusion of these women, who are more likely to have experienced the double 
burden of malnutrition themselves and therefore more likely to deliver LBW infants at risk for 
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stunting, is a limitation that could have contributed to the lower than expected stunting 
prevalence. 
 
The sample size of 290 infants with longitudinal anthropometric data from birth to 12 months 
and 144 infants with data up to 24 months was comparable with other regional South African 
studies. Limited information on milk feeds, age of introduction of solid foods and types of 
foods given at 6 months had been collected by MACE clinical staff for these infants. There was 
very little detail collected on feeding practises and the MACE questionnaires should be adapted 
to collect more accurate data. 
It was only possible to collect more detailed WHO Indicators data from 87 infants as this was 
the number of infants who attended their 12 month follow up visits in the year allocated to 
dietary data collection. An additional 7 infants had WHO Indicators data but no anthropometric 
data so their Indicators information was used for descriptive purposes only. Therefore, while 
the data was accurate as all the caregiver interviews were conducted by the researcher, the 
small sample size limited the ability to detect any associations with growth outcomes. The 
WHO Indicators provided only qualitative information regarding the complementary diet, and 
a more detailed questionnaire allowing for quantitative assessment of nutrient intake could 
have perhaps detected an association between feeding practices and growth outcomes. 
 
 Recommendations 
  Recommendations for dietetic practise 
It is important that dietitians ensure that training of staff conducting routine growth monitoring 
and promotion activities has an explicit focus on identifying early those infants on a rapid 
growth trajectory, particularly in the 6-12 month period, as they are at increased risk of later 
overweight. The emphasis in the past has been on identifying undernutrition and staff need to 
be aware of the increasing problem of childhood overweight. This is in line with the Strategy 
for Prevention and Management of Overweight and Obesity. The new Road to Health booklets  
include a section on detecting overweight in infancy while the KZN DoH has new Standard 
Operating Procedures (SOPs) for Malnutrition which includes SOPs on management of 
overweight and obesity in infancy, later childhood and adolescence. 
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Infant feeding messages should focus on ensuring optimal linear growth while avoiding 
excessive weight gain. This includes complementary feeding advice aimed at improving 
dietary diversity, particularly intake of micronutrient rich foods, and limiting intake of 
inappropriate energy dense, but nutrient poor foods and beverages. The draft Paediatric Food 
Based Dietary Guidelines, which have recently been field tested, emphasise all of these points 
and should be finalised and disseminated without unnecessary delay. Additional platforms for 
dissemination of optimal infant feeding messages, such as the Road to Health booklet, radio 
shows and social media, form part of the DOH Side by Side campaign, launched in 2018, and 
it is hoped that improvements in IYCF practices will result. 
 
In line with the WHO Guidelines and KZN SOPs, routine supplementation of stunted children 
with energy and protein supplements is not advised in view of the longer term risks of 
overweight and NCDs. 
 
 Recommendations for future research 
This study has made some important preliminary findings and therefore the need for follow up 
of these study infants at the age of 5 years is strongly recommended. This is important to 
determine whether birth anthropometric data and patterns of growth, particularly in the 6-12 
month period, remain significant predictors of BAZ in later childhood. The finding that they 
are associated with high BMI at 24 months indicates that there may be a longer term risk. The 
question of the significance of overweight or obesity at 12 or 24 months in predicting 
overweight in later childhood is also important to investigate, as is the association of slow linear 
growth in the second year of life with later stunting outcomes.  
 
The significant association of rapid weight gain in the 6-12 month period with higher BAZ at 
both 12 and 24 months indicates that complementary feeding practices are implicated in the 
development of overweight but the small sample size and lack of quantitative data meant that 
associations with growth outcomes were not identified in this study. It is recommended that the 
MACE fieldworkers continue to use the WHO Indicators questionnaire to collect data which 
will increase the sample size. The information is also useful to provide qualitative data 
regarding infant feeding practices. In addition future research should focus on collecting more 
detailed quantitative information on the complementary feeding diet to enable the calculation 
of macro and micronutrient intake which could be used to investigate associations with growth 
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outcomes. The role of responsive feeding practices in the prevention of overweight is another 
aspect of complementary feeding that should be further investigated. Further qualitative 
research is also recommended that explores the attitudes and beliefs of mothers regarding infant 
feeding practises, including HIV and infant feeding, and identifies reasons/barriers for poor 
adherence to the IYCF Policy. 
 
The MACE study has collected information on maternal diet and maternal BMI. Although 
beyond the scope of this study, future research should investigate the association between 
maternal nutritional status and diet, and growth outcomes in childhood. The fact that birth 
weight and length were associated with stunting and overweight at 12 and 24 months of age is 
indicative of the importance of the gestational period of the first 1000 days in later growth 
outcomes. 
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INTRODUCTION 
The prevalence of various chronic health outcomes in childhood, such as endocrine, 
respiratory and neuropsychological disorders have been increasing worldwide (Newacheck 
and Taylor, 1992) In developing countries, where acute infectious diseases remains the 
largest threat to the health of children under the age of five, the prevalence of these chronic 
non-communicable disorders are similarly increasing (WHO, 1998; Deen et al., 1999). The 
reasons for this are still unclear, however, a variety of factors have been postulated, 
including, environmental factors, such as ambient and indoor pollution and diet; genetic 
factors and biological risk factors (ISAAC, 1998). It is likely that the impact of environmental 
factors commence early in conception (Yeatts et al., 2006). In order to understand how 
these various risk factors are associated with health outcomes, cohort studies commencing 
in utero, and following children until the manifestation of these outcomes, probably provide 
the best epidemiological approach. 
 
Pregnancy and birth cohort studies provide one of the most powerful research methods for 
medical and social research. Data collected about the growth and development of children, 
from in utero through to early childhood can be used to determine which biological and 
environmental factors can be associated with the health and optimal development of the 
foetus, infant and child. 
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Non-communicable respiratory disorders among children are of particular concern. Not only 
does this result in substantial infant mortality, but among those infants surviving early years, 
are likely to experience adverse respiratory health in later childhood or adult life (Sram et 
al., 2005). The global increasing prevalence of childhood asthma in recent decades is seen 
as the most important non- communicable respiratory disease of childhood. The “hygiene 
hypothesis” has been postulated for this increase in prevalence. However, there is growing 
evidence in the scientific literature that shows that children from lower socio-economic 
backgrounds have a higher prevalence of disease, and also greater severity (Joseph et al., 
2010; Akinbami et al., 2002). The pathophysiological mechanisms for these disorders are 
complex, and act through multiple pathways (Figure 1) 
 
Understanding the reasons behind the profile of this and other non-communicable 
childhood respiratory disorders allows for the development of appropriate interventions. A 
birth cohort with well defined health outcomes, measuring a multiple of factors at different 
stages of development, including biochemical, genetic, epigenetic and environmental 
factors can provide such an understanding. We have completed an pilot study, which 
investigated genetic and biochemical inflammatory markers among pregnant women 
(n=100), while assessing their exposure to key pollutants. This proof of concept study, 
although lacking power to address associations, suggested that those mothers exposed to 
industrial pollution have differential levels of biochemical inflammatory markers compared 
to those without such exposure. 
 
The industrial basin in south Durban provides an opportunity to investigate these 
associations. The Durban south industrial basin (DSIB) is a complex mix of heavy industry 
and residential communities with high levels of community organisation, there has been a 
substantial focus by researchers, academics and the media on the prevalence of poor 
health outcomes as well as levels of ambient air pollution (Matooane et al, 2002). These 
have included, both published and unpublished studies, a large number of media reports, 
community organisation reports and commissioned reports (governmental, corporate and 
non-governmental). Studies have been conducted looking at exposure-health outcomes 
relationships, as well as documenting the environmental pollution patterns in the Basin. 
Studies among the communities in this area suggest that children of school-going age are 
at a higher risk for asthma and other respiratory outcomes, when compared to children of 
similar age and socio-economic status from less polluted northern communities within the 
city (eThekwini Health, 2007; Kistnasamy and Knapp, 1992; Nriagu et al, 1999; Kistnasamy 
et al., 2008; Naidoo et al., 2012) 
 
This area consists of approximately 200 000 people living in 25 designated "suburbs". The 
area has been reported to have a high unemployment rate, with approximately 52% of the 
population not economically active. The DSIB is subject to significant levels of ambient air 
pollution because of its geographic relationship with certain stationary sources of air 
pollutants. Specifically, two major petroleum refineries are within the community, together 
with a pulp and paper manufacturer, Mondi. Available reports indicate that each of these 
refineries has emitted, on average, in the range of 35 000 to 40 000 kg of SO2 per day. 
Through rigorous monitoring and enforcement, the total industrial SO2 emissions were 
reduced from 107 tons per day in 2000, to 61 tons per day in 2005 (eThekwini, 2007). Owing 
to a combination of its geographical relationship to the refineries, land contours, prevailing 
meteorological conditions, the use of a relatively short emissions stacks at these facilities 
(50 – 100 meters), the lack of or relative ineffectiveness of emission control devices on 
refinery stacks, the many sources of so-called fugitive air emissions at refineries, emissions 
from industrial and passenger vehicles, as well as the proximity of other industries and until 
recently, the Durban International Airport, the community is believed to be at risk for 
intermittent substantial exposure to ambient air pollutants. 
 
The recognition of this pollution risk is reflected in the various attempts to monitor levels of 
pollution in the Basin. This has included an industry-funded South Durban Sulphur Dioxide 
Management Systems Committee (SDSDMSC) which has been continuously monitoring 
one pollutant of concern, sulfur dioxide, at the Settlers' Primary School since June 2000. 
More recently, the establishment of the “Multipoint Plan” (MPP) of the local government 
(eThekwini Municipality) has resulted in a comprehensive continuous Air Quality Monitoring 
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System (AQMS). Available data from these and other monitoring systems suggest that 
although in the past pollutant measures, particularly sulphur dioxide, have frequently 
exceeded World Health organisation (WHO), the South African Department of 
Environmental Affairs (DEAT), since the implementation of the MPP, there has been a 
gradual decline in the ambient pollutant levels. (eThekwini, 2007) 
 
This longitudinal birth cohort study aims to examine the effects of environmental influences 
on the health and development of a cohort of women attending ante-natal clinics in the 
South Durban Basin, compared to a cohort of women from the less industrially polluted 
community north of the city. Priority outcomes will be indicators of respiratory development, 
as well as adverse respiratory outcomes. Risk factors to be investigated will include ambient 
and indoor pollution, dietary impacts, particularly reduced intake of antioxidants, genetic 
polymorphisms, epigenetic changes and adverse birth outcomes. Additionally, the 
proposed investigation will address the hypothesis that asthma risk may be influenced by 
environmentally induced epigenetic changes. This is cutting edge research which is gaining 
momentum in the USA and UK, but still in its infancy in Africa. We will determine if factors, 
such as environmental pollution, nutrition and genetic polymorphisms may interact to result 
in adverse outcomes such as low birth weight, intra-uterine growth retardation and 
premature births, in a population of pregnant females from communities with high levels of 
industrial environmental pollution, compared to pregnant females without such exposures, 
but with similar socio-economic status. Children will be followed up from before birth to six 
years of age. The Mother and Child in the Environment (MACE) study has the advantage 
of repeated measures of specific environmental exposures, collection of biological 
specimens over time, and comprehensive clinical outcomes assessment. This will 
contribute to a wealth of information on specific environmental triggers and critical time 
windows of susceptibility. Additionally, an African population will, for the first time, be 
evaluated in a study of environmental epigenomics. 
 
 
 
 
HYPOTHESIS, OVERALL AIM AND SPECIFIC OBJECTIVES 
Research Hypotheses 
 Childhood organ development is adversely and permanently affected by ambient 
pollution resulting in permanent deficits in organ function, including the respiratory 
system. These impacts occur in utero. 
 Ambient pollution may result in adverse birth outcomes such as low birth weight 
and intra- uterine growth retardation, which in turn may be risk factors for the 
development of respiratory diseases. 
 Additional exposures and risk factors such as indoor air pollution, inadequate dietary 
intake, environmental tobacco smoke, genetic polymorphisms and epigenetic changes 
and other unmeasured socio-economic factors contribute to these adverse outcomes 
 Subsets of children can be identified who are more susceptible to the effects of air 
pollution. This may be through oxidative stress mechanisms and genetic predisposition. 
 Specific biomarkers and genetic profiles can predict the likelihood of adverse outcomes 
 Human immunodeficiency viral infections contribute to these adverse outcomes, and 
may modify the effects of the other exposures. 
 Among those who are susceptible and those predicted to develop adverse outcomes, 
appropriate and early interventions will alter the course of the disease or outcome. 
 
Overall Aim 
 
To determine the effect of ambient and environmental pollution exposure on childhood 
respiratory development, and the modification of effect by birth factors, genetic 
predisposition, epigenetic changes and oxidative stress, and to test the effectiveness of 
dietary intervention in reducing the risk for adverse respiratory outcomes. 
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Specific Objectives 
 
 To characterise environmental exposure patterns among a cohort of pregnant 
women and subsequently, their offspring among communities with documented 
high levels of industrial exposure and a comparison communities without such 
exposures; 
 To describe perinatal risk factors including exposure to ambient and indoor pollutants, 
maternal smoking, or maternal exposure to passive smoking, allergen exposure 
(ingestion of peanuts, egg protein etc) and atopy status, diet generally and specifically 
dietary intake of antioxidants, HIV and anti-retroviral treatment status and other 
maternal stressors likely to impact on the foetus; 
 To describe neonatal, infant and early childhood risk factors, such as adverse birth 
outcomes (low birth weight, intra-uterine growth retardation and preterm deliveries), 
dietary factors (breastfeeding or formula feeding; intake of antioxidants etc), exposure 
to allergens (aerosol or dietary) and atopy status, exposure to environmental pollutants, 
ambient and indoor; 
 To assess genetic status of these children with respect to a set of polymorphisms in 
specific genes associated with response to oxidative stress and respiratory 
biomarkers, cellular changes from environmental pollutants, and to response to 
therapeutic interventions (dietary supplementation with vitamin C and vitamin E.) 
These genes include GSTM1, GSTP1, and TNF . 
 To investigate the genome wide DNA methylation status of the neonate using umbilical 
cord blood; 
 To investigate the relationship between genome wide DNA methylation status and 
prenatal environmental exposures; 
 To investigate the relationship between genome wide DNA methylation status and 
respiratory outcomes in children. 
 To assess baseline level of airway inflammation through measurement of FeNO, 
sputum ECP, metalloproteinase, neutrophil and eosinophil count; fibrinogen, C-reactive 
protein (CRP); as well as more general markers of asthma severity (spirometry, peak 
expiratory flow, airway hyperresponsiveness, symptoms, emergency ward visits and 
hospitalizations, and perhaps short acting beta agonist rescue use, corticosteroid use) 
at various stages of childhood within the cohort 
 Among the older children, to assess associations of short term fluctuations in ambient 
air pollutants with fluctuations in pulmonary function, symptom reports, and other 
markers of inflammation using generalized estimating equations and/or generalized 
linear mixed models. To assess effect modification of these associations by asthma 
severity, asthma type, medication use, allergen exposures, serum specific IgE/IgG4 
ratios to common inhalant allergens, specific polymorphisms and combinations of 
polymorphisms. 
 To assess the long term effect of ambient pollution on lung development generally and 
on adverse respiratory outcomes specifically, adjusting for perinatal risk factors, 
genetic polymorphisms, adverse birth outcomes, oxidative stress and indoor 
environmental pollution, through the development of appropriate multivariable 
regression modelling; 
 Evaluate the effectiveness of a dietary intervention (supplementation with vitamin C and 
vitamin E), in a randomized control trial, to reduce symptoms, improve pulmonary 
function and decrease markers of underlying inflammation among children with asthma. 
This objective assesses the hypothesis that in those children with evidence of 
suboptimal baseline antioxidant intake (evaluated through a combination of serum 
measurements of carotenoids, vitamin E, and food diaries), dietary supplementation will 
significantly improve all of these markers. 
 To investigate effect modification of this intervention effect by polymorphisms related to 
oxidative stress. This objective will test the hypothesis that children at high-risk for 
146 
 
 
adverse effects of exposure to ambient pollutants on the basis of their genotypes (e.g., 
GSTM1 null, etc.), will show a greater effect of dietary supplementation. 
 
 
BACKGROUND AND SIGNIFICANCE 
Introduction 
The scientific literature has consistently documented the association between various 
ambient and indoor pollutants and adverse health outcomes among children. These 
outcomes extend from birth outcomes such as low birth weight, prematurity and birth 
defects through to later childhood including respiratory outcomes such as asthma and 
neurological outcomes such as low IQ or learning disabilities (Glinianaia et al, 2004). These 
outcomes have been documented with a variety of pollutants, although some outcomes are 
pollutant-specific. Responses to pollutant insults vary within populations. These could be 
due to the nature and dose of particular exposures, genetic predisposition or inadequate 
defense mechanisms to respond to specific stressors, such as oxidative stress. 
 
Over recent times research into the potential impact of air pollution on the health of the 
developing foetus has grown rapidly. Foetuses may be considered a further sub group 
of a vulnerable population, which are known to be highly susceptible to a variety of 
toxins, because of their exposure pattern and physiologic immaturity (Sram et al, 
2005; Perera et al, 1998). Studies conducted in the United States, Brazil, China, Mexico 
and the Czech Republic have all related adverse birth outcomes such as low birth weight, 
intrauterine growth retardation, preterm birth and foetal mortality to ambient air pollution (Xu 
et al, 1995; Pereira et al, 1998; Bobak et al, 2000; Perera et al, 1998; Loomis et al, 1999; 
Woodruff et al, 1997). Neonatal susceptibility to environmental pollutants may be caused 
by either direct or indirect hits on several cell types to influence cell differentiation, 
proliferation and/or maturation. Air pollutants may also alter the normal developmental 
pattern for metabolic, immune and neurological functions that are constantly changing 
during in utero and postnatal growth. The sensitivity of neonatal cells to environmental 
toxins is likely to be completely different from these same cell types found in the adult. 
Delivery of an environmental toxicant to the respiratory system is also dramatically different 
during the foetal compared with the postnatal period (Pinkerton and Joad, 2006). There is 
accumulating evidence that there is a need for longitudinal studies in the developing world 
(International Interest Group, 2003). 
 
The period in which the developing foetus is most susceptible to organ maldevelopment is 
the period of organ formation during weeks 3-8 following fertilisation. Birth weight reflects 
intrauterine growth and wellbeing and is recognised globally as an indicator of perinatal and 
infant health. A low birth weight (less than 2500g), from either premature birth or intrauterine 
growth retardation (IUGR) is strongly associated with increased infant mortality and 
morbidity. These neonates are more likely to have hypertension and coronary heart disease 
(Sram et al, 2005). As well as being a marker of early child health, low birth weight is 
associated with increased risk of developing various diseases in later life including heart 
disease and type 2 diabetes (Spinillo et al, 1995; Osmond and Barker, 2000). 
 
Lung and airway development begins about 24 days after fertilization, with the pre-acinar 
airway pattern being finalised by 17 weeks of gestation. Respiratory bronchioles and acini 
continue to grow until about 36 weeks of gestation. The airways are almost fully developed 
by birth, with postnatal development in length and diameter of already developed tissue. 
Thus insults in early foetal life and early childhood have consequences later in childhood 
and adulthood (Devereaux, 2007). A number of factors influence the growth and maturation 
of the developing lung. These include transcription factors and molecular factors directing 
the development of epithelial and cellular proliferation. In addition, the enzyme systems 
necessary for the development of the respiratory system occurs late in the gestational 
period, and continues into early childhood. This includes the glutathione-S-tranferases, the 
cytochrome P450 mono-oxygenase systems and the other anti-oxidant enzymes (Pinkerton 
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and Joad, 2006). Environmental tobacco smoke, bioactivated compounds and oxidant 
gases have shown to adversely impact on the developing lung (Pinkerton and Joad, 2006). 
 
 
Although numerous studies have shown that exposure to outdoor air pollution exacerbates 
asthma, the effect on lung development has been less clear (American Academy of 
Pediatrics, 2004) Children are more vulnerable to the effects of air pollution than adults; 
they have increased exposure levels due to higher minute ventilation and higher levels of 
physical activity. Eighty percent of the alveoli are formed in the post natal period and 
changes in the lung continue until adolescence. This means that during the early post 
neonatal period the developing lung is highly susceptible to damage after exposure to 
environmental toxins. (American Academy of Pediatrics, 2004) To understand the health 
outcomes of exposure to a variety of environmental factors in the respiratory system of 
children requires careful consideration that lung development is a multistep process and 
cannot be based on studies in adults. Most babies and preschool children spend a very high 
fraction of their time indoors – if this is a critical window of exposure to allergens and the 
subsequent development of asthma, greater emphasis on the investigation of the indoor 
environment is necessary. 
 
Genetic and Molecular Changes in utero 
The complications observed during pregnancy and birth outcomes are primarily as a result 
of foetal development which is dependent on the state of maternal health. Pregnancy has 
been accepted as an inflammatory state in the maternal system accompanied with elevated 
oxidative stress, hence susceptibility to damage of biomolecules (Furness et al., 2011). A 
myriad of contributing factors are implicated in pregnancy complications which range from 
diet and lifestyle to genetic variation between individuals. Monitoring DNA damage is 
most frequently used to assess exposure to environmental pollutants. The measurement 
of DNA damage is of importance in pregnancy, both at the genomic and mitochondrial level, 
as the human foetus is exposed to a variety of environmental agents and drugs that cross 
the placenta (Furness et al., 2011). DNA damage has been well studied and several classes 
of products identified such as chromosome loss, single and double strand DNA breaks, 
DNA fragmentation, and base oxidation. Mitochondrial DNA, due to its close proximity to 
the electron transport change, is susceptible to damage due to pollutant induced oxidative 
stress (Figure 2). The significance of changes in the genome in foetal development is well 
described and understood (Furness et al., 2011). 
 
Epigenetic changes such as DNA methylation, chromatin and histone modification and 
microRNA expression, however, are stable and heritable changes which does not in itself 
affect the DNA sequence (Li et al., 2010). MicroRNA expression have been associated with 
embryonic development (Prieto et al., 2011), cell cycle and more importantly plays a crucial 
role in coordinating the inflammatory response by directly affecting the transcriptome and 
thus heavily influences gene expression patterns (Asirvatham et al., 2009). 
 
There is emerging evidence for modulation of the transcriptome by environmental factors 
(Jardim, 2011). MicroRNA expression profiling and its functional significance during 
pregnancy have been only recently documented (Prieto et al., 2011; Kotlabova et al., 2011) 
The effects of air pollution on these microRNA species during pregnancy are unknown. We 
hypothesise that industrialisation and ambient pollution exacerbates the inflammatory state 
during pregnancy and contributes to birth defects and pregnancy complications by 
influencing the level of microRNA expression and mitochondrial function. 
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Figure 2: Sources of oxidative stress. Oxidative stress derived from environmental 
pollutants results in inflammation. Cellular-derived oxidative stress from mitochondrial 
respiration, the NADPH oxidase system or xanthine oxidase system. Inflammation may 
have a feed forward effect triggering inflammatory cells to contribute to oxidative stress, 
exacerbating and intensifying the inflammatory response. PMNs, polymorphonucleocytes; 
Eos, eosinophils; AMs, alveolar macrophages. (Adapted from Kirkham, 2006) 
 
Studies have shown that asthma has a strong genetic component and research has shown 
that the genetic and environmental factors may interact to exacerbate the disease. Findings 
of studies evaluating gene environment interactions clearly indicate the importance of these 
interactions in respiratory disease. Large cohort studies on childrens’ respiratory health and 
genetics have been done or currently underway in several countries in the developed world 
but to date there has been no similar work done on the African continent. While there are 
other birth cohort studies from Africa, this is the first to include both genetics and 
environmental exposures as risk factors for the development of respiratory disease. 
However, there are few examples from the literature of specific gene-environment 
interactions in relation to asthma. The clearest examples of genetic interactions for inhaled 
pollutants exist for ozone, environmental tobacco smoke and endotoxin (London, 2007). 
 
The genetic and environmental factors that mediate asthma risk and expression are 
intricately linked. Environmental and genetic factors interact pre- and post-natally to 
determine phenotype in the child as shown in Figure 2(Carroll et al., 2005; Miller and Ho, 
2008). 
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Figure 3 Proposed model of gene–environment interactions in determining asthma 
phenotype (Carroll et al., 2005). 
 
Developments in laboratory sciences over the recent past have begun to identify a variety 
of markers of inflammation and inflammatory responses related to oxidative stress, 
including within the respiratory system. Some of these could be predictors of adverse 
respiratory outcomes in later life. The lung in the newborn is subject to a variety of oxidative 
stressors, including the large increase in oxygen concentration, and exposures to various 
environmental pollutants and irritants. This effect is exacerbated in the premature infant 
(Kelly, 2003). We have chosen to investigate GSTM1, GSTP1 and TNF-308 genes since 
these polymorphic genotypes have common functional variants (SNPs) which affect 
susceptibility to disease and have been implicated in possible gene- environment 
interactions in the context of respiratory diseases. GSTM1 and GSTP1 have been linked to 
oxidative stress responses, while TNF-308 has been associated with inflammatory 
responses. Research has mainly focused on a handful of common polymorphisms with 
well described functional effects in genes thought to be involved in oxidative stress 
responses (London and Romieu, 2009). The single most commonly examined is a highly 
prevalent deletion polymorphism of the glutathione S-transferase M1 gene (GSTM1). 
Deletion of both copies of the GSTM1 gene, referred to as homozygous deletion or the null 
genotype, abolishes GSTM1 activity (Strange et al., 2001) The high frequency of the 
GSTM1 null genotype, ranging from 25 to 60% depending on the ethnic group, enables 
examination of this polymorphism in studies that were not originally powered to study 
interactions. The second most commonly studied gene in relation to either ETS or ambient 
air pollution is glutathione S-transferase P1 (GSTP1). A functional polymorphism (Ile105Val; 
AA→AG/GG) occurs at relatively high frequency (Strange et al., 2001). The majority of 
published studies looking at interactions between air pollutant exposures and either or both 
GSTM1 and GSTP1 polymorphisms show positive findings, but not always in the same 
direction for GSTP1 (London and Romieu, 2009). TNF alpha is a 157 amino acid cytokine 
protein manufactured by white blood cells to stimulate and activate the immune system in 
response to cancer, infection, exposure to endotoxin, or other products of bacterial, viral, 
parasitic or inflammatory origin. Overproduction of this compound can lead to disease 
where the immune system acts against healthy tissues. (TNF)-alpha is a pro-inflammatory 
cytokine that has been implicated in many aspects of the airway pathology in asthma (Li et 
al., 2006). 
 
Epigenetics plays an important role in the regulation of a wide variety of genes, which 
includes the genes involved in the inflammatory immune response (Bousquet et al., 2004). 
These epigenetic modifications may help to explain the patterns of inheritance seen in 
asthma and explain how they interact with environmental factors (Miller and Ho, 2008). 
Aberrant DNA methylation, altered histone modifications, specific microRNA expression, 
and other chromatin alterations orchestrate a complex early-life reprogramming of immune 
T-cell response, dendritic cell function, macrophage activation, and a breach of airway 
epithelial barrier that dictates asthma risk and severity in later life. (Ho, 2010). This may be 
particularly valid when accounting for the effects of environmental stressor such as cigarette 
smoke and air pollution on enhancing the risk of asthma in children exposed in utero. 
Epigenetic changes do not alter the underlying genetic code of the person but affect a cell's 
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transcriptional programme in response to environmental challenge and, importantly, are 
reversible throughout a person's life (Adcock et al., 2006). Complex diseases such as 
asthma are ‘‘programmable’’ by specific early-life environmental exposures. The prenatal 
period (during growth of the airways and development of the immune system) is a critical 
window of programming. In this regard maternal exposure to ETS, traffic related pollutants, 
viral infection, dust mites, and certain nutritional factors during pregnancy have been shown 
to increase the risk of asthma in offspring (Miller and Ho, 2008). 
 
The first epigenetic mechanism recognised was DNA methylation, which is a reversible 
modification of DNA structure, adding a methyl group to the 5 position of a cytosine residue 
often as part of a CpG island or cluster which generally results in gene silencing (Ho, 2010). 
Epidemiologic studies have investigated the association between demographic, 
environmental and behavioral risk factors with both white blood cells (WBC) global and 
gene-specific DNA methylation (Terry et al., 2008). Pollutants such as ozone have been 
linked to epigenetic changes in the lung. For example, as with smoking, air pollution can 
result in oxidative stress, leading to DNA lesions and hypomethylation. Furthermore, 
pollution decreases methylation across the genome which was associated with oxidative 
stress (Miller and Ho, 2008). There are numerous gene-specific DNA methylation studies. 
Methylation of the ACSL3 59-CGI gene was found to be significantly associated with 
maternal airborne PAH exposure exceeding 2.41 ng/m3 (OR = 13.8; p =0.001) and with a 
parental report of asthma symptoms in children prior to age 5 (OR = 3.9; p,0.05). Thus, if 
validated, methylated ACSL3 59CGI in umbilical cord white blood cells DNA may be a 
surrogate endpoint for transplacental PAH exposure and/or a potential biomarker for 
environmentally-related asthma (Perera et al., 2009). DNA methylation might also be an 
epigenetic mechanism that can explain the lifelong effect of exposure to tobacco smoke in 
utero on asthma risk. Breton et al (2009) recently examined DNA methylation status in 
buccal cells from a cohort of children born to mothers who did or did not smoke during 
pregnancy. Children exposed to maternal smoking had lower methylation of the AluYb8 
repeat element, indicating global DNA hypomethylation. 
 
A large body of research has implicated specific time periods when individuals seem to be 
more susceptible to the effects of environmental exposures and other asthma triggers. 
These include prenatal development, early childhood, and adolescence (Ho, 2010). 
Experimental animal models also have shown that intrauterine exposure to airborne 
pollutants may increase the risk for respiratory disease in offspring. Differential DNA 
methylation of promoter regions of reprogrammable genes may be an important mechanism 
in establishing the imprint. Therefore a mother’s exposure to pollution during pregnancy 
may predispose her child to asthma, these alterations could occur, not only in target 
organs/ tissues such as fetal lung or the immune system, but also in peripheral tissues such 
as fetal circulating white blood cells and placental tissues, thus providing opportunities to 
discover and develop highly sensitive and specific, minimally invasive biomarkers for 
exposure assessments or clinical indications. There are limited published data that have 
examined the effects of prenatal exposure to ambient air pollutants, nutrition and 
other environmental exposures on DNA methylation patterns and potential association 
with asthma phenotypes in the offspring. This is an important gap in our understanding of 
asthma pathogenesis. (Miller and Ho, 2008). The dynamic nature of epigenetic regulation 
in contrast to the static nature of the gene sequence provides a mechanism for 
reprogramming gene function in response to changes in lifestyle trajectories. Thus, 
epigenetics could provide an explanation for well documented gene–environment 
interactions. An important implication of the possible involvement of epigenetics is the 
potential for therapeutic intervention. Moreover, once we understand the rules through 
which different environmental exposures modify the epigenetic processes, we might be able 
to design behavioural and therapeutic strategies to prevent and revert deleterious 
environmentally driven epigenetic alterations (Swanson et al., 2009) 
 
(a) Markers of Inflammation, Oxidative Stress and interventions 
Developments in laboratory sciences over the recent past have begun to identify a variety 
of markers of inflammation and inflammatory responses related to oxidative stress, 
including within the respiratory system. Some of these could be predictors of adverse 
respiratory outcomes in later life. The matrix metalloproteinases (MMP) 9 and 2 are type IV 
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collagenases released from inflammatory cells have been shown to have a role in 
respiratory basement membrane inflammation (Schock et al, 2001; Sweet et al, 2004). The 
latter studies showed that the ratio of MMP to its tissue inhibitor (tissue inhibitor of 
metalloproteinase-1 (TIMP-1)) was related to chronic lung disease in the first weeks of life. 
 
The lung is subject to a variety of oxidative stressors in the newborn, including the large 
increase in oxygen concentration, and exposures to various environmental pollutants and 
irritants. This effect is exacerbated in the premature infant (Kelly, 2003). Oxidative stress 
adversely impacts on the regulation of the T-helper cytokines. Additionally, pregnancy 
stimulates the T-helper2 (Th2) pathway with a consequent an up-regulation of interleukin 
(IL)-4 and IL-10 production and concurrent down-regulation of IL-2 and interferon-g (IFN-g) 
(Vance and Halloway, 2002). Sensitisation occurs in the early in pregnancy, with priming of 
T-helper precursors by 18-22 weeks of gestation. IgE and Th2 cytokines are present in the 
amniotic fluid, and ingested and aspirated by the foetus, exposing the respiratory tract to 
these immunoglobulins and cytokines. This creates the environment for the development of 
allergic sensitisation. 
 
Among pregnant women with asthma, T-lymphocyte activity results in increased production 
of IL-4, and IFN-gamma, which was shown to have a negative correlation with maternal 
peak flow and birth weight of infants, suggesting that both maternal respiratory systems and 
fetal development are affected (Tamasi et al, 2005). Inflammatory markers such as 
IL-1beta and TNF-alpha in amniotic fluid, blood and tracheal aspirates have been 
associated with adverse foetal respiratory outcomes (Viscardi et al, 2004). Neonates with 
evidence of respiratory impairment at birth were commoner among mothers with higher 
levels of circulating interleukins. 
 
Studies investigating the relationship between markers of oxidative stress (such as plasma 
thiobarbituric acid-reactive substances (TBARS), glutathione, glutathione peroxidase, and 
6- hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid ) and impacts on lung function 
among adults have shown a positive relationship with some markers, and inverse 
relationship with others on lung function, but only in men (Ochs-Balcom et al, 2005). 
Similarly, intake of antioxidant vitamins have been positively associated with lung function 
parameters (Schunemann et al, 2002). Zinc plays major role as an ant-oxidant and as an 
anti inflammatory marker. These functions of zinc highlight the importance of this trace 
element‘s role in various pathology, including asthma (Truong-Tran et al, 2001; Zalewski et 
al,2005). An association has been noted between selenium deficiency & chronic asthma, 
with low clinical improvement post selenium replacement.(Allam et al., 2004) 
 
Several intervention studies have examined the impact of introducing vitamin 
supplementation to counter the effects of oxidative stress on lung development. It is argued 
that substances such as Vitamin A, C and E may have a protective effect (Romieu and 
Trenga, 2001; Sempertegui, 2001; Gilliland et al. 2003). Individuals with the lowest intakes 
of vitamin C (97.3mg/day) were associated with a >5-fold increased risk of bronchial 
reactivity compared to those with higher intakes (104.5mg/day) (Soutar et al, 1997). It has 
also been argued that introduction of Vitamin E during pregnancy may reduce wheeze and 
eczema in the second year of life (Martindale et al, 2005). Studies have shown that reduced 
maternal intake of vitamin D and E results in increasing symptoms of wheeze and asthma 
in children up to five years of age (Devereaux 2007). Preterm infants have been shown to 
have reduced levels of antioxidant vitamins, placing them at greater risk for oxidative stress 
(Baydas, 2002) 
 
Antioxidants reduce phagocytotic NADPH oxidase activities and also impact on apoptotic 
pathways necessary for the clearance of airway phagocytes (Kelly F, 2003). 
Supplementation of diets with these antioxidants, such as Vitamins E and C have shown 
inconsistent response to protecting against asthma symptoms, however some studies have 
shown a response for specific air pollutants such as ozone (Romieu, 2002). Children who 
did not have a daily intake of fruit had almost a 79ml lower FEV1 compared to children eating 
at least one fruit a day (Cook et al, 1997). These respiratory outcomes-vitamin intake effects 
have been replicated in other studies (Forasteire et al, 2000) 
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Exposure to ambient and indoor pollutants, particularly cigarette smoking, oxone and 
particulates are postulated to impact on oxidative pathways, increasing oxidative stress. 
Studies have examined whether the impact of such exposures could be modified by 
antioxidant supplementation (Romieu 2002). The latter was able to show that there were 
protective effects against ozone associated with vitamin C and E supplementation amongst 
asthmatic children. 
 
 
 
METHODOLOGY 
Overview 
Cross sectional studies are limited in their ability to investigate associations between 
environmental pollution and multiple health outcomes, or predictors that may vary over time. 
The south Durban communities have been subjected to decades of environmental pollution 
from the adjacent industries, and have expressed concerns about a variety of outcomes, 
including respiratory, haematological, immunological and malignancies. In addition, cross 
sectional studies cannot assess the effectiveness of interventions. The methodology 
proposed for this study utilizes a longitudinal cohort design, with a primary focus on 
respiratory outcomes, however, additional outcomes will be investigated using the broad 
framework and structure of this project. 
 
Pregnant women will be selected from the public sector ante-natal clinics in participating 
communities in south Durban. A comparison sample of women with similar socio-economic 
background, but different exposure profiles will be selected from north Durban. In each of 
these communities, located in close proximity to these clinics (south and north), are 
environmental monitoring stations managed by the eThekwini municipality. These pregnant 
women will be followed up during their pregnancy, through to labour and delivery. The 
neonate will subsequently be followed up through infancy and on regular intervals until the 
age of 6 years. 
 
A randomised control trial study design will be developed to introduce dietary 
supplementation for the study participants (children), and evaluate its effectiveness in 
reducing adverse respiratory outcomes among the sample. 
 
Selection of Communities, study population and study sample 
The methodology to address the hypothesis, together with the overall objective and specific 
aims will be through a detailed assessment of a cohort of pregnant women attending the 
public sector ante-natal clinics in the Merebank, Bluff, Wentworth and Austerville areas, in 
south Durban, with a comparison sample of pregnant mothers of similar socio-economic 
status living in a less heavily industrial north of the city. These communities were 
deliberately selected for various reasons, including their proximity to the heavy industry 
outlined in the Introduction (in the south) or the absence of such (in the north), the presence 
of environmental monitoring stations, measuring a variety of ambient pollutants, as 
indicated; the presence of strong community based organisations and the experience of the 
research team in working with these communities, as reported in the background. In 
addition, all women with uneventful pregnancies and anticipated normal deliveries, 
attending these public sector ante-natal clinics, present at three hospitals in the south 
(Wentworth Hospital, Prince Mshiyeni Hospital and King Edward VIII Hospital) and at three 
hospitals in the north (Addington and Mahathma Gandhi, and King George V Hospitals). 
 
All pregnant women that meet our inclusion criteria, presenting to these ante-natal clinics 
over a recruitment period of two years, will be invited into this study. The children born to 
these women from the pregnancy of interest will subsequently form the child participants of 
the study. The following are the criteria for pregnant women entering into this longitudinal 
study: 
PREVIOUS STUDIES IN THE SOUTH DURBAN BASIN 
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Given the historical context of the communities located in the Durban South and the high 
levels of community organisation, there has been a substantial focus by researchers, 
academics and the media on the prevalence of poor health outcomes as well and levels of 
ambient air pollution. 
 
These have included, both published and unpublished studies, a large number of media 
reports, community organisation reports and commissioned reports (governmental, 
corporate and non- governmental). Studies have been conducted looking at exposure-
health outcomes relationships, as well as documenting the environmental pollution patterns 
in the Basin. This review attempts to provide an overview of some of these findings. 
 
Health and Exposure related epidemiologic studies 
In an unpublished study conducted in the early 1990s, Kistnasamy and Knapp found that 
learners at a primary school located between the two major refineries in the DSIB (Settlers' 
Primary School) were significantly more likely to report lower respiratory symptoms than 
learners from a school of similar socioeconomic/ethnic make-up in Chatsworth (prevalence 
ratios of 3.63, 2.71, 3.09, and 
3.01 for cough, chest congestion, wheeze, and visiting a doctor for chest illness, 
respectively) (Kistnasamy and Knapp, 1992). Other community based studies have 
documented prevalence rates for doctor diagnosed outcomes such as asthma in children 
(10%) and among adults (12%), higher than that documented for other populations in the 
scientific literature (Nriagu et al, 1999). 
 
In a study among students and teachers at the Settlers' Primary School, Kistnasamy et al 
have reported unusually high prevalence rates for asthma, with ranges of any type of non 
or probable asthma (symptoms assessed) from 53.5% to moderate to severe persistent 
asthma of 16.8%. In addition, approximately 20% of the study sample had marked airways 
hyperresponsiveness as diagnosed by methacholine challenge testing, a prevalence 
higher than any other population based reports in the scientific literature. This study 
found statistically significant associations between prior day and prior 48 hour PM10, SO2, 
and NO2 levels (continuously measured at the school) and increased respiratory symptoms 
and diminished pulmonary function measures (measured by digital recording peak flow 
meters) among students with persistent asthma. These effects were observed during a time 
period when all ambient pollutant measures were well within national and international 
standards. (Kistnasamy et al, 2008). 
 
The same research team as for the above study conducted the “South Durban Health 
Study”, (Naidoo et al, 2007) among seven communities in the highly industrialised south 
compared with the north Durban. In each community, one primary school was selected 
according to specific criteria. All students from within one or two randomly selected grade 
four classrooms were invited to participate in the study. Standardised interviews of child 
participants and caregivers were conducted, together with spirometry, non-specific 
bronchial hyperresponsiveness (BHR) testing and skin prick testing (SPT). At each of the 
schools particulate matter, sulphur dioxide, oxides of nitrogen and carbon monoxide were 
monitored for a year. Generalized estimating equations (GEE) were used to examine 
associations between daily mean levels of ambient air pollutants (NO2, NO, SO2, and 
PM10) and daily measures of pulmonary function (intraday variability and daily nadir values 
for FEV1 and peak expiratory flow [PEF]) across 4 seasons among 423 primary 
schoolchildren in models adjusted for age, gender, race/ethnicity, school, caregiver 
smoking, caregiver education, household income, and season. Asthma severity was 
considered as an effect modifier. Possible lag effects (1 to 5 days), as well as 5-day 
averages, were modelled. 
 
Mean daily NO2 concentrations varied from a low of 11 ppb in non-industrial areas to 19 - 
24 ppb in the city centre and industrial areas. Average SO2 concentrations varied from 1 - 
3 ppb in non- industrial to 12 - 20 ppb in industrial areas. Mean daily filter-based PM10 
concentrations ranged from 41 – 57 μg m-3. 
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The prevalence of reported symptoms consistent with persistent asthma was 32%. 
Adjusted predicted prevalence of symptom-defined persistent asthma was higher among 
schools in the south as compared to schools in the north (12.2% vs. 9.6%). A similar 
geographic difference was seen for marked BHR (8.0% vs. 2.8%). Living in south Durban 
presented a significantly higher risk for the presence of persistent asthma (OR=1.8) and 
BHR (OR=2.6). Statistically significant lagged decrements in pulmonary function associated 
with higher ambient concentrations were present for a substantial proportion of the 
regression models evaluated for each of the four pollutants, with associations stronger and 
much more frequent among those children with persistent asthma, as compared to those 
with mild intermittent or no asthma. 
 
Inclusion Criteria 
 The recruited participants will have to be resident in the geographical area within 
which the clinic and monitoring station is located. They will have to be in this area 
for the full duration of the pregnancy, and for the follow-up period of 5-6 years. The 
children (from the pregnancy of interest) must also be resident in the communities 
for the duration of follow- up. It will be preferable for the mothers to be living 
within a 5km radius of the monitoring station, but this will not be essential. Based 
on our previous studies among these communities, extended residency, 
sometimes over a couple of generations, is the norm. 
 Preferably such females should be at gestational age less than 20 weeks. However, 
females presenting above 20 weeks will not be excluded. 
 Women who test positive for human immunodeficiency virus (HIV) during their 
routine ante- natal testing will be included in the study. 
 Participating females with any complications of pregnancy such as hypertension, 
diabetes, placenta previa or genital tract infections, or other complications which 
result in adverse growth effects on the foetus will be included. 
 
The following will not exclude participation: 
 Females with multiple pregnancies will be excluded 
 
Periods of Follow-up 
Assessments conducted during each trimester of pregnancy, shortly after delivery, and at 
regular intervals in the neonatal and infancy period: The cohort children will be followed up 
at the age of 1, 3, 6, 12, and 18 months, and from then on at yearly intervals within 3 months 
of the child's birthday up to the age of 5 years. Further follow-up and assessment will depend 
on the availability of funding. 
 
Collection of questionnaire data 
(a) Carefully selected interviewers drawn from the communities and will be trained and 
supervised to conduct baseline interviews with participants. Training will include 
techniques and practice in conducting interviews in a consistent and neutral fashion. The 
instrument that was used in the pilot study will be revised for use in the cohort study. 
The latter instrument consists of standardised questions extracted from past and current 
European birth cohorts, as well as environmental health studies conducted by the research 
team previously. Components of this questionnaire will include demographic information; 
antenatal history; place of birth and residential history and potential confounding factors 
such as maternal; smoking, exposure to cigarette smoke, occupational and 
environmental exposures, dietary history, pre-existing medical conditions, past medical 
and obstetric history. Other questions will include residential and occupational history, 
general quality of life; use of biomass fuels, smoking and neighbourhood matters 
(Appendix 1). The questionnaire will be administered to the pregnant females on enrolment 
into the study. Data will be captured at the time of the interview, using a mobile telephone 
system, automatically uploading data onto the study database using wireless technology 
called Mobile Researcher. 
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(b) Follow-up interviews will be conducted with the pregnant women in each trimester 
subsequent to enrolment, and just prior to delivery to evaluate any change in status, 
particularly in exposures, dietary changes, pregnancy complications. 
 
(c) Maternal interviews about the health of the child, including respiratory diseases in the 
neonatal period, especially the need for oxygen therapy, feeding regimes (for the one year 
olds and above, information on dietary intake using a validated food frequency 
questionnaire will be included (Rockett et al, 1997a and 1997b) and vaccination 
history will be conducted within a week of delivery, and repeated at 6 weeks, 3, 6, 12, 
18, 24 and 36 months (Appendix 2). At the ages of 4 and 5 years, interviews about 
respiratory health and symptoms, will be conducted with the child themselves, with 
verification of the information provided by the mother (Appendix 3). 
 
(c) Questionnaire language: All questionnaires will be available in English and isiZulu. The 
isiZulu versions will be translated from English and then backtranslated by a second 
translator to assure that the instruments are truly equivalent. 
 
Clinical Assessments 
Abdominal ultrasounds are not available at the participating clinics. In instances where this 
assessment is performed, the data will be obtained. The basic clinical data of all the 
participating children will be obtained from the birth records, including intra-labour history 
such as fetal distress, normal, assisted or caesarean deliveries; birth weight and other 
anthropometric data, APGAR scores etc. Each child will be assessed at each assessment 
interval. These assessments will include growth and developmental milestones, as well as 
detailed clinical respiratory evaluation. Lung function assessments will be conducted, and 
these are detailed below. 
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Biochemical Assessments 
 
(a) Maternal Blood Assessments 
These biochemical asssessment plan is based on the assessments we conducted within 
the Birth Outcomes Pilot. 
 
Third trimester maternal blood samples and cord blood at birth will be taken for laboratory 
analysis. Samples will be analysed for markers of oxidative stress (lipid peroxidation), 
allergic potential and atopy. These include the interleukins IL-4, IL-5 and IL-13, cytokines 
tumour necrosis factor (TNF) and interferon (INF), salivary cortisol, IgE, IgA and vitamins 
C, D and E and beta-carotene. The role of the mitochondria in the development of oxidative 
stress will be determined by analysing protein levels and mRNA expression of sirtuins, 
uncoupling proteins and mitochondrial DNA damage of PBMCs.Sample preparation for 
mitochondrial analysis will include the isolation of mitochondria based on MACS 
Technology. Briefly, the density and viability of isolated PBMCs (Histopaque 1077) will be 
determined by Trypan Blue exclusion and resuspended in cold PBS (107 cells/ml) and 
pelleted (300 xg; 10 min; 4oC). Pellets will be resuspended in Cell Lysis Buffer (1ml) and 
homogenised using a 29G needle (20x) prior to the addition of and incubation with 
separation buffer (9ml) and 50µl of AntiTOM22 microbeads (4oC, 1 hour with gentle 
shaking). Samples are then transferred to prepare LS Columns in a magnetic field of a 
MACS separator. Following 3 washes (3ml wash buffer), columns will be transferred to 
collection tubes and collected using 1x Separation buffer for further analysis. Mitochondrial 
yields will be split for RNA isolation, Protein isolation and DNA isolation. 
 
The mitochondrial DNA damage assay that will be used is a quantitative PCR assay which 
determines the level of mitochondrial damage by quantifying the presence in circulation. 
Briefly, a pre-mixed SYBR®Green Supermix, primers and DNA template (10ng/µl) will be 
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made up to a volume of 25µl per reaction, as well as a corresponding housekeeping gene 
and amplified using a BioRad Chromo4 Thermocycler. 
 
MicroRNA analysis will be conducted using the TaqMan® MicroRNA 384-well Array cards. 
Briefly, total RNA will be isolated using an in-house triazol-phenol extraction after which, 
microRNA will be isolated and cDNA synthesised using the TaqMan® miRNA Reverse 
Transcriptase Kit. Total mature microRNAs will then be determined by Quantitative PCR 
methods on the Applied Biosystems Viia7 instrument. 
 
The JC-1 Mitoscreen assay (BD Biosciences) will be used to assess mitochondrial 
membrane polarity. Many toxic agents tend to affect mitochondrial ATP production. Several 
known pollutants (e.g. lead) tend to interfere with haem synthesis and compromise the 
electron transport chain. A rapid assessment of mitochondrial integrity is the measurement 
its polarity. Depolarized mitochondria are good indicators of toxicity and apoptosis. 
Peripheral lymphocytes (approximately 
105) will be transferred into 5ml polystyrene cytometry tubes. The JC-1 dye (150ul) will be 
added to lymphocytes and allowed to incubate at 370C for 10 minutes. Thereafter, 
lymphocytes are washed twice in JC-1 wash buffer and re-suspended in 200ul flow 
cytometry sheath fluid. Labelled lymphocytes are enumerated by flow cytometry using a 4-
colour FACS Calibur flow cytometer. Data is recorded for green and red fluorescent 
channels from 50,000 events for each sample. Analysis is performed with FlowJo 7.1 (Tree 
Star Inc.) software. 
 
The COMET assay measures DNA damage in PBMCs resulting from exposure to a broad 
spectrum of genotoxic and cytotoxic compounds in vivo. Under both neutral and alkaline 
conditions, DNA damage is visualized by the characteristic comet shape formed as a result 
of the migration of genetic material from the nucleus towards the anode. The length of the 
DNA tail is measured using SCION image. 
 
Lipid peroxidation occurs when polyunsaturated lipid come into contact with reactive oxygen 
species. Lipid hydroperoxides can degrade into, among other things, malondialdehyde, 
which forms a 1:2 adduct with thiobarbituric acid (TBA). This assay is a good measure of 
oxidative stress. 
 
 
Correlations between lipid peroxidation and mitochondrial depolarization will be done. The 
result is a coloured product with a maximum absorbance at 532 nm.. Finally, 
spectrophotometric measurements are made at both 532 nm (maximum absorbance for 
TBARS) and 600 nm. The absorbance at 600 nm is due to the solution and is subtracted 
from the absorbance at 532 nm. Absorbances from the blank reaction are also measured 
to account for substances that may also result in a signal at 532 nm. 
 
The GSH-Glo™ Glutathione Assay is a luminescence-based assay for the detection and 
quantification of glutathione (GSH). The assay is based on the conversion of a luciferin 
derivative into luciferin in the presence of glutathione, catalyzed by glutathione S-
transferase (GST). The signal generated in a coupled reaction with firefly luciferase is 
proportional to the amount of glutathione present in the sample. This assay is a measure of 
intracellular antioxidant concentration. 
 
The Human Inflammatory Cytokines & Receptors RT² Profiler™ PCR Array profiles the 
expression of 84 key genes involved in the inflammatory response. This array contains 
genes involved in mediating immune cascade reactions during inflammation. The 
chemokines, cytokines, and interleukins involved in the inflammatory response are 
represented as well as their receptors. Using real-time PCR, it can easily and reliably 
analyze expression of a focused panel of genes related to inflammation with this array. The 
PCR array is a set of optimized real-time PCR primer assays on 96-well plate for pathway 
or disease focused genes as well as appropriate RNA quality controls. The PCR array 
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performs gene expression analysis with RT-PCR sensitivity and the multi- gene profiling 
capability of a microarray. The cDNA template is mixed with the appropriate ready- to-use 
PCR master mix, aliquoted in equal volumes to each well of the same plate, and then run 
on a real-time PCR cycling program. 
 
Analysis of samples for trace elements zinc ,copper & selenium as well analyses of vitamin 
A, C and E and FeNO, sputum ECP, metalloproteinase, neutrophil and eosinophil count; 
fibrinogen, C- reactive protein (CRP) will be carried out by the chemical analytic laboratories 
at the National Institute for Occupational Health. 
 
As a substantial focus of this study is on basic sciences, laboratory quality assurance 
and validation of tests form an important aspect of this project. This takes several forms. 
Firstly, many of these tests have been conducted previously by the Departments of Medical 
Biochemistry, using, in the main, internationally standardised kits. These analyses have 
been conducted in scientific projects, which have been published in peer-reviewed journals 
– for example, Prof Chutturgoon (Medical Biochemistry) has done research on oxidative 
stress and rheumatoid arthritis as well as inflammatory markers and cardiac disease, 
and other aspects of oxidative stress, as well as micronutrients and various diseases. 
Analytic methods used are all based on internationally standardised techniques (as stated 
above) and reported in the peer-reviewed literature. The laboratories are accredited by 
the accreditation body (SANAS) in South Africa. As additional measures, for all new 
tests conducted or new methods used, split samples will be sent to either nationally 
accredited or international laboratories using extenal standardisation processes, such as 
the Chemical Analytic laboratories at the National Institute for Occupational Health. 
 
(b) Genotyping 
These tests were performed during the conduct of the pilot. 
 
Collection of blood from the mother will be done by venipuncture during the third trimester. 
Genomic DNA will be extracted using a PUREGENE DNA isolation kit (GENTRA, 
Minneapolis, MN). DNA samples will be banked and stored at -20C. Umbilical cord white 
blood cells (UCWBC) will be collected for genomic DNA isolation for the neonate and for 
DNA methylation analysis. UCWBC provide a reasonable surrogate for our target 
organ/tissue (lung/immune cells) because they contain stem cells that can populate the 
lungs in later life and also provide a rich source of T cells (Miller and Ho, 2008) which are 
important producers of cytokines and other asthma mediators. The Illumina DNA 
Methylation Analysis kit (450K) will be used to determine genome wide DNA methylation. 
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Single nucleotide polymorphisms (SNPs) in GSTM1 (null vs positive); GSTP1 (Ile-Val) and TNFα- 
(308) will be determined using standard PCR procedures, including in some instances, 
restriction fragment length polymorphism analysis (RFLPs). DNA sequencing will be used 
to verify PCR products and appropriate quality control procedures will be followed 
(Appendix 4). 
 
(c) Cord Blood Assessments 
Cord blood for methylated DNA testing, IgE levels as well as metals, such as lead and 
manganese and vitamins A, C, E and beta-carotene will be done. 
 
(d) Neonatal and Infant Assessments 
The neonate will be subjected to biochemical markers of oxidative stress, allergy, atopy 
and genetic polymorphisms. These assessments will include: salivary cortisol, interleukins 
IL-4, IL5 and IL-13, cytokines IFN and TNF, IgE and IgA, Vitamins C, D and E and beta-
carotene. Inflammatory markers, such as Eosinophilic cationic protein (ECP); neutrophil 
and eosinophil count; fibrinogen, C-reactive protein (CRP). 
 
(e) Childhood assessments 
158 
 
 
All children participating in the study will be requested to provide a blood sample collected 
using standard techniques for assessment of blood lead, mercury and manganese, as well 
as the markers of oxidative stress, inflammation, allergy and atopy. All of these 
assessments, will be done annually from the age of 3 years until the end of follow-up. In 
order to reduce the degree of contamination during the blood sampling, the following 
washing procedure for the area to be punctured will be used. The skin will be carefully 
scrubbed with soap and water, followed by an alcohol swab. The cleaned surface will be 
rinsed with distilled water and dried with metal-free tissue paper before puncture. Only 
trained nurses or phlebotomists will be employed in the collection of blood samples. 
 
Immediately after the cleaning, the puncture will be made using a Minilancet or a similar 
device. About 2.5 mL of the blood will be collected in a lead-free plastic vacutainers 
containing EDTA powder. The vacuutainers will be capped and stored for analysis in 
temperature controlled storage boxes. The personnel involved in the blood sampling will be 
instructed on how to minimize sample contamination, by wearing acid-washed polyethylene 
gloves and avoiding contact between sampling material and any unclean material prior to 
fingerstick. 
 
Lung Function assessments 
Minute ventilation, mean tidal inspiratory and expiratory flow measures (newborns and 
infants) ; forced expiratory manouevres and peak flow measures (3-4), spirometry (4-
5 years old) and methacholine challenge testing (6 year olds) will be done over the course 
of the study. 
 
Funding dependent, testing will be conducted in unsedated newborns and infants 
during natural sleep, using an infant mask using the European Respiratory Society 
(ERS)/American Thoracic Society (ATS) standards of infant lung function testing, with 
an ultrasonic flowmeter (Bates et al, 2000). 
 
All American Thoracic Society (ATS) guidelines for conducting spirometry will be followed 
among the older children (American Thoracic Society, 1995). Spirometers will be calibrated 
at least twice a day with a three-liter syringe. Technologists who have undergone training 
in standard technique will conduct spirometry. Spirometry will be performed in a sitting 
position with nose clips. The lung function indices of primary interest will include forced vital 
capacity (FVC) and forced expiratory volume in one second (FEV1). Special instructions will 
be given to participants to ensure that tested individuals do not take any anti-asthmatic 
inhalers (12 hours before) or oral asthma medications (48 hours before) prior to the test. 
Participants with an obstructive pattern at baseline (FEV1/FVC < 0.75) will be administered 
an inhaled bronchodilator and have testing repeated. 
 
 
 
All children will be assessed at the assessment centre. Transport will be arranged for these 
participants. 
 
(b) Intensive Phase Assessments 
To address Specific Objective 6 (airway response to short term fluctuations in pollutant 
measures), intensive phases of data collection (health measures and pollutant monitoring) 
will be conducted. All children will be asked to participate, however, only children above the 
ages of 4 will undergo the intensive lung function assessments. These intensive phases will 
take place for a full week (including the weekends) at the midpoint of each of the four 
seasons for each of the years of follow-up. These will be in end January (summer), end 
April (autumn), end July (winter), and end October (spring). This data will be used to 
determine whether there is an association between daily fluctuations in ambient air 
pollution levels and fluctuations in health status. The ability of the research investigators 
to collect such data successfully was demonstrated during the South Durban Health Study. 
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Based on this previous study, this population of children appeared suitably sensitive to 
potential acute health effects associated with fluctuations in ambient air pollution. 
 
(a) Daily Diaries 
Each child-participant, with the assistance of a parent or other adult caretaker, will be asked 
to keep a daily diary for the full week of these intensive phases, completed before going to 
bed on each day. In these diaries will be recorded symptoms, activities, medication use, 
encounters with the medical system, time spent indoors/outdoors, and child and parent 
quality of life measures. These diaries will be used to create single day summary severity, 
medication, and quality of life scores for use in statistical analyses examining the 
relationship between daily and seasonal fluctuations in exposure measures and 
fluctuations in these outcome measures. An example of a similar diary used in the South 
Durban Health Study can be found in (Appendix 5). 
 
(b) Tri-daily measures of pulmonary function during the intensive phases 
The AirWatch (Imetrikus.com, Mountain View, California, USA) airway monitoring 
equipment to monitor fluctuations in peak expiratory flow (PEF) and forced expiratory 
volume at one second (FEV1) of each participant, will be used. This portable, hand-held 
device has a number of distinct advantages over methods used previously to obtain 
repeated measures of a forced expiratory manoeuver in field studies. First, unlike the case 
with traditional peak flow meters, the FEV1 is also obtainable. FEV1 has inherently greater 
reproducibility than PEF and is a more clinically relevant measure. Second, results of up to 
500 expiratory maneuvers are digitally stored in each Air Watch. A unique patient identifier 
and the time and date of each expiratory maneuver can be manually downloaded into a 
data base. Each participant will receive his/her own peak flow device, which will be kept at 
the participant’s home, and will be clearly labeled with the participant’s full name to ensure 
that devices are not interchanged during retrieval, data download and returning to 
participant. At the end of each intensive phase, the data will be manually downloaded. 
 
The quality of such peak flow and FEV1 measures collected in the field tends to be quite 
variable, but is responsive to focused training of participants in good technique with frequent 
reinforcement. We will conduct training sessions with the participants in the proper 
performance of peak flow manoeuvers. As part of this training we will individually coach and 
observe each participant to ensure his or her ability to perform valid and reproducible 
expiratory manoeuvers. In addition, trained technicians will randomly visit the homes of the 
participants and observe expiratory manoeuvers to reinforce proper technique. We will re-
train the participants at the beginning of each of the subsequent one-week intensive data 
collection periods. As additional quality control, FEV1 obtained by means of the Airwatch 
will be compared to those obtained by the trained technician performing the full spirometry. 
Readings from the airwatch that is less than 80% or more than 120% of the technician 
obtained recording will be rejected. 
 
On each of the days during the week of intensive monitoring, participants will be asked to 
perform a session of three consecutive manoeuvers once in the morning before 07h00, 
again on return at 15h00 and again before going to bed. The highest PEF and highest FEV1 
from each session, even if from different manoeuvers, will be used in data analyses. 
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We have implemented the above serial peak flow recordings among children, using similar 
handheld devices previously. 
 
(c) Skin Prick tests 
This will be done on all the children at 4 years of life. All children will be requested to 
participate in skin prick testing. Antigens to be tested will include mixed cockroach, mixed 
dust mite, mould mix (Aspergillus, Cladosporium and Penicillium), cat, dog, mouse, rat, 
mixed grasses, plus histamine as a positive control and saline (or glycerol) as a negative 
control. Participants will be informed to stop any antihistamines and any other reactive 
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medication (H2 antagonists, tricyclic antidepressants, corticosteroids etc) at least 24 – 72 
hours pre-test. The test will be applied to the volar surface of the forearm, and will be read 
approximately 15 – 20 minutes later. The wheal and erythema will be read and measured 
according to a standardised method, and an outline of the wheal and erythema will be 
recorded on see through tape for a permanent record. A greater than 2 mm difference in 
mean diameter between allergen and control wheal will be considered positive. A medical 
doctor will be on site to clear each participant to receive skin testing and will have proper 
medications and resuscitation equipment in the exceedingly unlikely event that individual 
has a severe reaction to a skin test. Collection of this data will allow for the assessment of 
whether skin test positivity is associated with increased susceptibility to the effect of ambient 
air pollutants. 
 
(d) Measurements of Ambient Air Pollutants and Exposure Assessment Modelling 
(a) Continuous monitoring – site locations 
The location of the communities under study (Austerville, Merebank and Bluff in the south, 
and Newlands East in the north) were deliberately selected because of the location of 
continuous monitoring stations in these communities. These stations are part of the Air 
Quality Management System (AQMS) of the eThekwini metropolitan government. The 
number of sites in the different geographical areas also vary, with a single site (Ferndale) 
in the less industrialised north (Newlands East), and six sites (Nizam, Wentworth, Southern 
Works, Settlers, Ganges and Grosvenor) in the south. 
 
(b) Continuous monitoring – parameters 
Currently the pollutants measured at these sites vary, and the details are provided in 
Appendix 6. Additional monitoring will be set up at stations where key pollutants of interest 
are not being monitored. All stations should monitor particulate matter less than 10 microns 
in diameter (PM10), particulate matter less than 2.5 microns in size (PM2.5), oxides of 
nitrogen (NOx), sulphur dioxide (SO2), oxone (O3), carbon monoxide (CO), temperature and 
relative humidity (RH). These measurements will be compared to TEOM measurements. 
Additional parameters will include wind direction and speed. A strict quality assurance plan 
will be adhered to during the monitoring (See the Quality Assurance Project Plan in 
Appendix 7.) 
 
(c) Analysis of collected samples 
Samples will be analyzed, to the extent possible, using the available technology and 
laboratory services in the country. Each laboratory will participate in a quality assurance 
program (see below) to ensure that data quality objectives are achieved. 
 
(d) Exposure Modelling 
All pregnant women selected into the study will have to be resident within a reasonable 
radius of these monitoring stations for the entire duration of their pregnancy and birth, and 
for as much of the follow-up period as possible. Children will only contribute data to the 
study for the period in which they are resident in proximity to these stations. 
 
No personal sampling for any pollutants will be conducted – all data will be obtained from 
the above mentioned area monitors. However, based on the geographic, spatial and 
temporal variablity of data from previous studies conducted by the researchers in Durban 
and historical data from the Air Quality Monitoring System in the city and on time activity 
surveys of each of the participants (pregnant female up to time of delivery, and thereafter 
participating child) conducted at various times during the study, personal exposure metrics 
will be calculated. This will allow factors such as pregnant females working outside or 
spending vacations of the monitoring station range to be factored into the exposure metric. 
It is recognised that the absence of personal monitoring is a weakness, but the cost of either 
continually monitoring or phase monitoring of each individual participating in the study will 
be exorbitant. The development of land use regression techniques has been employed in 
our pilot, and a similar strategy will be employed here, for the key pollutants of interest. 
 
A land use regression model (LUR) regresses pollutants of interest against site-specific 
geographic predictors (independent variables) such as traffic, land use, topography and 
161 
 
 
meteorology in a multivariate regression model. The parameter estimates derived from this 
regression equation are then used to estimate pollutant levels at unmonitored locations 
such as participant homes. The use of site-specific variables in this method, captures small-
scale variability more effectively than other well known methods of interpolation. The 
development of a LUR model comprises two key steps, i.e. determining pollutant 
concentrations either from an existing monitoring network or though passive sampling 
efforts and subsequently deriving geographic predictor variables within varying buffer 
distances around each sampling site. This data is translated into a regression equation, 
which is applied within a GIS framework, thus rendering a pollutant concentration map 
which provides information on exposure at unmonitored locations such as the participant 
homes. 
 
(e) Sampling details 
The sampling procedures for all of the following pollutants was successfully employed by 
the research team during the conduct of the South Durban Health Study, and we therefore 
have full confidence in our ability to implement this strategy, as well as ensure the requisite 
quality assurance. 
PM2.5: TEOM samplers will be used. TEOM samplers can be used to measure PM2.5 
although it is recognized that this is not a US EPA Federal Reference Method (FRM) at 
present, due to some artifact issues. However, correlation between TEOM and gravimetric 
measurements is expected to be high. Previous collocation studies conducted by the 
researchers, using the TEOMs and gravimetric samplers showed this to be true (Naidoo 
et al, 2007). With appropriate filter media (see below), the same samplers will be used to 
collect filter samples for metals and other analyses. 
Filter samples will use 24-hour samples. Sampling periods from 8:00 am to 8:00pm 
samples, rather than calendar day, are acceptable and more easily achieved. Further, this 
averaging period is preferable for the health study since it better corresponds to the 
exposure period prior to lung function and other health measures in the children and adults 
being measured. 
Trace metals. Selected PM10 and PM2.5 samples, collected on quartz fiber filters, will be 
analyzed for trace metals, including chromium, copper, manganese, and lead, all key toxic 
pollutants. The best analytical performance is obtained using Inductively Coupled Argon 
Plasma Mass Spectroscopy (ICP-MS). Individual filters will be analyzed; no composite 
samples will be used although this is a lower cost option. We proposed to develop estimates 
of annual average levels for trace metals and the spatial gradient across South Durban, 
including levels at the population sites, the traffic impacted sites, and the North Durban 
sites. At these sites, we propose 24-hour sampling every 12th day, giving an 1 year total of 
31 observations, which should be sufficient to provide a robust annual average. There will 
be 10 percent trip and field blanks included in the analysis. The determination of ambient 
trace metal concentrations is a critical input in the health risk assessment including the 
prediction of cancer and systemic disease. 
Pollen/Moulds. Daily measurements are required during the intensive period. Outdoor 
pollen counts will be performed using sterilized filter cassette (AirCheck) or equivalent 
methods; we will also consider the use of final stage Anderson impactors and appropriate 
culture media. Because these are short-term samples, each sampling event will utilize at 
least two replicates. 
 
(e) Assessment of Indoor Environment 
A random sample of 25% participating households will be selected for detailed indoor 
environmental assessments. These assessments will be done at particular points during 
the follow- up. An assessment will be conducted during the pregnancy phase, preferably in 
the first trimester, as this may be a critical period for the development of allergies in the 
child, and repeated at least twice during follow-up – once in the first year of the life of the 
participating child, and again before the end of follow-up. The data from this random sample 
will be used to develop a model, which will be used to predict that pollution found in homes 
not similarly assessed. The methods described below have been utilised by the research 
team previously in the South Durban Health Study. 
162 
 
 
 
(f) Walkthrough indoor assessment 
The indoor environment of the household of each participant will be assessed by means of 
a walkthrough evaluation, using a standardised instrument (this instrument will be modified 
from one successfully used by the investigators in the South Durban Health Study -- 
(Appendix 8). The instrument includes room by room observation together with some 
questions put to an adult respondent. This assessment will include building age, type, 
condition and temperature, dust and lead control behaviour; moisture problems (sources, 
indications, ventilation, heating); indoor air quality (combustion products -- particularly use 
of biomass fuels for cooking and heating, formaldehyde, radon, asbestos, home chemicals); 
and nearby environment, including proximity to pollution sources. 
 
(g) Household dust 
This will be collected for allergen assessments: specifically dustmite, cockroach, and total 
moulds. Dust samples will be additionally assessed for lead and other metals. These will be 
analysed at the University of KwaZulu-Natal and externally validated at the University of 
Michigan. Vacuum samples will be collected from each household: one from the room the 
child sleeps in will be directly measured, the second a composite sample of other rooms in 
the house. The protocol to be followed will be based on one successfully used previously in 
the above-mentioned study (Appendix 9). 
 
(h) (c) Indoor monitoring 
Selected indoor airborne contaminants monitoring will be conducted in selected 
households. Monitoring for O3, SO2, NOx and VOCs is feasible using passive samplers with 
sampling periods of approximately 1 to 3 weeks. PM10 or PM2.5 and airborne spores 
require the use of active samplers. These samples will be repeated and simultaneously 
conducted outdoors. Outdoor pollen counts and indoor airborne endotoxins will also be 
sampled and analysed using electrostatic dust fall collector (EDC) (Noss et al, 2008). The 
number of households selected for indoor monitoring will be sufficient to constitute a 
validation subset, very useful to establish, for example, the indoor/outdoor ratio of major 
pollutants, the range of variation from the community air pollution monitor, and other 
purposes. 
 
(i) Antioxidant Intervention – Randomised Control Trial Design 
Based on our previous studies, we expect a prevalence of persistent asthma (based on 
symptoms reported by mother/caregiver) of approximately 20%, across the city. From a 
total study sample of 1100 children, an expected 220 are likely to exhibit asthma-like 
symptoms. Using a double blind randomised control study design, 50% of this subset of the 
study sample will be given antioxidant supplementation and the remainder a placebo. In 
order to increase the number of particpants, additional known asthmatics from within the 
communities under study, recruited from local family practitioner practices in these 
communities will be included into the trial. Children will be recruited at the age of 3 years 
and followed up as per the study plan described previously. The specific observations 
between treatment and placebo groups that will be considered will be symptoms, based on 
reports from caregivers, lung function estimates from intensive phases and technician 
conducted spirometry, markers of inflammation, oxidative stress and allergy, responses to 
pollutant fluctuations, as measured in the intensive phases. 
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Health Risk Appraisal Exercises 
An exercise attempting to characterise health risk in the basin concluded that the SO2 
associated risk for the community was low to acceptable (Matooane and Diab, 2001). The 
study, using the US Environmental Protection Agency (US EPA) health risk assessment 
model, made assumptions about similarities in exposed populations in the US and in a 
developing country as represented by the Durban South community. These assumptions 
included the "averaging time", "exposure scenarios" and "inhalation rates" - unless these 
assumptions are adequately tested in the field, the conclusions of this study can be 
considered untested, as acknowledged in part by the authors. Moreover, it would appear 
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that the presented methodology may not take sufficient cognizance of the increased 
sensitivity of asthmatics to adverse respiratory effects of air pollutants. 
 
More recently, as part of the South Durban Health Study, health risk assessments in the 
south Durban found that a substantial health risk exists for both acute and chronic diseases 
(Naidoo et al, 2007). Long term exposures to major air toxic pollutants, including trace 
metals, polycyclic aromatic hydrocarbons (PAHs), persistent chlorinated pesticides, 
polyhalogenated dioxin/furans (D/F), polychlorinated biphenyls (PCBs), and volatile organic 
compounds (VOCs), were estimated using periodic measurements over 2004-5 at three 
sites: two sites in the Durban South Industrial Basin, and a comparison site in north Durban. 
Additionally, lead and manganese were monitored in blood drawn from 358 children. Using 
current estimates of chronic cancer and non-cancer toxicities, individual lifetime risks and 
hazard indices were calculated to identify risk drivers. The differences between the sites 
were evaluated, and results to risks estimated for other cities was compared. A small 
number of pollutants contribute most of the total estimated cancer risks (1.8– 
2.5 x 10-4), and the following classes pollutants warrant attention due to the presence of 
elevated ambient concentrations: (1) VOCs, specifically benzene, which was high (average 
of 9 µg/m3) at multiple sites in the DSIB and had a strong spatial gradient, showing the 
importance of local sources. (2) Selected D/F congeners and PAHs (e.g, naphthalene), 
which showed a diffuse spatial pattern and suggested the importance of both local and 
regional sources. This also indicates that such exposures are widespread among the 
population in Durban. (3) Selected metals, including chromium, nickel, lead, and 
manganese. Non-cancer risks fell just below a hazard index of one, the usual criterion. 
Based on both ambient and biomonitoring, elevated exposures of toxics are found in 
portions of Durban (Naidoo et al, 2007). 
 
Environmental studies and available Environmental Data for DSIB 
The peculiarities of geography and land development strategies for the Durban South region 
have been documented in numerous reports since the late sixties, strongly implying a lack 
of appropriate town planning on the part of the local government. The DSIB is bounded on 
the southeast by the Bluff ridge (70 - 100m high) and in the northeast by the Berea ridge 
(110m high) (Diab, 1995). This allows for the drainage of cold night air along the 
Umhlatuzana and Umbilo rivers in the Durban south, damming against the Bluff ridge, and 
diverted northwards to the Berea ridge, and subsequently toward the sea. Through land 
warming during the day, sea currents direct the air back inland, causing continuous re-
circulation (Matooane, 2001). These lesion patterns are accompanied by temperature 
inversions from late autumn to early spring, limiting the vertical diffusion of pollutants 
(Diab, 1995). 
 
The Durban south industrial basin (DSIB) is a complex mix of heavy industry and residential 
communities. Owing to a combination of its geographical relationship to the refineries, land 
contours, prevailing meteorological conditions, the use of a relatively short emissions stacks 
at these facilities (50 – 100 meters), the lack of or relative ineffectiveness of emission control 
devices on refinery stacks, the many sources of so-called fugitive air emissions at refineries, 
emissions from industrial and passenger vehicles, as well as the proximity of other 
industries, the community is believed to be at risk for intermittent substantial exposure to 
ambient air pollutants. 
 
The key pollutants that are monitored in the DSIB are SO2, NOx, PM and to a lesser extent, 
CO. Lead, O3 and volatile organic compounds (VOCs) are not monitored intensively. 
Most of the monitoring in DSIB is done by private consultants contracted to the Durban 
Metro for management of the Durban Metro Air Quality and Emission Survey, which has 
been responsible for the Durban South Sulphur Dioxide Monitoring System. 
 
The ambient pollutant findings from the recent South Durban Health study revealed NO2 
concentrations lowest in the north (mean of 11 ppb), highest in the city centre and industrial 
areas (19 - 24 ppb), and lower at sites in the south (12 - 14 ppb). Average SO2 
concentrations varied widely; with low concentrations (1 - 3 ppb) at sites in the north; 
medium to high concentrations (6 - 
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10 ppb) at central and south-central sites and (12 - 20 ppb) in the south. The SO2 spatial 
distribution reflects the location of emitting industries in the South Basin. Annual average 
PM10 concentrations was in a narrow range of 38 – 57 μm m-3, across north and south 
sites. Maximum 24-hr average concentrations approached or exceeded 150 μg m-3 at most 
sites. The highest concentrations were observed at one south site, and one north site, two 
widely separated monitors. PM2.5 concentrations measured at three sites were nearly 
identical, 20 – 21 μm m-3, with maximum 24-hr concentrations ranging from 79 to 131 µg m-
3. PM10 and PM2.5 concentrations across the region were high relative to international norms 
and standards. (Naidoo et al, 2007) 
Although a steady decline has been observed for annual SO2 levels since 1989, at some 
monitoring stations the international WHO standard has been exceed since 1995. One hour 
and 24 hour exceedances of national Department of Environmental Affairs and Tourism 
(DEAT) standards are reasonably common occurrences, with approximately 176 one hour 
exceedance episodes in 1999 and 17 24 hour exceedances between 1997 - 1999 have 
been reported. Similar patterns of exceedances have not been shown for NOx (Matooane, 
2001). 
 
Lead exposures have been poorly documented in the Durban South area. Reported 
airborne lead concentrations range from 0.44ug/m3 - 6.42 ug/m3, which exceed national 
and international standards several fold (Nriagu et al., 1996). Dust lead loadings among 
primary schools in the basin ranged from 9 - 264 ug/m3, much higher than recorded in other 
studies elsewhere in the world (Liggans et al., 1998). This contrasts to the findings of the 
South Durban Health Study of 8.7ug/m3 in the north and 6.3ug/m3 in the south (Naidoo et 
al, 2007). 
 
Studying Birth Outcomes in Durban 
In preparation for a longitudinal birth cohort, the researchers embarked on a pilot study, 
intending to test the proposed study’s ability to recruit participants, work with the healthcare 
facilities, test instruments and in-field procedures (phlebotomy and transport of samples to 
laboratories); basic science assessments and follow-up of patients until delivery. The pilot 
also focused on the development of exposure assessment strategies for the cohort study. 
 
In this pilot of 100 women (50 from north and south Durban respectively), there were only 
meaningful differences between education and HIV status. Average years of education was 
lower and HIV positive prevalence was higher in the south compared to the north. Although 
a substantial percentage of participants were exposed to environmental tobacco smoke 
(ETS), neither this or other risk factors varied geographically. 
 
There were three stillbirths and 8.7% low birthweight (<2.5kg) newborns. The mean 
gestational age (weeks), (38.2, south; 38.4, north), birthweights (kg) (3.1, south; 3.2, north) 
and apgar scores and 1 and 5 minutes did not differ significantly between north and south. 
No differences were seen for adverse birth outcomes, although these were consistently 
higher in the south. The biochemical assays (Table 1) only varied between the two regions 
for apoptosis and GSH. 
 
 
(j) Table 1: Biochemical markers for participants from the south and north 
 
 
South (mean North (mean 
  
 
 (SD)) (SD)) 
Malondialdehyde (MDA) 0.07 (0.07) 0.07 (0.05) 
Comet tail length* 0.56 (0.13) 0.47 (0.10) 
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Mitochondrial depolarisation 44.4 (18.7) 43.32 (20.6) 
Apoptosis* 15.2 (7.46) 20.24 (11.8) 
Caspase 3/7 20.86 (22.82 ) 15.30 (25.3) 
Caspase 8 14.8 (16.55) 85.89 (431.6) 
Caspase 9 36.7 (90.3) 52.7 (131.6) 
 GSH* 5.3 (0.9) 6.9 (1.8)       
  
 
Biochemical evidence of oxidative stress did not vary between north and south. These 
markers were not associated with low birthweight. HIV status was not associated with low 
birthweight. Living in the south resulted in a non-statistically significant elevated risk (odds 
ratio=1.3, 95% CI: 0.4-3.6) for adverse birth outcomes, adjusted for ethnicity, education, 
income, HIV status and cigarette smoke (personal or passive). Geographical area was also 
a significant predictor of the GSH, Comet Tail Length and apoptosis biomarkers. 
 
(k) Summary 
We have successfully completed a pilot birth cohort study investigating air pollution and risk 
factors for adverse birth outcomes in 2011. It served as preparation and proof of concept 
for a full scale longitudinal birth cohort study which will examine the effects of environmental 
influences on the health and development of a cohort of 1200 women attending ante-natal 
clinics and children will be followed up from before birth to six years of age to evaluate 
respiratory health. Participants will be recruited from south and north Durban in South Africa, 
areas of high and low ambient pollution respectively. This is a unique opportunity investigate 
the epigenetic contribution of environmental and dietary contributors to respiratory health. 
The proposed study has the potential to address key questions, such as those concerning 
the influence of timing of exposure, dose of exposure, diet, and ethnicity on susceptibility to 
asthma development. The study will further investigate the argument that prenatal 
environmental exposures may induce epigenetic modification and subsequently influence 
the risk for asthma. 
 
The proposed project has three distinct features: 
 
 Research in epigenetics is ongoing in Europe, the USA and Asia, however thus far; 
Africa has not entered this arena of research in terms of the link between epigenomics 
and epidemiology. This is the first opportunity to study an African ethnic group in this 
context. 
 
 While studies have been published on gene-specific DNA methylation, there is less 
data on genome wide DNA methylation and association with environmental exposures 
and asthma. 
 
 Despite progress made in experimental and cross sectional studies, fundamental 
questions related to asthma risk can only be addressed by cohort studies using 
specimens linked to well- annotated clinical and environmental exposure data which 
will be collected during the MACE study. 
 
 
DATA MANAGEMENT AND ANALYSIS 
 
Data Management 
A data manager will be employed to track outgoing and incoming instruments, validate 
interviewer collected responses, ensure accuracy of data and clarify any obvious omitted 
data or errors. Data capturers will capture data as this becomes available, using pre-
designed databases. All questionnaire, lung function, peak flow and exposure data will be 
double entered, by different capturers, blinded to the previous entries, with subsequent 
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checking for errors. All data will be maintained under tight security to ensure no breach of 
confidentiality. 
 
Data Analytic Strategies, including Sample Size Calculations 
Our study proposes the evaluation of several independent variables and health outcomes 
over the duration of follow-up in the cohort. Attempting to establish an appropriate sample 
size is a challenge. For the purposes of ensuring an adequate sample size for addressing 
our primary concerns (ambient pollution and childhood asthma), we have considered data 
generated from our previous studies in these communities. However, because of our 
interest in understanding the relationship of environmental exposures to birth outcomes, 
as contributory factors to asthma outcomes, we additionally considered these variables 
in the sample size calculations. 
 
Our previous studies of asthma, atopy and airway hyperresponsiveness in these 
communities, showed the prevalence of persistent asthma in the pollution affected 
communities of 16.5 and 9.1% in the non-polluted communities, prevalence of marked and 
probable bronchial hyperresponsiveness of 18.8% and 12.6% respectively; prevalence of 
atopy of 35%, and covariate adjusted risk estimates of asthma between polluted and non-
polluted communities of 1.3. The prevalence of adverse birth outcomes generally and low 
birth weight specifically in an unexposed population in South Africa is about 15% (Van der 
Merwe, 2011). In our pilot study, our low birth weight findings were 13.7% and 5.9% in the 
high vs low pollution exposed participants respectively, while overall adverse birth outcomes 
were 25.5% and 21.6% respectively. Based on these findings, a sample size of 1200 
children should be adequate to detect effects between pollutant exposure and respiratory 
outcomes, while adjusting for the various covariates indicated below, with a 95% level of 
confidence and power of 80%. 
 
These children will be recruited in utero, over a period of two years from the above-
mentioned antenatal clinics in the communities under study. For all analyses a 5% alpha 
level will indicate significance. Analyses will be performed using STATA version 12. 
 
Our pilot study indicated that at least 30-40 pregnant mothers present in each geographical 
location (north and south) per week. The non-random arm of the study will recruit additional 
mothers with histories of atopy, as well as mothers who are HIV positive 
 
This study includes a variety of exposure, outcome, intermediate, and potential confounding 
variables of interest. Key exposure (independent) variables include: ambient air pollution 
(specific pollutants, including sulphur dioxide, particulate matter and oxides of nitrogen and 
metals); indoor air pollutants, including particulate matter and volatile organic compounds, 
cigarette smoking and use of biomass fuels; indoor dust lead and allergen levels. The 
primary outcome (dependent) variables of interest are respiratory related and birth 
outcomes which may impact on respiratory health during development of the lungs. The 
respiratory outcomes include peak expiratory flow (PEF) and forced expiratory volume in 
one second (FEV1) measured at repeated intervals during the course of the study; bronchial 
hyperresponsiveness (BHR) measured at the age of 6 years; specific respiratory symptoms, 
especially cough, wheeze, shortness of breath and chest tightness; any asthma and 
persistent asthma. The non-respiratory dependent and/or intermediate variables 
quantitatively assessed in the study will be skin test allergic status, and markers of 
inflammation, including eosinophilic cationic protein (ECP); neutrophil and eosinophil count; 
fibrinogen, salivary cortisol and C-reactive protein (CRP). Markers of oxidative stress, 
allergy and atopy will also be additional covariates assessed (these include: interleukins IL-
4, IL5 and IL-13, cytokines IFN and TNF, IgE and IgA, Vitamins C, D and E, beta-carotene 
and the matrix metalloproteinases). Birth outcomes of particular interest include birthweight, 
stillbirth and preterm deliveries. Other outcomes of interest assessed through interviews will 
include reported medical history or symptoms consistent with respiratory infections. 
Maternal and child dietary intakes, particularly with regard to the intake of antioxidants will 
also be intermediate variables of interest. 
 
Birth outcomes will be defined as follows: low birthweight (LBW), birthweight less than 2500 
g; very low birthweight (VLBW), birthweight less than 1500 g; intrauterine growth 
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retardation (IUGR), birthweight at a given gestational age and sex less than 10th percentile 
based on national standards for live births; preterm birth, birth at gestational age less than 
37 completed weeks; and stillbirth, fetal loss at gestational age 28 weeks and more, 
birthweight 1000 g or more, or fetal length 35 cm or more. LBW will be adjusted for 
gestational age, while IUGR is restricted growth at any gestation. For lung function 
outcomes, because of the lack of any useful validated external prediction equations, 
internal predictors will be developed by adjusting for age, age2, height, height2 and 
sex. 
 
Before conducting formal statistical analysis, preliminary analysis will be performed. 
Frequency tables and descriptive statistics such as means and variances of the variables 
of interest will be calculated. 
 
Statistical analyses will proceed from univariate analyses, which are used to describe the 
characteristics of the study population and to examine the crude associations between 
variables of interests. Such analyses will provide us a rough picture of the data and would 
be useful in the subsequent stratified and multivariate analyses. For categorical dependent 
variables, odds ratios will be calculated. For continuous dependent variables, correlation 
coefficients will be calculated. Stratified and multivariate analyses using multiple regression 
models for cross-sectional data and longitudinal data will then be performed to study the 
effects of ambient air contaminant levels on symptoms and pulmonary function status while 
adjusting for potential confounding variables. Descriptive analysis will be followed by chi-
square tests to investigate possible differences in DNA methylation between participants 
from the 2 areas and between categories of environmental exposures and asthma 
outcome. Logistic regression will be performed to evaluate the association between parental 
report of asthma and methylation status; and between different environmental exposures 
and methylation status. 
 
Advantages of a longitudinal study include the ability of studying the change of an outcome 
over time and increased power of analysis. However, analysis of longitudinal data is often 
complicated, since the observations obtained from the same subject over time are likely to 
be correlated and conventional regression techniques, such as linear and logistic 
regression, which assume independence among observations, lead to invalid results. 
Statistical methods specifically designed for analyzing longitudinal data will be used to 
account for within-subject correlation. 
 
For continuous outcome variables, such as FEV1, PEF linear mixed models will be used. 
Linear mixed models account for within-subject autocorrelation over time using subject-
specific random effects. Distributions of these continuous outcome variables will be 
examined and appropriate transformations will be taken to achieve normality. Logistic 
regression models will be developed for discrete outcome variables, such as frequency of 
specific lower respiratory symptoms (cough, wheeze, shortness of breath, chest tightness). 
We will adjust for relevant covariates, such as smoking status and demographic variables. 
Effect modifications will be examined by including interaction terms in the models. The 
baseline disease status of participants will receive particular attention as an effect modifier. 
 
Bivariate analysis will be conducted for the exposed and comparison communities 
separately, looking for statistically significant differences between the populations, 
using chi square tests (categorical outcomes) and differences in means (continuous 
outcomes). Multivariable analysis will also be conducted by stratifying on comparison status 
and then combining all data into single regression models, while controlling for levels of 
exposure and other variables of interest. 
 
29 
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HUMAN SUBJECTS 
 
Institutional Ethical Clearance 
The research proposal will be submitted to the Ethics Committee of the University of Natal 
Medical School. The latter committee consists of academics from the Medical School, 
representatives of communities and of the private sector, headed by a specialist in 
Biomedical Ethics. 
 
Individual Informed Consent 
Individual informed consent will be necessary for all participants. In the case of children, 
this will be obtained from their parent or guardian. In this instance each participant will be 
given a comprehensive explanation in the language of their choice. The content of this 
discussion will include the aims of the research, the purpose of the interview, the tests that 
will be conducted on them, use of their data and the confidentiality of all results. It will be 
emphasised that participation is voluntary and withdrawal at any time is permitted. Each 
participant will be asked to sign a consent form. No financial incentives will be provided for 
participation in the study. 
 
Participants’ Confidentiality 
All participants will be individually given a copy of their results, together with interpretations 
of the data and if indicated, referral to an appropriate centre of their choice for further 
medical management. Individual results will be strictly confidential and will only be 
accessible to the research team. These results will be released to any 
clinician/guardian/agency should this be desired by the individual participant. 
 
Publication of Results and Reports 
In the publication of research results and reports, all data will be treated as grouped, thus 
no individual will be identified from such documentation. Semi-annual or more frequent 
reports will be submitted to all stakeholders, as required by contract. A draft final report will 
be also submitted for comment. All comments will receive careful consideration. As per the 
required guidelines of the University of Natal, the final content of the articles submitted to 
peer review scientific journals will be the responsibility of the researchers. 
 
 
 
Ethical Issues 
Individual informed consent will be necessary for all participants. In this instance each 
participant will be given a comprehensive explanation in the language of their choice. The 
content of this discussion will include the aims of the research, the purpose of the interview, 
the tests that will be conducted on them, use of their data and the confidentiality of all 
results. It will be emphasised that participation is purely voluntary and withdrawal at any 
time is permitted. Each participant will be asked to sign a consent form. A separate consent 
form will be administered documenting the taking of biological samples for genetic analysis 
and storage. Women may still enter into the study is they refuse consent to storage of 
biological samples and genetic analysis. No financial incentives will be provided for 
participation in the study; however as this is a longitudinal cohort study some form of 
incentive will be used to improve retention rates. These will take the form of gift vouchers 
and small gifts in the form of baby blankets and food. 
 
PUBLIC HEALTH SIGNIFICANCE 
The findings of this project will provide a better understanding of the interactions between 
environmental factors, biochemical and genetic factors that result in adverse respiratory 
health. These findings will allow for appropriate interventions at all levels, including 
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improved control of environmental pollution and improved diets during pregnancy and for 
the newborn. 
 
Potential applications of this research include primary prevention (such as aiding at 
understanding the biology of diseases, potentially leading to the development of strategies 
based on mass intervention or target risk intervention approaches, this could facilitate the 
setting up of a genetic risk profile for the development of asthma and would enable us, for 
the first time, to take preventative action early in life for children with an increased genetic 
risk increased genetic risk to allergic diseases), secondary prevention (such as the 
development of primary tests for population wide screening) and therapy (such as choosing 
among alternative interventions or assist in the design of new drugs which are more specific, 
effective and safe (Bierbaum 2007, Bierbaum and Heinzmann, 2007; Castro-Giner, 2006). 
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APPENDIX B:  MACE ENROLMENT QUESTIONNAIRE 
Mother and Child in the Environment (MACE) 
Enrollment Questionnaire 
 
1. Date:____/____/____
 Day     Month     Year 
2. Mother Identification No.    -    -    
 
Gestational Week __________________ 
 
 
1. Name of respondent:  
 
______________________ 
First 
______________________ 
Middle 
______________________ 
Surname 
 
2. Phone numbers:  
home: ________________ 
work: ________________ 
cell: __________________ 
other: ________________ 
 
3. What is your physical address? 
 
_______________ 
House  No. 
_____________________________________ 
Road/Street                                                                                                                                                       
_____________________________________ 
City 
______________________  
Postal Code 
4. How old are you?  _________years 
5. What is your date of birth?   
_____/_____/_____   
    day        month        year 
9   Refused 
6. What is your marital status?  1 Married 
2 Living together 
3 Single 
4 Divorced 
5 Separated 
6 Widow 
7 Other ______________ 
7. What is the highest grade or year of school you 
completed?  [READ CHOICES – select only 
one] 
1  Never attended school or only pre-school 
2  Class 1 – Std 5  (Grades 1 through 7 )  
3 Std 6 – Std 9 (Grades 9 through 11- Some high 
school)  
4 Std 10 / Matric (Grade 12 - High school 
graduate) 
5 Non-degree training 
6 College / technikon  /  university (1 year to 3 
years)  
7   Refused to answer 
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8. What is the highest grade or year of school your 
baby’s father completed?  [READ CHOICES] 
1  Never attended school or only pre-school 
2  Class 1 – Std 5  (Grades 1 through 7 )  
3 Std 6 – Std 9 (Grades 9 through 11- Some high 
school)  
4 Std 10 / Matric (Grade 12 - High school 
graduate) 
5 Non-degree training 
6 College / technikon  /  university (1 year to 3 
years)  
7   Refused to answer  
  
  
 
 
[INTRODUCTION: INTERVIEWER READS TO RESPONDENT] 
 
The purpose of this questionnaire is to collect information about your pregnancy and 
reproductive health . If there is a question you do not want to answer, please let me know 
and we can skip it.  All of your responses are confidential and will not shown to anyone 
outside the study team without your written consent. If you wish to stop the interview at 
anytime, please advise me. We can continue at a later time at your convenience 
 
A. HOUSEHOLD CONDITIONS 
9. With whom do you live? (Fill in one or several boxes.)  1   Spouse 
2   Partner 
3   Parents 
4   Parents-in-law 
5   Children 
6   No one 
88  Others, describe ____________ 
10. How many people including you live in your home?  1  Number of people over 18 years 
2  Number of people between 12 and 
18 years 
3  Number of people between 6 and 
11 years 
4  Number of people under 6 years 
11. Usual language spoken at home:  1  English 
2  Zulu  
3  Xhosa 
4  Afrikaans 
88  Other 
(Specify:____________________) 
12. How many of your children are at nursery school?  ______  
no. of children  
13. What is your yearly gross income? (Include child 
support, unemployment benefits and other allowances.)  
0  No income 
1  Less than R2 000  
2  R10 001–30 000 
3  R30 001–75 000 
4  R75 001–150 000 
5  R150 001 and above 
6  Refused to answer 
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14. What is the baby’s father’s yearly gross income? 
(Include child support, unemployment benefits and 
other allowances.) 
0  No income 
1  Less than R2 000  
2  R10 001–30 000 
3  R30 001–75 000 
4  R75 001–150 000 
5  R150 001 and above 
6  Refused to answer 
  
15. What type of housing do you live in?  1 Detached house, Semidetached 
2 Farm 
3 Flat,  Terraced flat, Apartment 
building 
4 Refused to answer 
88 Other _____________________ 
16. Has there been water damage, visible signs of 
fungus/mildew or a smell of mildew in your home in the 
past 3 months? (Fill in one or several boxes.)  
1  No 
2  Yes, water damage  
3  Yes, signs of fungus and mould 
4  Yes, a smell of mildew  
  
17. What year was this house/structure originally built?
     
____________ 
year 
99 don't know 
IF RESPONDENT IS UNSURE ASK:  
18. Would you say it was built: 
1  before 1970  
2  between 1970 and 1985  
3  after 1985 
19. How many rooms are there in your home? (counting the 
kitchen, but not the bathroom or toilet) 
 
________________rooms 
20 How long have you lived at this address?                                               
___________ years 
1 less than 1 year 
21. Is your home drinking water from the tap or from a river 
or dam? 
1  tap 
2  river or dam 
3  well 
88 other, please specify: 
 _________________________ 
22. Do any pets live in this home?   
    
1 Yes   
2  No  [If no, skip to Q24] 
23. What kind of pets live here?  
(a). a dog? 1 Yes   
2  No  
(b). a cat? 1  Yes   
2  No  
c). a bird? 1  Yes   
2  No  
(d). any other pet(s) 1  Yes   
2  No  
88  please specify: 
__________________ 
24. During the past 12 
months was a room 
heater used to heat 
one or more rooms in 
this house? 
1  Yes  
2  No [If no, skip to Q25] 
99 don't know [If don’t know, skip to 
Q25] 
(a). Was this heater fueled by  0  not applicable – no furnace 
1  paraffin 
173 
 
 
2  gas  
3  electricity  
4  wood 
5  coal 
6  Gel 
88  other, please specify: 
_________________ 
88  don’t know 
25. During the past 12 months was one or more wood 
stoves used in this house? 
1  Yes   
2  No   
99   Don’t know 
26. During the past 12 months was a fireplace used to heat 
the rooms in this house? 
1  Yes   
2  No   
99   Don’t know 
27. During the past 12 months was the stove or oven ever 
used to heat this house? 
1  Yes   
2  No   
99   Don’t know 
28. Is a stove or oven used for cooking in this house? 1  Yes   
2  No   
99   Don’t know 
(a). What is the primary source of heat for this stove or 
oven? 
1  paraffin 
2  gas  
3  electricity  
4  wood 
5  coal 
6  Gel 
88  other, please specify: 
_________________ 
99  don’t know 
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APPENDIX C:  MACE 3RD TRIMESTER QUESTIONNAIRE PART 2 
Mother and Child in the Environment (MACE) 
3RD TRIMESTER + PART 2 
 
1. Date:____/____/____ 
 Day     Month     Year 
2. Mother Identification No.    -    -    
 
Gestational Week __________________ 
 
Work and leisure  
145. What was your work situation when you became 
pregnant? (Fill on one or several boxes for each.)  
1   Student [skip to Q162] 
2   At home [skip to Q162] 
3   Intern/apprentice 
4   Military service 
5   Unemployed/laid off 
6   Rehabilitation/disabled [skip to Q162] 
7   Employed in public sector 
8   Self-employed 
9   Family member without steady income 
in family company  
10  manufacturing  
11  chemical  
12   mining  
13   commercial and retail  
14   agricultural and farming  
88  Other 
___________________________ 
 
146. What kind of work do/did you do? 1   general assistant  
2  clerical/administrative  
3  machine operator  
4   farm assistant  
5 supervisor/manager  
6  engineering, designer or planning  
88 other, please specify: ____________ 
147. Did you have an extra job (with or without salary) 
when you became pregnant? (For example, 
accountant, hair dresser, singer in a dance band, 
club leader)  
1 Yes   
2  No 
Describe: ______________________ 
148. Have you been absent from work more than two 
weeks during this pregnancy?  
1 Yes   
2  No 
149. Are you absent from your work at the present 
time?  
1 Yes   
2  No 
150. If yes, what is the reason for your absence? (Fill in 
one or several boxes.)  
1  Medical leave 
2  Leave of absence 
3   Sick child 
88   Other: 
______________________________ 
151 The usual number of paid working hours a week 
before you became pregnant and at present.  
Before the pregnancy 
hours_________________ 
During the pregnancy hours 
________________ 
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HABITS 
202. Did your mother smoke when she was pregnant with 
you?  
1 Yes   
2  No 
Don’t know 
2034. Are you exposed to passive smoking at home?  1 Yes   
2  No 
2045. If yes, how many hours a day are you exposed to 
passive smoking?  
______________ hours a day  
2056. Are you exposed to passive smoking at work?  1 Yes   
2  No 
2067. If yes, how many hours a day are you exposed to 
passive smoking?  
______________hours a day  
2078. Did the baby’s father smoke before you became 
pregnant?  
1 Yes   
2  No 
2089. Does he smoke now?  1 Yes   
2  No 
209. Have you ever smoked?  1  Yes  
2  No (proceed question 104) 
2109. Do you smoke now (after you became pregnant)?  1  No 
2  Sometimes 
3  Daily  
 (a). If yes, how many _________ cigarettes per week  
_________ cigarettes per day 
211. Did you smoke during the last 3 months before you 
became pregnant this time?  
1  No 
2  Sometimes 
3  Daily  
 (a). If yes, how many _________ cigarettes per week  
_________ cigarettes per day 
212. How old were you when you started to smoke on a 
daily basis?  
__________ years  
213. Have you stopped smoking completely?  1 Yes   
2  No 
214. If yes, how old were you when you stopped smoking?  ____________ years  
215. If you stopped smoking after you became pregnant, in 
which week of pregnancy did you stop?  
____________ week of pregnancy  
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APPENDIX D:  MACE CLINICAL DATA 3RD TRIMESTER QUESTIONNAIRE 
 
Mother and Child in the Environment (MACE) 
Clinical data @ 3rd Trimester 
 
1. Date:____/____/____ 
 Day     Month     Year 
2. Mother Identification 
No. 
     3.  Gestational week    
_______ 
 
1. Weight _______________kg 
2. Height _______________m 
3. Body Mass index  
4. Blood pressure SYS_________  DYS_________ 
5.  Urine analaysis 1   Sg 
2   pH 
3   Glucose 
4   Protein 
5   Blood 
6   Bilirubin 
7   Ketones 
8   Nitrites 
9   Urobilinogen 
10  Leucocytes 
11  None of the above 
6. Heamglobin (Hb)  
7. Iron (Fe)  
8. WR  
9. RPR        
10. Pap smear  
11.  Do you know your HIV status 1   Yes 
2   No [If No, skip to Q 19] 
3   Refused to answer 
12.  What is your status? 1   Positive 
2   Negative [If negative, skip to Q 19] 
3   Refused to answer 
13.  Do you know your CD4 count? 1   Yes 
2   No [If No, skip to Q15] 
3   Refused to answer 
14.  What is your CD4 count? _____________________ 
15.  Do you know your Viral load? 1   Yes 
2   No [If negative, skip to Q17] 
3   Refused to answer 
16.  What is your viral load? ______________________ 
17.  Are you currently on HIV treatment? 1   Yes 
2   No [If No, skip to Q 19] 
3   Refused to answer 
18.  Please list all HIV Medication ______________________________ 
______________________________ 
______________________________ 
______________________________ 
______________________________ 
______________________________ 
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19.  Have you had an ultrasound done during this 
pregnancy? 
1   Yes 
2   No [If No, skip to Q22] 
3   Refused to answer 
20.  What were the results? 1   Normal [If Normal, skip to Q22] 
2  Abnormal 
3   Refused to answer [Skip to Q22] 
21.  If abnormal, explain the ultrasound results Explain:  
22.  What is your expected delivery date? Date: 
 
23.  What type of delivery are you expecting? 1   Normal vaginal delivery 
2   Elective Ceaser 
3   Refused to answer 
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APPENDIX E:  MACE LABOUR/POSTNATAL QUESTIONNAIRE 
Mother and Child in the Environment (MACE) 
Labour/Postnatal data of Baby 
Date:____/____/____ 
        Day Month Year 
Mother Identification No.       
 
 
 Child Identification No.       
 
 
1. Date of delivery:  
_____/_____/_____   
    day        month        year 
9   Unknown 
 
 
2. Time of delivery: 
 
Time:  _ _:_ _   am/pm 
9   Unknown 
 
3. Gestational age:  
   
Weeks_____________     
9   Unknown 
4. What type of delivery occurred? 
 
1 NVD 
2 Caesarian section 
 
5.  What is the babies gender? 1 Male 
2 Female 
 
6. What is the babies birth weight?   
______________grams 
9   Unknown 
7. What is the babies birth length?   
______________cm 
9   Unknown  
 
8. What is the babies head circumference?   
______________cm 
9   Unknown  
9. What is the APGAR score? 
 
___________ 1minute 
 
___________ 5 minute 
 
10. Complications of baby  
1  Jaundice 
2  Fever  
3  Sneezing 
4  Respiratory distress  
5  Pneumonia 
6  Sepsis 
7  TB 
8  None 
88  Other 
 
__________________________________ 
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9   Unknown  
 
 
11. Was the mother on any medication during 
labour? 
1 Yes   
2  No (if no skip to Q12) 
9   Unknown  
 
 
(a) If yes, please list the medication 
 
 
Medication 1: ________________________ 
 
Medication 2: ________________________ 
 
Medication 3: ________________________. 
 
Medication 4: ________________________ 
 
Medication 5: ________________________ 
12.  Did the mother receive any of the ffg: drugs 
after labour? 
1 Yes   
2  No       (if no skip to Q13) 
9   Unknown 
(a). HAART 
 
 
1 Yes   
2  No 
9   Unknown  
(b). Vit A 
 
1 Yes   
2  No 
9   Unknown 
(c). PMTCT 
 
1 Yes   
2  No 
9   Unknown 
 
13.  Did the mother have any complications 
during labour? 
 
1 Yes   
2  No  (if no skip to Q14) 
9   Unknown  
 
(a) If yes, please list any complications 
 
_________________________________ 
 
_________________________________ 
 
 
14.  Did the baby receive any medication after 
delivery? 
1 Yes   
2  No  (if no skip to Q15) 
9   Unknown 
(a)  If yes, please list the medication. ____________________________ 
____________________________ 
____________________________ 
 
15.  Did your baby stay in nursery? 
 
1 Yes   
2  No (if no skip to Q19) 
9   Unknown 
   (a)  If yes, how long did the baby stay in 
nursery? 
 
   (b)  Did the baby receive oxygen in nursery? 
 
1 Yes   
2  No 
9   Unknown 
16.  Why was the baby admitted to nursery?   
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18.  When did he/she get discharged?  
19.  What are you feeding the baby? 1 Exclusive breastfeeding 
2 Exclusive formulae feeding 
3 Mixed feeding 
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APPENDIX F:  MACE 6 MONTH FOLLOW UP QUESTIONNAIRE 
Mother and Child in the Environment (MACE) 
6 month infant follow-up 
Date:____/____/____ 
        Day Month Year 
Mother Identification No.       
 
 
 Child Identification No.       
 
 
1. Date of Birth:  
 
_____/_____/_____   
 day   month  year 
 
 
2. Chronological age   
 
__________________months 
 
 
3. Corrected age 
 
 
__________________months 
 
4.  GA at birth 
 
 
______________weeks 
 
5.  Baby’s birth weight  
 
______________grams 
 
 
6. Baby’s birth Length 
 
_____________cm 
9   Unknown  
 
 
7. Baby’s birth OFC 
 
_____________cm 
9   Unknown  
 
8. Baby’s MUAC  
_____________cm 
9   Unknown 
 
9.  Baby’s current weight 
 
______________grams 
9   Unknown 
 
 
10. Baby’s current length(cm) 
 
 
_____________cm 
9   Unknown  
 
 
11. Baby’s current OFC (cm) 
 
______________cm 
9   Unknown  
12.  Is the baby’s Immunization up to date? 1 Yes   
2  No 
 
a) If No, why was your child not 1 Child unwell 
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immunised? 2 Mother missed visit 
3 Clinic had no stock 
4  Other_____________________________ 
 
 
13. What feeds is your baby receiving 
currently? 
1 Breastmilk 
2 Formulae 
3 Mixed feeding (breastmilk and formulae) 
4 Porridge 
a) What formulae you are feeding? 1 Nan 
2 Nan HA 
3 Infarcare 
4 S26 
5 Pelagon 
5 Isomil 
5 Lactogen 
7 Other 
b) What porridge are you feeding? 1 Nestum 
2 Ceralac 
3 Maize meal 
4 Purity 
5 Other 
_____________________________________
_____________________________________ 
c) Which month did you start 
supplementary food? 
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APPENDIX G:  MACE 12 MONTH FOLLOW UP QUESTIONNAIRE 
Mother and Child in the Environment (MACE) 
1 YEAR infant follow-up 
[To be completed by Doctor attending to patient] 
  
 
Date: :____/____/____          MID:    ____________________  CID: _____________________ 
        Day Month Year 
 
 
1. Date of Birth:  
 
_____/_____/_____   
 day   month  year 
 
 
2. Chronological age   
 
__________________months 
 
 
3. Corrected age 
 
 
__________________months 
 
4.  Baby’s birth weight  
 
______________grams 
 
 
5. Baby’s birth Length 
 
_____________cm 
9   Unknown  
 
6. Baby’s birth Head circumference 
 
_____________cm 
9   Unknown  
 
7.  Baby’s current weight 
 
______________grams 
  
 
8. Baby’s current length 
 
 
_____________cm 
 
 
9. Baby’s current OFC  
 
______________cm 
 
10.  BABY’S CURRENT MUAC 
 
_____________cm 
9   Unknown 
 
 
A) Classify MUAC 
 
1 Normal      
2 Moderate wasting 
3 Severe wasting 
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11.  Is the baby’s Immunization up to date?  
[INTERVIEWER TO CONFIRM WITH RTHC] 
 
1 Yes (If  Yes,Skip to Q 13)  
2  No 
12.  If No, why was your child not immunised? 
 
 
1 Child unwell 
2 Mother missed visit 
3 Clinic had no stock 
4  Other_____________________________ 
13.  Did your baby receive de-worming? 
 
 
1 Yes (If  Yes,Skip to Q 15)  
2  No 
 
14.  If No, why was your child not de-wormed? 
 
_____________________________________
_____________________________________
_____________________________________ 
 
15.  Did your baby receive Vitamin A? 
 
 
1 Yes (If  Yes,Skip to Q 17)  
2  No 
16.  If No, why has your child not received Vit 
      A? 
_____________________________________
_____________________________________
_____________________________________ 
 
17. What feeds is your baby receiving      
currently? 
1 Breastmilk 
2 Formulae 
3 Mixed feeding (breastmilk and formulae) 
4 Porridge 
18. What formulae you are feeding? 
 
1 Nan 
2 Nan HA 
3 Infarcare 
4 S26 
5 Pelagon 
5 Isomil 
5 Lactogen 
7 Other 
 
19. What supplementary feeds are you 
feeding? 
 
1 Veg only 
2 Meat only 
3 All foods 
4 Other 
_____________________________________
_____________________________________
_____________________________________ 
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APPENDIX H:  12 MONTH NUTRITION QUESTIONNAIRE 
Date:______/_______/_____ 
         Day     month       year 
 
MID:_______________________ 
 
CID:_______________________ 
Gender: M/F (Circle) 
1. Has the baby ever been breastfed 1 Yes    2 No  
2. Was the baby breastfed yesterday during the 
day or at night 
1 Yes    2 No  
3. Is the baby receiving any other liquids  1 Yes    2 No  
4. What other liquids did the baby have yesterday during the day or at night.    5. If YES for  B,C or D, 
ask how many times the previous day or night 
A. Plain water 1 Yes  
2 No 
 
B. Infant formula eg Infacare/ Nan 1 Yes 
2 No 
5. B.     
TIMES 
C. Fresh milk or powdered milk eg Nespray, 
Klim, Growing Up milks. NOT Cremora 
or Ellis Brown 
1 Yes  
2 No 
       C.        
TIMES 
     
D. Maas or yoghurt eg Danone. NOT Yogisip 1 Yes  
2 No 
       D.    
TIMES 
E. Rooibos or other tea 1 Yes  
2 No 
 
6. During the past month how often has the baby had the following foods or drinks: 
Food or Drink 
Never 
/once a 
month 
Twice a 
month 
Once a 
week 
2-4/ 
week 
Once a 
day 
2-
4/day 
A. 100% fruit juice       
B. Mix juice eg Fusion, 
Jumbo, Daly’s, Oros, 
Halls 
      
C. Fizzy drinks eg 
Coke, Cooee, Busta 
      
D. Sweets       
E. Crisps eg Snax, 
NikNaks, Bhamfoqo 
or slap (fried) chips, 
vetkoek/amagwinya 
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7. Please describe everything the baby ate yesterday during the day or night, whether at home or outside 
the home.                
a) Think about when the baby first woke up yesterday. Did he/she eat anything at that time? If 
YES:  Please tell me everything he/she ate at that time. PROBE: Anything else? UNTIL 
CAREGIVER SAYS NOTHING ELSE. IF NO, CONTINUE TO QUESTION b). 
b) What did the baby do after that? Did she/he eat anything at that time? If YES: Please tell me 
everything she/he ate at that time. PROBE: Anything else? UNTIL CAREGIVER SAYS 
NOTHING ELSE. 
REPEAT QUESTION b) UNTIL CAREGIVER SAYS CHILD WENT TO SLEEP UNTIL THE 
NEXT DAY. 
IF CAREGIVER MENTIONS MIXED DISHES LIKE SAUCE OR STEW/CURRY, PROBE:  
What ingredients were in that mixed dish? PROBE: Anything else? 
AS THE CAREGIVER RECALLS FOODS, UNDERLINE THE FOOD IN THE TABLE BELOW 
AND CIRCLE 1 IN THE COLUMN NEXT TO THE FOOD GROUP. IF THE FOOD IS NOT 
LISTED IN ANY OF THE FOOD GROUPS BELOW, WRITE THE FOOD IN THE ‘OTHER 
FOODS’ BOX. 
 
ONCE THE CAREGIVER FINISHES RECALLING FOODS EATEN, READ EACH FOOD 
GROUP WHERE 1 WAS NOT CIRCLED. ASK THE FOLLOWING QUESTION, CIRCLE ‘1’ 
FOR YES AND ‘2’ FOR NO: 
Yesterday during the day or night did the baby eat/drink any (FOOD GROUP ITEMS)? 
OTHER FOODS: PLEASE WRITE DOWN FOODS THAT ARE MENTIONED BUT ARE NOT ON 
THE LIST BELOW: 
 
 
NO
. 
FOOD GROUPS CODING CATEGORIES 
   YES NO 
A Porridge, Phuthu, Samp, bread, rice, pasta, ijeqe, noodles  1 2 
B Infant cereal eg Purity cereal, Nestum, Cerelac etc  1 2 
C Potato, white fleshed sweet potato,amadumbe  1 2 
D Pumpkin, butternut, orange fleshed sweet potato, carrots  1 2 
E Dark green leafy vegetables eg Spinach, imifino  1 2 
F Ripe mangoes , pawpaws  1 2 
G Any other fruit or vegetables  1 2 
H Liver, kidney, heart, or other organ meats  1 2 
I Beef, lamb, pork, chicken or fish  1 2 
J Polony or Vienna sausages  1 2 
K Eggs  1 2 
L Dried beans (Ubhontshisi) or peanut butter  1 2 
M  Cheese, maas or yoghurt  1 2 
N Oil or margarine  1 2 
O Purity Jar foods . Flavour_____________  1 2 
 
8. How many times did the baby eat solid, semi solid, or soft foods other than 
liquids yesterday during the day or at night? 
 TIMES 
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APPENDIX J:  KZN DEPARTMENT OF HEALTH APPROVAL
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APPENDIX K:  MACE CONSENT FORM 
a) The Mother and child in the Environment (MACE cohort)Consent Form  
 
Mother Identification no.______________________________ 
 
1. Title of research project 
 Mother and Child in the Environment 
 
2. Purpose of the research 
The University of KwaZulu-Natal, Department of Occupational and Environmental Health is 
conducting this study of the health effects of air pollution in the eThekwini municipality. In this 
study we want to learn whether pollution has an effect on the unborn child, and whether these 
effects are likely to create health problems for the child has he or she grows.  The study has 
the support of the local industry, community groups concerned about these sorts of health 
problems, and the City Health Department.  We are studying this community because of its 
location near sources of air pollutants such as oil refineries and because of health concerns 
expressed by teachers and students at schools and by the larger community.  The purpose of 
the study is to figure out whether any health problems are being caused by air pollution in the 
community, its effect on pregnant mothers and the unborn child, and, if so, to make 
recommendations to improve the situation. 
 
3. Description of the research project 
 If you agree to participate, you will be interviewed during your pregnancy, and we will ask you 
to provide us with blood samples while you are pregnant. We will do a home visit during the 
pregnancy and conduct indoor air assessments in your home.  We will also ask you to allow us 
to take a sample of blood from the birth cord after the delivery of your child, and for permission 
to take a spot of blood from your newborn baby and follow-up the baby until 5 years old.  
 
Interviews: You will be interviewed by a trained interviewer from our research team. This 
interview will be done at the clinic, in the complete privacy of one of the consulting rooms at the 
clinic. You can choose the language in which you will prefer to be interviewed. During the course 
of this interview you will be asked many questions about your pregnancy, diet, work exposures 
etc. You may refuse to answer any questions that you feel uncomfortable about answering. If 
during the course of the interview, you wish to stop and continue at a later stage, you may do 
so. 
 
Blood tests: Trained medical staff will take samples of blood from you. This blood will be 
analysed for your body’s reaction to external environmental factors (referred to as “oxidative 
stress”), assessing your allergy status and potential, vitamin analysis and genetic analysis will 
be done on the blood prenatally.  4 Tablespoons of blood will be taken during your pregnancy.  
A home visit to assess indoor air quality will be done twice during the study period.  You will be 
informed prior to these visits.  Similarly, a sample of blood will be taken from the umbilical cord, 
once this is removed after the birth of your child and a heel prick will be done on your baby 
within 6 days of birth. These tests will then be repeated. Only these specified tests will be 
conducted on this blood sample. We will store a sample of your DNA so that we can check for 
new genes that are discovered in the future that might make your child more likely to develop 
lung conditions such as asthma. The total amount of blood taken will not exceed more than four 
tablespoons. YOU WILL NOT BE INJECTED WITH ANY SUBSTANCE/MEDICATION.  
 
During the 5 year follow-up period we will assess your child at different time points where lung 
functions tests will be performed and blood samples will be taken. However you will be informed 
in advance when this will occur. 
 
4.  Confidentiality of information collected 
The interview and blood test information we collect about you is completely confidential and will 
never be seen by anyone other than the personnel conducting the study without your written 
consent.  The results of the overall study, which will be made available to the local government 
and the community, will presented so as to protect the identity of individual participants. 
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5. Risks and discomforts of the research 
There are no risks from the interviews and the blood tests. 
 
 
6. Expected benefits to you and to others 
You will be given a written copy of all your test results along with an explanation of what they 
mean.  You may wish to show these to your doctor if you are having any problems.  If problems 
are found in the community, we may be able to make specific recommendations about air 
pollution to improve the situation.  What we learn from this study may help to protect people in 
South Africa and other parts of the world from problems caused by air pollution.  
 
7. Costs to you resulting from participation in the study 
The study is offered at no cost to you.  In the event a problem is discovered and you wish to be 
seen by a doctor for it, we can recommend to you who to see.  However, the study cannot pay 
for these additional medical visits or treatments. 
 
8. Voluntary nature of participation 
You are free to decline to participate or to withdraw from the study at any time without suffering 
any penalty or disadvantage. 
 
9. Contact person.   
You may contact the Project Manager, Kareshma Asharam (telephone no. 031-2604523 or the 
Principal Investigator of the study Dr Rajen Naidoo (telephone no: 031 260 4385) for answers 
to further questions about the research. For reporting of complaints/problems, you may contact 
the Biomedical Research Ethics Committee, whose details are shown below: 
 
Contact details of BREC Administrator or Chair –  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal  
Research Office, Westville Campus  
Govan Mbeki Building  
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: 27 31 2604769 - Fax: 27 31 2604609  
Email: BREC@ukzn.ac.za 
10. Consent of the participant 
 I have read the information given above, or it has been read to me.  I understand the meaning 
of this information, Dr./Mr./Ms. 
________________________________________________________ 
has offered to answer any questions concerning the study.  By signing this form, I hereby 
consent to participate in the study.  I also understand that I am free to withdraw from the study 
at any time without penalty. 
 
11. Documentation of the consent 
 One copy of this signed document will be kept together with our research records for this study. 
A copy of the information sheet about the study will be given to you to keep. 
 
 
 __________________________________  _____________________________ 
 Printed name of participant    Signature, Mark, or Thumb Print  
 
 
__________________________________ 
 ______________________________ 
 Interviewer’s name (Print)    Signature 
 
 DATE: ____________________ 
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b) The Mother and Child in the Environment Study 
Informed Consent: Genetic Study (Mother and baby) 
 
MID::  ____________________________   
 
If you do not understand any part of this document, please ask for an explanation from a member 
of the study team before giving consent 
 
Your consent is required so that you and your baby can participate in a research study conducted by 
the Discipline of Occupational and Environmental Health, at the University of KwaZulu-Natal. We are 
investigating genetic influences on the health effects of environmental pollution. This may reveal 
information about improving the health of children living in polluted areas.  
 
I hereby consent to donate a small quantity (5mls) of my babies cord blood at delivery and a heel prick 
to be done on my baby that will to be used in this project. This will be taken by trained medical staff and 
has minimal risks to us both. 
 
I am aware that the genetic information arising from this project will not be used for any discriminatory 
purpose. I am aware that the results and information that is collected from my baby and I will remain 
completely confidential. The overall results of the project will be made available to the community but 
my name and identity will be protected and not revealed.  I know that this study is done at no cost to 
me. 
 
I am aware that the biological samples taken during this study will be stored at the Department of 
Medical Biochemistry at the Nelson R Mandela Medical and may be used for future genetic research. 
This research will restricted to respiratory and other health effects linked to air pollution. 
 
I am also aware that should I change my mind, this consent can be withdrawn at any time without 
suffering any penalty or disadvantages.   
 
Consent: I have read and understood the meaning of this form. 
Dr./Mr./Ms. ________________________________________________________ has offered to 
answer any questions concerning the study.  I hereby consent to participating in the study.   
Documentation of the consent.  One copy of this document will be kept together with our research 
records on this study. A second copy will be given to you to keep. 
 
Contact person.  You may contact Project Manager, Kareshma Asharam (telephone no. 031-2604523 
or the Principal Investigator of the study Dr Rajen Naidoo (telephone no: 031 260 4385) for answers to 
further questions about the research. For reporting of complaints/problems, you may contact the 
Biomedical Research Ethics Committee, whose details are shown below: 
 
Contact details of BREC Administrator or Chair –  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal  
Research Office, Westville Campus  
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: 27 31 2604769 - Fax: 27 31 2604609  
Email: BREC@ukzn.ac.za 
________________________ _____   ___________________________ 
Printed name of participant    Signature 
 
______________________________               ___________________________ 
Interviewer’s name (Print)                  Signature 
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c) The Mother and Child in the Environment Study 
Storage of Genetic Samples (Mother and baby) 
MID:___________________________ 
 
If you do not understand any part of this document, please ask for an explanation from a member of the 
study team before giving consent 
 
I am aware that my and my baby’s genetic material will be securely stored at the Department of Medical 
Biochemistry at the Nelson R Mandela Medical (UKZN) and used in future research. The genetic 
material collected from me and my baby will be used for the purpose of respiratory related research 
only by members of the study team.  I am aware that my and my baby’s genetic material will be stored 
for a maximum period of 5 years after which it will be destroyed and disposed using methods of medical 
waste disposal. 
 
For future genetic research, please sign one of the two clauses below. 
 
Should the analysis of my or my baby’s genetic material result in financial gain / probability of financial 
gain for the researchers concerned, 
 
1.1.  I hereby waive (give up) my right to being informed of the results of such research and 
accompanying financial gain / probability of financial gain which may arise from such research, 
and forfeit (give up) any legal claim to such genetic material and any financial benefit which 
may arise from research on such material. By doing so, I do not waive my rights to confidentiality 
related to the research on, and subsequent publication of, (if any), such material. 
 
Signed __________________________________ OR 
1.2. I hereby declare my intention to being informed of the results of such research and do not waive 
(give up) my rights to such genetic material and any financial benefit which arise / may arise 
from research on such material. By doing so, I do not waive (give up) my rights to confidentiality 
related to the research on, and subsequent publication of (if any), such material.   
 
 Signed ___________________________________ 
 
I am ensured privacy and confidentiality in the recording, storage and release of any future research 
resulting from use of my and my baby’s genetic material. No predictive disease tests on stored samples 
may be linked to me without my consent. I am also aware that should I change my mind, this consent 
for storage of genetic material can be withdrawn at any time without suffering any penalty or 
disadvantages.   
I have read and understood  this form. 
Dr./Mr./Ms. ________________________________________________________ has offered to 
answer any questions concerning the study.  I hereby consent to participating in the study.   
Documentation of the consent.  One copy of this document will be kept together with our research 
records on this study. A second copy will be given to you to keep. 
Contact person.  You may contact Project Manager, Kareshma Asharam (telephone no. 031-2604523 
or the Principal Investigator of the study Dr Rajen Naidoo (telephone no: 031 260 4385) for answers to 
further questions about the research. For reporting of complaints/problems, you may contact the 
Biomedical Research Ethics Committee, whose details are shown below: 
Contact details of BREC Administrator or Chair –  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal   Research Office, Westville Campus  
Govan Mbeki Building   Private Bag X 54001, Durban, 4000 KwaZulu-Natal, SOUTH 
AFRICA   
Tel: 27 31 2604769 - Fax: 27 31 2604609  Email: BREC@ukzn.ac.za 
______________________ ______   ___________________________ 
Printed name of participant    Signature 
 
______________________________               ___________________________ 
Interviewer’s name (Print)                Signature 
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APPENDIX L:  MSc DIETETICS BREC APPROVAL 
 
